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In the development of new medicinal products, poor oral bioavailability, due to the low
solubilities of many active pharmaceutical ingredients (APIs), is increasingly a barrier for
treatments to be administered using tablet or capsule formulations and one of the main
challenges facing the pharmaceutical industry. Non-crystalline phases such as the amor-
phous and nanostructured states can confer increased solubility to a drug, and therefore,
have recently garnered a lot of interest from pharmaceutical researchers. However, little is
known about local ordering in non-crystalline pharmaceuticals due to the lack of reliable
experimental probes, hindering the clinical application of these compounds. The power-
ful tools of crystallography begin to lose their potency for structures on the nanoscale;
conventional X-ray powder diraction (XRPD) patterns become broad and featureless in
these cases and are not useful for dierentiating between dierent local molecular packing
arrangements.
In this thesis, we introduce the use of high energy X-rays coupled with total scatter-
ing pair distribution function (TSPDF) and ngerprinting analysis to investigate the local
structures of non-crystalline pharmaceutical compounds. The high energy X-rays allow us
to experimentally collect diuse scattering intensities, which contain information about a
sample's local ordering, in addition to the Bragg scattering available in conventional XRPD
experiments, while the TSPDF allows us to view the intra- and inter-molecular correlations
in real space.
The goal of this study was to address some fundamental problems involving ngerprint-
ing non-crystalline APIs using TSPDF in order to lay the groundwork for the proper use
of the technique by the pharmaceutical community. We achieved this by developing the
methodology as well as the exploring the scientic implications. On the methodology side,
we introduced PDFGetX3, a new software program for calculating TSPDFs that simplies
the procedure and reduces user interaction. We also set a baseline for the minimum X-ray
energy that is needed for ngerprinting analysis, which had implications on the type of X-ray
diractometers that can be used. On the science side, we investigated the local structures of
nanocrystalline and amorphous materials as well mixtures containing crystalline and amor-
phous phases. First, we identied a non-crystalline sample of the mood-stabilizing drug
carbamazepine as a nanocrystalline version of one of its polymorphs. Next, we found that
amorphous forms created by spray drying and cryomilling a proprietary compound have
the same local structure. Finally, we quantied the phase fractions of polymorphic and
amorphous components in a sample of the antibiotic sulfamerazine that was recrystallizing
from a cryomilling-induced amorphous state.
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Chapter 1
Introduction to the Pair
Distribution Function
Our natural curiosity has motivated us, throughout the ages, to study the properties of the
world, as the Roman poet Virgil (70 - 19 BCE) wrote, \Happy is he who gets to know the
reasons for things". Until the late 19th century, light was used to probe the world around
us - rst via macroscopic observation, and later with the microscope [Hooke, 1665]. The
optical microscope, though, is resolution limited. Since it uses visible light as a probe, it
is unable to discern features that are smaller in size than the wavelength of light, roughly
400 nm. For this reason, it is dicult to overstate the importance of Rontgen's discovery
in 1895 of the X-ray [Stanton, 1896].
X-rays, like visible light, are electromagnetic radiation. However, the wavelength of X-
rays is several orders of magnitude shorter than visible light. Although X-ray wavelengths
can be as long as 10 nm, the X-rays that are relevant to this thesis are in the range of
0.01-0.15 nm, or 0.1-1.5 A [Guinier, 1963].
X-rays have become ubiquitous in modern society. Initially, they were used for med-
ical applications such as imaging bone, owing to the fact that X-rays pass through skin
and esh but are absorbed by bones [Pasveer, 1989]. In additional to the medical appli-
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cations, thanks to the pioneering work of Bragg [Bragg and Bragg, 1913], Ewald [Ewald,
1921], Laue [Friedrich et al., 1913], Compton [Compton, 1923], and many others, X-ray
crystallography has become an indispensable tool in the laboratory owing to the fact that
X-ray wavelengths are roughly on the same scale the distances between atoms. These
days, X-rays are frequently used to characterize inorganic compounds such as ceramics and
metals [Warren, 1990], and organic compounds like small molecules [Lowes et al., 1987],
polymers [Cullity and Stock, 2001], and proteins [Frauenfelder et al., 1979].
1.1 Experimental Basics
This thesis assumes that the reader has a basic understanding of the main ideas of X-
ray diraction and crystallography, such as Bragg's Law, reciprocal space, and the Ewald
sphere. A full treatment of these concepts is available elsewhere [Schwartz and Cohen, 1987;
Cullity and Stock, 2001; Warren, 1990]. We will instead focus on the foundations of the
pair distribution function (PDF).
X-ray diraction experiments can be performed on single crystal and powder samples.
For our discussions here, we will focus on X-ray powder diraction (XRPD). In a typical
XRPD experiment, a beam of X-rays with a known energy and wavelength is directed
at the sample, whose atoms scatter the beam at some scattering angle, 2. A detector
measures the intensity of the scattered beam as a function of the scattering angle and the
scientist uses these data to study the structure of the sample [Egami and Billinge, 2003]. The
technique we discuss here is often referred to as total scattering to highlight the fact that the
intensities collected at the detector include not just elastic Bragg scattering, but also elastic
diuse scattering and inelastic scattering and all of reciprocal space is measured [Egami and
Billinge, 2003]. Diuse scattering, which occurs in disordered materials where diracted
intensities can be observed in all directions [Dinnebier and Billinge, 2008], is particularly
important in the study of amorphous and nanostructured pharmaceuticals and will be
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discussed later.
For elastic scattering, if we dene the incident wavevector as ~ki and the scattered
wavevector as ~kf , then the dierence between the two is
~Q = ~ki   ~kf (1.1)
where ~Q is the so-called momentum transfer or diraction vector. Since momentum is
conserved, k = j~kij = j~kf j = 2 . Thus, Equation (1.1) becomes
Q = jQj = 2k sin() = 4 sin()

(1.2)
where  is half of the scattering angle and  is the wavelength of the X-rays, which is depen-
dent on the energy of the X-rays used in the experiment and is a known quantity [Egami
and Billinge, 2003].
Excellent formal derivations of the PDF from rst principles are readily available [Farrow
and Billinge, 2009; Egami and Billinge, 2003; Dinnebier and Billinge, 2008], Farrow in
particular does a thorough analysis, and will not be re-derived in full detail here. However,
Sections 1.3- 1.6 do provide a high level outline of the PDF derivation. First, though, we
introduce the total scattering experiment.
1.1.1 Detectors
As mentioned previously, the detector measures the intensity of the scattered beam of X-rays
as a function of the scattering angle. Generally, either 1-dimensional point detectors or 2-
dimensional linear or image plate area detectors are used [Chupas et al., 2003]. 1-D detectors
are often used in laboratory-based X-ray diractometers. Generally, they move along a xed
axis in an arc collecting data at pre-specied values of the scattering angle, 2. Since it is
possible to dene the values of 2 at which measurements should occur, 1-D detectors can
collect high resolution data. However, this also makes them slow. 2-D detectors are used
at synchrotrons and in some lab-based diractometers. 2-D linear detectors are detector
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strips in an arc around the sample, while 2-D image plates are rectangular detectors are
located perpendicular to the incident X-ray beam at some known distance away from the
sample. Both types of 2-D detectors are able to catch X-rays from many scattering angles
at once, thereby making collection time relatively quick [Chupas et al., 2003]. However,
2-D detectors can be resolution limited depending on the pixel size of the image plate. The
experiments discussed in this thesis, unless otherwise stated, were performed with 2-D area
detectors.
In an XRPD experiment, the scattered X-rays appear on the 2-D detector as rings known
as Debye-Scherrer rings. For an ideal powder, by which we mean the grains are suciently
small relative to the X-ray beam and randomly oriented, the intensity around the ring is
uniform [Dinnebier and Billinge, 2008]. A typical Debye-Scherrer ring pattern of a ne
crystalline powder is in Figure 1.1. The distance of each ring from the origin can be related
to the scattering angle, 2, because the distance from the sample to the detector is known.
Software, such as Fit2D [Hammersley, 1998], can be used to integrate the intensities of the
rings as a function of 2, as we see in Figure 1.2.
We note that in Figure 1.1 intensity of the rings (i.e. brightness) drops o with increasing
2. This is due to the behavior of the atomic scattering factor, f(Q), and the Debye-Waller
factor, both of which will be discussed later.
The XRPD pattern in Figure 1.2 was created from data collected using a 2-D image
plate detector at a synchrotron, but a similar plot of intensity as a function of 2 could be
created using a 1-D detector.
1.2 Data Analysis
The rst step to transforming an experimental dataset into a PDF is to convert from 2-
space into Q-space [Egami and Billinge, 2003]. If we assume that the sample is isotropic,
only the magnitude of Q, and not the direction, is important [Billinge, 2008a]. Since the
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Figure 1.1: Debye-Scherrer ring pattern from a powder.






















Figure 1.2: XRPD pattern from integrating rings of a Debye-Scherrer pattern.
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wavelength of the X-rays is known, Equation (1.2) is used for the conversion, where  is
half the scattering angle, 22 , and  is the wavelength of the X-ray. Here we note that
since sin()  1, the maximum Q accessible in an experiment strongly depends on . For
example, a copper K diractometer, which is widely used in the laboratory environment,
has  = 1:54 A, so its available Qmax  8 A 1. On the other hand, a synchrotron used
for PDF analysis, which can produce X-rays with wavelength on the order of   0:1 A 1,
is capable of Qmax  45 A 1 [Petkov et al., 1999; I.-K. Jeong et al., 2001]. As we will see
throughout this chapter and in Chapter 6, the Qmax is a very important parameter because
it aects the resolution of the PDF.
The experimentally collected intensities, Iexp(Q), like those in Figure 1.2, consist of
several components [Egami and Billinge, 2003]:
Iexp(Q) = IC(Q) + II(Q) + IMC(Q) + IBG(Q) (1.3)
where IC(Q) is the coherent scattering intensity, II(Q) is the incoherent scattering intensity,
IMC(Q) is the multiple-scattering intensity, and IBG(Q) is the background scattering inten-
sity [Egami and Billinge, 2003]. The incoherent scattering occurs when there is no phase re-
lationship between the scattered waves, meaning that it does not contain structural informa-
tion. Multiple scattering occurs when X-rays are re-scattered within the sample. Also, the
sample container (i.e. a capillary), can contribute to the multiple scattering. Background
scattering can be due to the sample container or the environment [Egami and Billinge, 2003;
Chupas et al., 2003].
Structural information is in the coherent scattering intensity, IC(Q). Therefore, before
we can use experimental data for analysis, we must correct the Iexp(Q) by removing incoher-
ent scattering, multiple scattering, and background scattering components. The background
scattering correction is performed by collecting data on only the sample container and then
subtracting them from the total experimental data. For instance, if the sample was loaded
in a capillary, then data would be collected on an empty capillary. Background data can
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also be collected on the sample environment, (i.e. air). Depending on collection time and
ux, the background data might need to be scaled prior to subtraction. Corrections for
multiple scattering and incoherent scattering have typically been calculated by software
such as PDFGetX2 [Qiu et al., 2004]. These corrections will be discussed in greater detail
in Chapter 3.
Sections 1.3- 1.6 oer an analytical derivation of the PDF starting from the denition
of the coherent scattering cross section. Although the derivation is not necessary for an
understanding of PDF, it does provide deep insight into the technique.
1.3 Coherent Scattering Intensity
First, we introduce the concept of the coherent scattering cross section, dCd
 where C is
the coherent cross section and d
 is a solid angle. The coherent scattering cross section,
which has units of area, is the probability of a particle being scattered into some solid angle
element d
. It can be thought of as the area around a single atom that would scatter
an incident X-ray photon with some given solid angle relative to the detector [Egami and
Billinge, 2003]. In other words it is the probability per single atom that it will coherently
scatter in some known direction.
After the coherent scattering intensity is corrected for absorption, polarization, and
incident ux, which will be discussed later, we nd that it is actually the same as the
coherent scattering cross section [Egami and Billinge, 2003]. Therefore, we want to use the
denition of the coherent scattering cross section above to nd an expression for the coherent
scattering intensity, IC(Q). A much more complete treatment of the following derivations
is available in books [Egami and Billinge, 2003; Billinge, 2008a] and a paper [Farrow and
Billinge, 2009], although here we try to explain important parts in an easy to understand,
qualitative way.
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where 	(Q) is the wavefunction of the scattered wave, f(Q) is the atomic scattering factor
for X-rays, i is the imaginary number, Q is the momentum transfer, R is the position of
the -th atom, and we sum over all atoms.




= hV i2j	(Q)j2 (1.5)
where hV i is the average scattering potential of an atom. In our case, hV i = hf(Q)i,
where f(Q) is the aforementioned atomic scattering factor and h:::i is a compositional
average [Egami and Billinge, 2003]. We can imagine hf(Q)i and hf(Q)i2 to be the amplitude
and the intensity of a solitary photon scattered by one atom in a material, respectively. In
other words, the hf(Q)i2 is the average scattering power per atom [Billinge, 2008a]. The
behavior and shape of the atomic scattering factor will be discussed in more depth later,






where f represents the complex conjugate of the atomic scattering factor, N is the total
number of atoms, and we sum across all atom pairs. From here onward, we simplify the no-
tation by not always mentioning the Q dependence of f , although it is obviously dependent
on Q throughout the derivation.
When we square the wavefunction of the scattering amplitude and the atomic scattering
factor, we have to take the complex conjugate. Therefore, substituting Equations (1.4)
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As mentioned previously, the measured coherent scattering intensity, IC(Q) is related
to the dCd
 modied by the absorption and polarization factors, A and P respectively. We















In Equation (1.10) we dened a new function, IcorrC (Q) which is the coherent scattering
cross section corrected for the absorption and polarization factors, A and P , respectively. We
dened this new function because we do not want to carry the A and P through the rest of
the derivations and also to stay consistent with the notation introduced in Equation (1.3).
We still need to keep in mind, though, throughout the rest of this derivation that the
absorption and polarization corrections are important for obtaining a proper IC(Q).
Finally, we account for self-scattering where i = j (i.e. the same atom), and so














where N is the total number of atoms.
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1.4 The Total Scattering Structure Function
We now have isolated the coherent scattering intensity, IC(Q), but we cannot use it directly
to study structures. Instead, we prefer to work with a normalized version of the scattering
intensity. We normalize it by dividing by the number of atoms, N , and the average scattering
per atom, hfi2, this is important for the high-Q behavior of the structure function that we






























We dene the quantity in Equation (1.16) as S(Q)   1 where S(Q) is the total scat-
tering structure function, or just structure function for short [Egami and Billinge, 2003].
Substituting this into Equation (1.16)









Finally, we pull out the N by dening I(Q) = IcorrC (Q)=N , which also means that




The S(Q) is the normalized scattering intensity from a sample, it includes both Bragg
and diuse scattering [Egami and Billinge, 2003]. In general, we assume that scattering from
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Figure 1.3: Example of a typical S(Q). Created from the I(Q) data in Figure 1.2. Note
the Bragg scattering at low-to-mid Q and diuse scattering at high Q.
a powder is isotropic, and depends on the magnitude of the wavevector, not the direction.
To cement this point, we will no longer use the vector notation for Q. A typical-looking
S(Q), created from the I(Q) data in Figure 1.2 is in Figure 1.3.
1.4.1 Properties of the Structure Function
The S(Q) has a few interesting features that we would like to briey touch on, using
Figure 1.3 as a reference. First, we note that the function oscillates around 1, and, in fact,
the average value hS(Q)i = 1 [Billinge, 2008a]. The behavior of S(Q) as Q ! 1 is an
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important phenomenon that will be discussed later. Also, we see the intensity of peaks
decreases at higher values of Q. This is due to the Debye-Waller factor, which reduces
intensities of Bragg scattering due the thermal motions of atoms [I.-K. Jeong et al., 1999].
Finally, we note that the S(Q) contains both Bragg intensities, in the form of sharp peaks
in the Q-range up to about 12 A 1 and broad, diuse intensities in the Q-range 12-16 A 1.
The Qmax value, 16 A
 1, was not arbitrarily chosen. In fact, the Qmax is a very important
parameter in data processing, which will be discussed in detail later. In general, we want to
have a high Qmax [Dykhne et al., 2011], which is why we prefer to use high-energy XRPD
instruments such as synchrotrons. However, we need to be cognizant of the fact that noise
in the data collection has a strong eect at high Q because the hfi2 (by which we divided the
IcorrC (Q)) amplies oscillations in the signal because it approaches 0 at high Q. Therefore,
long collection times or high X-ray ux might be necessary for good signal-to-noise ratio.
1.5 Reduced Structure Function
In practice, for reasons that will become obvious below in Section 1.6, we prefer to discuss
total scattering data in terms of the so-called reduced structure function, F (Q), as described
in Equation (1.20):
F (Q) = Q(S(Q)  1) (1.20)
As we see in equation (1.20), the transformation between S(Q) and F (Q) is trivial, and
indeed all of the structural information present in one is present in the other. Figure 1.4
contains a plot of the F (Q) corresponding to the S(Q) of the data in Figure 1.3.
As expected from Equation (1.20), the F (Q) is centered around 0 and hF (Q)i = 0.
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Figure 1.4: Example of a typical F (Q). Created from the S(Q) data in Figure 1.3.
1.6 Pair Distribution Function
Finally, we are ready to introduce three avors of the pair distribution function - the atomic
pair distribution function, g(r), the reduced pair distribution function, G(r), and the radial
distribution function, R(r). Luckily, the sine Fourier transform of the normalized scattered
intensity, S(Q), leads us directly to the all three functions [Egami and Billinge, 2003]. We
use the sine transform because the S(Q) is an even function [Farrow and Billinge, 2009].




Q[S(Q)  1] sin(Qr)dQ (1.21)
R(r) = 4r20g(r) (1.22)






F (Q) sin(Qr)dQ (1.23)
where 0 is the average number density of the material (i.e. the number of atoms per
unit cell). It is easy to transform between the g(r), G(r), and R(r) by simply adding and
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multiplying constants.
From Equation (1.23), we instantly see the reasoning behind the introduction of the
F (Q) in Equation (1.20) - although the F (Q) in and of itself does not provide any new
structural information, it is nonetheless the function that we Fourier transform, so it makes
sense in practice to work with it.
The g(r) is, in eect, a histogram of the atom-atom distances in a material [Egami and
Billinge, 2003]. It gives the probability of nding two atoms separated by some distance
r inside of the sample. Each of the peaks in the PDF can be attributed to an atom-atom
correlation, and the relative intensities of the peaks is related to how many such correlations
are in the sample, meaning that taller peaks correspond to more atoms that distance apart
in the sample.
We introduced the R(r) in Equation (1.22) mostly for completeness and illustrative
purposes. The RDF is rarely used in our analysis because it diverges like r2, so the data
are dicult to analyze when plotted [Egami and Billinge, 2003]. However, the RDF is the
most physically intuitive of the correlation functions [Egami and Billinge, 2003] because it
gives the number of atoms in an annulus of thickness dr at distance r from another atom,
as shown in Figure 1.5, which illustrates an idealized R(r) (right panel) for one atom at the
origin of a two dimensional lattice (left panel, represented by a red `x'). The closest atoms
to the origin are the four atoms which are 2 A away, as marked by the red circle in the left
panel of Figure 1.5. The RDF, in response, has a peak at 2 A. Going a bit further out, the
next nearest neighbors also happen to be four atoms, now at a distance of 2
p
2  2:8 A
from the origin. We note that both peaks in the RDF have the same relative height, given
that they correspond to the same number of atom pairs. Four more atoms are found 4 A
from the origin, and so we see another peak of the same height as the previous two. The
next peak is at 2
p
5  4:47 A from the origin. However, in this case, we note that the circle
hits eight atoms, and, accordingly, the peak in the RDF is twice as tall as the previous
peaks. This is an idealized case. In reality, the background of the RDF would be increasing
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Figure 1.5: Idealized schematic of a radial distribution function. The rings in the left panel
correspond to peaks at various r distances away from the origin in the right panel [Billinge,
2007].
as r2 instead of being constant at 0.
The process of calculating partial PDFs or RDFs from atom-atom correlations, as above,
is repeated for each atom in the structure [Billinge, 2007]. In this case, since all atoms are
separated by exactly 2 A, they would each provide the same partial PDF. However, in a
real material atoms can have dierent neighborhoods. Also, if a sample contains multiple
components, then peak height is also correlated to the scattering power of dierent species
of atom [Billinge, 2007].
In Equation (1.21) we dened both the atomic pair distribution function, g(r) and the
reduced pair distribution function, G(r). The two functions contain the same structural
information about the compound, and are eectively dierent by a factor of 40. From
Equation (1.21) we see that, as r ! 0, g(r)! 0 while G(r)!  40 [Egami and Billinge,
2003]. In general, we nd that, the G(r) has a background of a straight line with slope
 40 at low r. Although, in this sense, the G(r) is less physically intuitive, it is still the
PDF function that is the most widely used [Egami and Billinge, 2003] for two reasons. The
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rst reason, as per Equation (1.21), is that the G(r) is the direct Fourier transformation
of the S(Q). No additional information is necessary to convert between the two functions.
The number density, 0, is needed in order to obtain the g(r). Of course, even though
this value could be calculated if the crystal structure is known, or even estimated from the
G(r), it is still much easier and more philosophically satisfying to do the transformation
with no additional a-priori knowledge. The second reason, which is a little bit more subtle,
is that in the g(r) the amplitudes of oscillations containing structural information fall o
like 1=r [Egami and Billinge, 2003]. This means that uncertainties in the low-r region are
more heavily weighted than the high-r region. In the G(r), the uncertainties in the data are
constant in r, so all of the data are equally weighted. This result becomes very important
when trying to t a model to the PDF or ngerprint the PDF against other PDFs. For these
reasons, from this point onward, when we discuss the PDF, we are exclusively referring to
the G(r).
At this point, we want to dierentiate between normal PDFs and total scattering PDFs
(TSPDFs). In principle, both functions have the same theoretical underpinning and are
processed in the same manner with the TSPDF accessing a larger range of Q. However,
as we will see in Chapters 5 and 6, a large Q-range, beyond what is accessible to copper-
based laboratory diractometers is needed in order to positively ngerprint pharmaceutical
compounds. Therefore, for the rest of this thesis, we will specically refer to PDFs made
with Qmax  8:5 A 1 as TSPDFs.
A real TSPDF, from the experimental data in Figure 1.4 is in Figure 1.6. This TSPDF
is actually of the over-the-counter drug Tylenol R (which mostly consists of the active
ingredient acetaminophen) that had been ground up into a powder and measured at the
synchrotron (we will discuss this TSPDF in great detail in Chapter 9). First, we note that
this TSPDF of a 'real' compound is much more complicated than the idealized RDF in
Figure 1.5 (of course it's also a slightly dierent function). In general, it is dicult to
get an understanding for a whole structure by simply observing a PDF. However, we can
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Figure 1.6: Example of a G(r) of a pharmaceutical compound, in this case of Tylenol R.
Created from the F (Q) data in Figure 1.4. The dashed line represents the background with
slope  40.
still visually observe some key features in Figure 1.6. For instance, the two most intense
peaks are at 1.4 A and 2.4 A. These distances correspond to nearest and next-nearest
neighbor carbon atoms in a carbon ring, and these features will be present in all carbon-
based pharmaceutical compounds. As discussed earlier, we also note the linear baseline
slope at low values of r as represented by the dashed line. The baseline should touch the
bottoms of the rst few peaks in the TSPDF. In this case, it slightly overshoots the bottom
of the peak at 1.07 A and just misses the bottom of the peak at 2.7 A, but it is quite close.
The peak at 1.9 A, as we discuss below, is a termination ripple.
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Unlike the Q-range and Qmax which have profound eects on the quality of a PDF,
any range of r can be used, although the signal will naturally die out at some point due to
the Debye-Waller factor. In Figure 1.6, we have set the rmax to be 20 A, but this was an
arbitrary decision and other values could have been used. In practice, though, since PDF
if used to study local structure, r-ranges of 20 A to 30 A are used in the literature.
Peak broadness also plays an important role in the PDF. Theoretically, if there was no
atomic disorder, then peaks would simply be delta functions [Egami and Billinge, 2003].
However, atomic disorder in the form of the thermal motion of atoms and static displacement
of atoms away from ideal lattice sites in the case of crystalline materials results in a distribu-
tion of atom-atom distances and broadens the peaks into Gaussian distributions [Billinge,
2008a]. As we will see later, the eects of thermal motion and static displacement be-
come important when dealing with disordered materials such as amorphous pharmaceutical
compounds.
Not every single oscillation in a PDF carries structural information. For instance, in
Figure 1.6 we see a very small peak at 1.9 A, between the rst two tall peaks at 1.4 A and
2.4 A. This peak is most likely a termination ripple. Termination ripples are not noise.
Rather, they arise from the limited range over which the Fourier transform is performed.
In Equation (1.21), we see that the Fourier transformation is being performed from 0 to1.
In reality, of course, this is not the case. We do the integration from Qmin to Qmax. Often-
times, the Qmin = 0 (although experimental intensities will start at higher values because
scattered intensities will be blocked by the beamstop at extremely low Q), but the Qmax
is always nite. The consequence of doing the nite Fourier transform is that termination
ripples appear in the PDF with wavelength  2=Qmax [Egami and Billinge, 2003]. For
example, the PDF in Figure 1.6 was created with Qmax = 16.0 A
 1, so 2=Qmax  0:39 A,
and indeed the width of the peak at 1.9 A is  0:4 A. The eect of the termination ripples
can be reduced in a few ways including increasing Qmax, which would require increasing
experimental collection time (to improve statistics) [Chupas et al., 2007], and reducing
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experimental artifacts by properly applying data corrections and good instrument align-
ment [Laaziri et al., 1999]. In fact, as we will see later, if too low of a Qmax is used, then
it will be dicult to tell the dierence between oscillations coming from the structure and
those coming from termination ripples [Dykhne et al., 2011].
We want to again emphasize here that the pair distribution function is in real space,
r, not reciprocal space, Q. Although this statement is quite obvious, the implications of it
are huge. No information is gained or lost in the Fourier transform, in fact we could work
exclusively in reciprocal space and t the S(Q) to a model, but, the Fourier transform allows
us to measure relative positions of atoms in a solid - both from the periodic structure in the
form of Bragg peaks, and the local structure in the form of diuse scattering - something
that regular crystallographic methods do not allow. Taking this one step further, ab initio
methods have been developed that seek to build structures purely from the information
contained in the PDF [Juhas et al., 2006]. Going beyond the science, there is just something
satisfying that arises from being able to directly relate real space atom-atom distances to
their structure.
1.7 Applying the PDF
1.7.1 Modeling
One of the best ways to extract structural information out of a PDF is to try to reproduce
the PDF using a calculated structure model by rening parameters such as atom positions,
lattice constants, and thermal factors [Egami and Billinge, 2003]. The structure models
are typically calculated using powerful software tools such as PDFt2 and PDFgui [Farrow
et al., 2007]. We demonstrate several structural renements using PDFgui on a variety of
compounds in Chapter 4.
Amorphous pharmaceuticals are dicult to model using existing software methods be-
cause they only contain short range structural information. New modeling tools, that allow
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for structures with 'rigid' and 'oppy' components need to be developed to face the chal-
lenges presented by these materials. However, these tools are beyond the scope of the work
presented here. For this reason, traditional PDF modeling will not be used in our analysis
of PDFs of pharmaceutical compounds.
1.7.2 Fingerprinting
Since tools for modeling TSPDFs of pharmaceutical compounds have not fully been worked
out, we instead rely on ngerprinting them against one another. Fingerprinting can be used
to provide unambiguous structural identication of a compound or to highlight possible
structural changes over time that may lead to product performance, e.g. due to crystal-
lization of an amorphous pharmaceutical [Dykhne et al., 2011]. In fact, as we will learn
later, an important practical barrier to the development of amorphous pharmaceuticals in
product development is a lack of reliable methods for ngerprinting them [Dykhne et al.,
2011].
We do ngerprinting both qualitatively and quantitatively. For the qualitative analysis
we simply use a visual comparison of the plots of the PDFs. For the quantitative analysis
we quantify the similarity of curves by using a home-written program that computes the














where X and x are the mean and standard deviation of a data set, respectively, and n is
the total number of data points in the data set. The Pearson correlation technique creates
an m  m matrix that contains a correlation value R in the range -1 to 1 between each
pair of m data-sets. The value 1 implies complete correlation, zero implies no correlation,
and -1 implies an anti-correlation. The Pearson correlation technique is extremely powerful
because it ignores absolute scaling, but is sensitive to relative scaling and slight shifts in
peak positions. Empirically, we have found that correlations between two PDFs above 0.8
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mean that they are highly correlated.
We study the correlations between PDFs in the range r = 3:0   20 A. We chose this
range because the very local structure (i.e. r < 3:0 A) of all molecular samples is similar due
to intra-molecular atom pairs, for example, consisting of nearest and next-nearest neighbor
carbon-carbon bonds at 1.4 A and 2.4 A, respectively. Applying the correlation analysis to
the entire data range does not change the result signicantly but reduces the sensitivity to
nding dierences in molecular packing of the correlation analysis by including a range of
r-that is highly similar regardless of the packing.
A sample table of Pearson correlations is in Table 6.1, reproduced from Chapter 6.
This table shows correlations between three phases of the pharmaceutical compound carba-
mazepine (CBZ) and three phases of the compound indomethacin (IND). Crystalline phases
of CBZ are CBZ-I and CBZ-III, and crystalline phases of indomethacin are  and . In
both cases, the non-crystalline phases are denoted with an `a'. From the table, we see very
high correlations between CBZ-III and CBZ-a (0.881) and no high correlations between any
other pair of compounds. As we will see in Chapters 5 and 6, this led us to correctly identify
the non-crystalline phase structure to be similar to that of CBZ-III. In fact, this was the
rst time that TSPDF was used to successfully identify the structure of a non-crystalline
phase of a pharmaceutical compound [Billinge et al., 2010].
1.8 The Rest of the Thesis
In this chapter, we briey highlighted a typical total scattering experiment, the derivation
of the PDF from rst principles, the properties of a PDF, and how we use PDF to study
structures. In the next chapter we will introduce the importance of non-crystalline phar-
maceutical compounds. In Chapter 3 we will study the data corrections in more detail. In
Chapter 4 we will discuss a new algorithm for creating PDFs that allows for high-throughput
data processing with little user interaction. In Chapters 5, 6, 7, 8, and 9 we will show ex-
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Table 1.1: Summary of Pearson correlation coecients between the PDFs of carbamazepine
and indomethacin with Qmax = 20 A
 1. Correlations higher than 0.8 are shown in bold
(except when they are trivially unity).
CBZ-III CBZ-a CBZ-I IND- IND-a IND-
Qmax = 20 A
 1
CBZ-III 1 0.88121 0.580032 0.36072 0.520868 0.535466
CBZ-a 1 0.721854 0.499347 0.692577 0.585051
CBZ-I 1 0.4143 0.607663 0.353945
IND- 1 0.706309 0.477629
IND-a 1 0.648231
IND- 1
amples of TSPDFs being used to study non-crystalline and mixed phase pharmaceuticals
and then we will conclude in Chapter 10. Appendix A has safety guidelines for handling
pharmaceutical compounds and Appendix B is the manual for PDFGetX3 (introduced in
Chapter 4).
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Chapter 2
Introduction to Pharmaceuticals
Pharmaceutical drugs are, in the most broad sense, chemical compounds used to treat an
illness. Treatment with drugs, also known as active pharmaceutical ingredients (APIs),
is the most frequently used and usually most cost-eective preferred method of treating
disease [Banker and Rhodes, 2002]. Although drugs can be administered into the body using
a variety of routes (e.g. orally, intravenously, rectally, nasally, subcutaneously, etc. [Banker
and Rhodes, 2002]), here we will focus on drugs that are delivered orally in solid dosage
forms such as tablets.
Although the pharmaceutical industry spends more money on medical research than do
the National Institutes of Health in the United States [Lexchin et al., 2003], a major problem
facing the industry is that it is becoming harder to discover new drugs that could be brought
to market. In fact, even as R&D expenditures continue to increase dramatically, fewer new
products enter the market [Gardner et al., 2004b]. A variety of explanations have been
proposed to explain this phenomenon such as: poorly understood in vivo physico-chemical
properties of pharmaceutical materials, poor control over materials properties, and poor
aqueous solubility and dissolution rate [Gardner et al., 2004b].
In this chapter, and indeed the thesis, we focus on the last of those explanations -
the problem of poor aqueous solubility, or, to be more precise, bioavailability of pharma-
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ceutical products. We begin by introducing some basic information about pharmaceutical
compounds.
2.1 Basics of Pharmaceutical Drugs
As mentioned earlier, we conne our discussion here to APIs that are delivered orally in solid
dosage forms such as tablets, which are generally compacted crystalline powders. Crystalline
forms are used largely for reasons of physico-chemical stability and processibility [Dykhne
et al., 2011]. As discussed in Chapter 1, crystalline compounds can be characterized and
ngerprinted using the tools of crystallography such as XRPD.
2.1.1 XRPD Fingerprinting
A ngerprint of an API is a very powerful tool. In addition to being used at the formulation
stage to identify the structure of a compound or highlight structural changes [Dykhne et
al., 2011], the ngerprint is also used for litigation purposes [Shankland et al., 2004], and
for quality control [Maurin et al., 2008]. XRPD is a common technique for ngerprinting
crystalline APIs because it is easy and quick [Byrn, 1982].
A detailed discussion of the XRPD ngerprinting process is in Chapter 1, but, in sum-
mary, XRPD patterns collected from samples are either visually compared to reference
XRPD patterns (which are calculated from models or obtained from databases) by plotting
them on top of one another and identifying similar features, or quantitatively compared
using software such as PolySNAP [Barr et al., 2004], which uses algorithms to determine
the degree of similarity between two XRPD patterns [Billinge et al., 2010].
2.1.2 Polymorphism
Fingerprints play a particularly important role in the formulation stage when dealing with
drugs that exhibit polymorphism.
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A polymorph is a unique crystal packing arrangement of a compound [Byrn, 1982].
When an API is synthesized, great care is taken to determine whether or not the compound
can exist in polymorphic crystal forms and to characterize any such polymorphs [Byrn,
1982]. Knowledge of the polymorphs is important because dierent forms can have dierent
thermodynamic properties such as melting points and solubilities [Hancock and Zogra,
1997].
Since polymorphs of the same compound have dierent crystal packing arrangements,
they also have dierent XRPD patterns [Byrn, 1982] and PDFs [Dykhne et al., 2011], as
we see in Figure 2.1.
Figure 2.1 shows XRPD patterns and PDFs of two polymorphs of the API carba-
mazepine (CBZ), called Form I and Form III (or CBZ-I and CBZ-III for short). Panels
(a) and (b) show the XRPD patterns of CBZ-I and CBZ-III, respectively, while panels
(c) and (d) show the TSPDFs of the those polymorphs. We see that the XRPD patterns
look completely dierent, while the TSPDFs share strong peaks at 1.4 A and 2.4 A which
we've mentioned before correspond to carbon-carbon nearest- and next-nearest neighbor
distances. We also see that the PDFs share peaks at 3.7 A and 4.4 A. These two peaks
correspond to short range distances where the crystals structures are the same (i.e. intra-
molecular distances). Beyond 4.4 A, the PDFs look completely dierent from one another
(due to inter-molecular distances).
Fingerprints of all known polymorphs of a compound are needed when trying to nger-
print an unknown formulation (particularly when dealing with amorphous and nanostruc-
tured APIs, as we will discuss later). Databases such as the Cambridge Crystal Structure
Database (CCSD) [Allen, 2002] contain structure models of many known polymorphs for
many compounds. Using structural models for ngerprinting will be briey touched on in
Chapter 8.
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Figure 2.1: XRPD patters and PDFs of two polymorphs of the API carbamazepine (CBZ),
CBZ-I and CBZ-III. Panels (a) and (b) contain the XRPD patterns of CBZ-I and CBZ-III,
respectively. Panels (c) and (d) contain the TSPDFs of the two forms.
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2.1.3 Excipients
A typical solid drug formulation that is delivered orally, i.e. a tablet, has two main com-
ponents, the API, which is the focus of our discussion, and the excipient [Baldrick, 2000].
Excipients are the `everything else', so to speak, that is inside of a tablet. Excipients are
used for a variety of applications such as binders which hold the tablet together, coatings
which protect the API from the environment, and llers if an API needs to delivered in a
small dosage [Baldrick, 2000; Rowe et al., 2006].
Excipients tend to be polymeric compounds that lack long range structure and thus do
not typically show up in the XRPD pattern [Hancock and Zogra, 1997]. In our investi-
gations we tend to look at powders that contain purely APIs without any excipients for
simplicity, and in this sense we ignore excipients for most of this thesis except at the end in
Chapter 9 where we investigate some over-the-counter analgesic medications that contain
both an API and excipient by ngerprinting a TSPDF of Tylenol R against TSPDFs of the
three known polymorphs of its API, acetaminophen.
2.1.4 Bioavailability
Bioavailability is a pharmacokinetic property which measures the fraction of an administered
API that reaches the circulatory system and then is not metabolized before it can exert its
intended biological eect, in other words it is the degree to which drugs dissolve in their
intended destination in the body [Byrn, 1982; Heaney, 2001]. Bioavailability is incredibly
important because drug dissolution is a prerequisite to drug absorption and clinical response
for almost all drugs given orally [Amidon et al., 1995]. Obviously, a poor bioavailability
means that a drug might not have any therapeutic eect.
Bioavailability can be measured using a variety of analytical methods including chem-
ical methods such as chromatography and mass spectroscopy, biological methods such as
those based on immunoassay procedures, and microbiological methods [Shah et al., 1992].
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A general approach is to rst administer pharmacologically relevant dosages of an API in-
travenously via an IV infusion, then measure the concentration of the API in the blood
at various time intervals using liquid chromatography mass spectroscopy (LC-MS). Next,
after the API clears from the blood, the same dosage of the API is administered orally
and measurements are made the same way using LC-MS at the same time points [Veber
et al., 2002]. Since the intravenously administered API is considered to be fully soluble,
then the ratio of the blood concentration of the oral dosage to the intravenous dosage is the
bioavailability. This value is typically plotted as a function of time [Veber et al., 2002].
Although in-vivo bioavailability depends on many factors such as the fasted/fed state
of the subject, gastric-emptying and intestinal transit, metabolism, etc. [Amidon et al.,
1995], we will focus on the aqueous solubility of the API as the main measurement of
bioavailability.
In the development of new medicinal products, poor oral bioavailability, due to low
solubility of many crystalline API candidates, is increasingly a potential barrier to enabling
treatments to be administered using tablet or capsule formulations [Hancock and Parks,
2000]. One reason for the increasing occurrence of poor aqueous solubility is that new high-
throughput screening techniques used for discovering new molecules often lead to large
lipophilic candidates, which are poorly soluble in water [Gardner et al., 2004a].
2.2 The Amorphous Phase
Compounds in the amorphous phase lack the three-dimensional long-range order that exists
in crystalline materials [Hancock and Zogra, 1997]. In the case of amorphous pharmaceu-
tical compounds, the positioning of molecules relative to one another is more random.
Therefore, amorphous pharmaceuticals typically have short-range order (intra-molecular
and extending to neighboring molecules), but no long-range order or well-dened molecular
conformation if the constituent molecules are conformationally exible [Yu, 2001].
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Due to the lack of long-range order, amorphous systems are in a highly energetic
state [Hancock and Parks, 2000]. This means that solubilities of amorphous phase com-
pounds are generally expected to be higher than their crystalline versions. For this reason,
the amorphous state is of signicant interest within the pharmaceutical industry as a means
to enhance the aqueous solubility of APIs [Hancock and Parks, 2000].
Several examples in the literature have shown that increases in solubility for various
pharmaceuticals after they have been amorphized [Imaizumi et al., 1980; Sato et al., 1981]
(please refer to [Hancock and Parks, 2000] for a more complete listing). An in-vivo study in
rabbits found that amorphous indomethacin (IND) had a higher absorption rate over time
than crystalline IND [Fukuoka et al., 1987].
2.2.1 Amorphous Stability
The high potential energy of amorphous APIs also means that they are more unstable than
their crystalline analogues and are prone to recrystallization [Yu, 2001]. This recrystalliza-
tion can happen unexpectedly and with potentially disastrous results. For instance, the
Pzer drug atorvastatin (popularly known as Lipitor R) was formulated as an amorphous
salt during the development phase, but then the salt crystallized during Phase III clinical
trials. Additional studies had to be performed on the new crystalline compound because its
properties had changed from the amorphous form that was originally developed [Gardner
et al., 2004b].
One interesting technique that has been proposed to stabilize amorphous phase APIs is
by encapsulating them in polymer emulsions [Shaikh et al., 2009; Kesisoglou et al., 2007].
These stabilizers prevent them from aggregating [Kesisoglou et al., 2007].
2.2.2 Breakdown of XRPD
Since traditional XRPD techniques rely on a sample having long range structure, the tech-
nique breaks down when it is applied to the amorphous phase [Hancock and Parks, 2000;
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Dykhne et al., 2011; Billinge et al., 2010]. For example, Figure 2.2 shows the XRPD pat-
terns collected from amorphous and crystalline phases of CBZ and IND. Amorphous CBZ
and IND are in panels (a) and (b) while crystalline CBZ-I and IND- are in panels (c) and
(d). The amorphous forms of each compound were created by melt-quenching their respec-
tive crystalline phases. Unlike the XRPD patterns from crystalline data, the amorphous
patterns have no unique, identiable features. They cannot be used for ngerprinting or
for extracting structural information.
The inability to characterize the local packing in amorphous compounds has long been a
roadblock toward popularizing amorphous APIs and bringing them to market. However, as
we will discuss throughout most of this thesis, the TSPDF method seems to oer a solution
to this long-standing problem because of the local structural information available in the
diuse (non-Bragg) scattering.
2.2.3 Nanostructuring
Between the two extremes of completely amorphous and crystalline phases sit nanostruc-
tured APIs. Nanostructured compounds can be thought as being partially crystalline or
partially amorphous and can be created by introducing some disorder into a crystalline com-
pound using techniques such as milling or melt-quenching [Hancock and Parks, 2000]. These
compounds are attractive because they oer increased bioavailability over purely crystalline
compounds, and, unlike the purely amorphous compounds in Figure 2.2(a) and 2.2(b), have
some order. XRPD patterns of nanostructured compounds have some peaks, albeit they
are broader and less intense than Bragg peaks [Hu et al., 2002].
A bottleneck in the development of this class of APIs is that it is dicult to determine
the degree to which a compound is nanostructured purely from XRPD patterns [Hu et al.,
2002]. However, as we will see in Chapter 5, TSPDFs can be used as a powerful tool to
determine the domain size of the nanoparticles that constitute a nanostructured API.
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Figure 2.2: XRPD patters of amorphous and crystalline forms of carbamazepine (CBZ) and
indomethacin (IND). Panels (a) and (b) contain the XRPD patterns of amorphous CBZ
and IND, respectively. Panels (c) and (d) contain the XRPD patterns of the CBZ-I and
IND- polymorphs. The amorphous forms of each sample were made by melt-quenching
the respective crystalline forms.
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Chapter 3
PDF Data Corrections
In Chapter 1, we made several references to various corrections applied to the experimental
Iexp(Q) during its transformation to the S(Q). In this chapter, we discuss those corrections
in more detail. We keep our discussion relatively qualitative and only show equations where
analytical solutions exist and are relatively easily understood. Just as in Chapter 1, our goal
here is not to exhaustively detail the step-by-step process of creating a PDF, but instead to
provide insight into the process. Indeed, since these corrections are nowadays performed by
software, it is more important to understand why these corrections are needed than their
nitty-gritty details.
For this discussion, we re-introduce equations (1.3) and (1.9), now referred to as (3.1)
and (3.2)






From equations (3.1) and (3.2), there are ve main corrections we consider, these cor-
rections can be divided into two groups. Additive corrections (those in equation (3.1)),
CHAPTER 3. PDF DATA CORRECTIONS 34
such as incoherent scattering, multiple scattering, and background scattering, and multi-
plicative corrections (those in equation (3.2)) such as absorption and polarization. There
are obviously more corrections that can be applied, such as oblique incidence, uorescence,
detector eciency, incident ux, etc., but since the goal of this chapter is to be a survey,
not a technical manual, they will not be considered here.
3.1 Multiplicative Corrections
3.1.1 Absorption
The absorption correction is used to account for the X-rays that are absorbed by the sample.
To calculate the absorption correction, one needs to know the geometry of the experiment,
the energy of the X-rays (this can be obtained given their wavelength with the relationship
E = hc where E is the energy, h is Planck's constant and c is the speed of light in a vacuum),
the mass absorption coecient, (E) [Chantler, 1995], of the sample, the elements that make
up the sample, its density, and its thickness.
Most necessary parameters for the absorption calculation are reasonably easy to obtain.
The energy of the X-rays used in an experiment should be known ahead of time. The total
mass absorption coecient of a material is a linear addition of the absorption coecients of
each element weighted by the ratio of the elements in the compound. (E) of most elements
has been tabulated as a function of X-ray energy in the literature [Chantler, 1995] and on
the website of the National Institute of Standards and Technology (NIST) [Hubbell and
Seltzer, 2004]. We usually express the mass absorption coecient of each element divided
by its density, (E)=. Luckily, the densities elements have also been tabulated [Klug and
Alexander, 1974]. We multiply the total mass absorption coecient by the thickness of
the sample, t, to obtain the value t, which is an important variable in the absorption
calculation.
Finally, the geometry of the experiment also has an eect on the absorption. A more
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detailed discussion can be found in [Egami and Billinge, 2003] and [Jeong et al., 2001], but
briey at plate geometries (both reection and transmission) have analytic expressions
for the absorption correction. The capillary geometry has a more complicated correction
dependent on the diameter of the capillary.
The nal absorption correction is tabulated by software using several complicated equa-
tions and then applied to the experimental data. In general, the magnitude of t is inversely
proportional to the magnitude of the correction, so a larger t will mean that a smaller
correction is necessary, and Q is proportional to the correction, so the absorption correction
is bigger at larger values of Q.
3.1.2 Polarization Correction
The Thompson scattering process polarizes the scattered X-ray beam [Egami and Billinge,
2003] such that the electric vector lies in a direction perpendicular to the scattering plane.
This aects the measured intensities as a function of the scattering angle [Egami and
Billinge, 2003]. Unlike the other corrections described in this chapter, which rely on compli-
cated functions with tabulated values, the polarization correction to account for this angle
dependence can be expressed relatively easily analytically as a function of scattering angle
and degree of polarization of the incident beam [Egami and Billinge, 2003], as below in
Equation (3.3)
P =
1 +A cos2 2
1 +A
(3.3)
where A is a term that depends on the degree of polarization of the incident beam and 2 is
the scattering angle [Egami and Billinge, 2003]. A, not to be confused with the absorption
correction in Equation (3.2), can take on values between 0 and 1.0, where A = 0 means
that the incident beam is unpolarized, while A = 1:0 means that the incident beam is fully
polarized.
Synchrotron radiation is theoretically fully plane polarized perpendicular to the scatter-
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Figure 3.1: Plot of the polarization correction as a function of angle in radians. The blue
curve corresponds to the incident beam being fully polarized perpendicular to the scattering
plane (A = 1), the green curve to a half polarized incident beam (A = 0:5), and the red
curve to an unpolarized incident beam (A = 0).
ing plane, and therefore does not need to be corrected for polarization. However, in reality,
the beam is not completely polarized and some small corrections might be necessary [Egami
and Billinge, 2003; Jeong et al., 2001].
In Figure 3.1, we see the polarization correction plotted as a function of angle, , in
radians with dierent values of A. The blue curve corresponds to a situation where A = 1,
the green to when A = 0:5, and the red to A = 0. We see that when the beam is not fully
polarized, the shape of the correction function is roughly the same: P = 1 at  = 0 and =2
and reaches its minimum, P = 11+A , at  = =4. Overall, as A gets smaller, the magnitude
of the polarization correction increases.
There are two special geometries that are worth a mention [Egami and Billinge, 2003].
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In the rst geometry, a monochromator crystal is placed in the unpolarized incident beam
(i.e. placed in the beam before it hits the sample). In this case, A = cos2 2, where 2
is the scattering angle of the monochromator, in Equation (3.3). In the other geometry,
the monochromator crystal is placed in the diracted beam (i.e. after the beam hits the





instead of Equation (3.3).
3.2 Additive Corrections
3.2.1 Multiple Scattering
The multiple scattering contribution contains no usable structural inormation and must be
removed from the measured intensity before we can obtain the S(Q) [Egami and Billinge,
2003]. Multiple scattering occurs when the primary beam is scattered twice or more by
the sample and container before reaching the detector [Egami and Billinge, 2003; Warren,
1990]. In our analysis, we consider only double scattering because it represents the majority
of the contribution of multiple scattering to the data and higher orders are much more
dicult to calculate [Egami and Billinge, 2003; Jeong et al., 2001]. We also assume that
the double dierential cross section is isotropic, which is not the case in reality, however
the assumption does simplify the math and has been found to work [Egami and Billinge,
2003]. We further simplify the calculation by separating out the incoherent scattering (i.e.
Compton scattering), as done in equation (3.1) so that only completely elastic multiple
scattering events need to be considered for this correction [I.-K. Jeong et al., 2001].
The multiple scattering correction depend on sample thickness, transparency, absorp-
tion [Egami and Billinge, 2003] (a discussion of absorption is above in section 3.1.1), ex-
periment geometry, and a complicated function that is dependent on Q, sample absorption,
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thickness, density, and other parameters [Warren and Mozzi, 1966]. Luckily, values of this
function have been tabulated so that they could be used in computer assisted calculations [C.
W. Dwiggins, Jr and Park, 1971]. Multiple scattering contributions increase with sample
thickness and with higher energy X-rays [I.-K. Jeong et al., 2001] and therefore the correc-
tion is important in TSPDF experiments where X-ray energies are generally high and the
data in the high-Q region contain important information [I.-K. Jeong et al., 2001]. Finally,
multiple scattering is far larger in transmission geometry than reection geometry [Egami
and Billinge, 2003].
3.2.2 Incoherent Scattering
Incoherently scattering waves do not interfere when diracted o the sample (unlike coherent
scattering where the waves interfere either constructively or destructively), meaning that
there is no phase relationship between the waves [Egami and Billinge, 2003]. Since structural
information in scattering comes from the interference eects of scattered waves, incoherently
scattered waves do not contain any structural information [Egami and Billinge, 2003].
As incoherent scattering mainly consists of Compton scattering [Egami and Billinge,
2003], we devote our discussion exclusively to it. Compton scattering is an inelastic in-
coherent type of scattering that occurs when an incident X-ray photon collides when an
electron in the sample and transfers some of its energy to the electron. The scattered
photon thus has a dierent energy and wavelength than the incident [Egami and Billinge,
2003].
We correct for Compton scattering by subtracting Compton intensities from the data.
These intensities have been calculated as a function of Q from tabulated data of the Comp-
ton scattering cross section [Balyuzi, 1975; Cromer and Mann, 1967]. A proper correction for
Compton scattering is very important in high-energy total scattering analysis because the
Compton signal can be larger than the coherent scattering intensity at high-Q [I.-K. Jeong
et al., 2001]. This is due to the fact that the elastic scattering cross section decreases as the
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Figure 3.2: Compton correction for nickel. The blue line is the mean-square atomic scatter-
ing factor, hf2i, the green line is the tabulated Compton scattering intensity, and the red
line is the Compton modied by the Ruland attenuation function (0.01 width).
Compton scattering cross section increases [Egami and Billinge, 2003]. This also leads to
a problem because, as we see in Figure 3.2, at high-Q values ( 20 A 1 in this case) sub-
tracting the Compton scattering (green) from the experimental scattering intensities (blue,
mean-square atomic scattering factor, hf2i, is used as a proxy for the coherent scattering)
will result in a negative intensity. We solve this problem by applying a smooth attenuation
function to the Compton intensities as suggested by Ruland [Ruland, 1964] (red) and then
subtracting the attenuated intensities from those that were collected experimentally.
3.2.3 Background Subtraction
Background scattering intensities come from scattering that is not done by the sample. For
instance, the sample container (e.g. a capillary) contributes to the background scattering,
as does air, and the instrument itself can have a background signal [Chupas et al., 2003]. We
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want to minimize the contribution of background scattering intensities to the total intensity.
This can be done in two ways, rst by optimizing the experiment and second by subtracting
the background [Chupas et al., 2003]. We optimize the experiment by, for example, using
a poorly diracting sample container (i.e. a Kapton R capillary rather than glass) and
collecting a dark current on the detector between measurements. To properly subtract the
background, we collect three data sets: (1) the sample and container together; (2) an empty
container; and (3) the air [Toby and Egami, 1992]. The scattering the container and the
air are then subtracted from the total measurement.
For optimal background subtraction, we want the collection time for all data sets to be
the same. In reality, though, this rarely happens because samples are measured for dierent
time periods depending on how well (or how poorly) they diract, while a background
measurement is done once. In this case, we simply scale the background measurements by
multiplying them by a factor equal to the ratio of the collection times in order to even out
the counts. For example, if the container was measured for 5 minutes and the sample was
measured for 10 minutes, then the background data would be multiplied by 2 prior to being
subtracted from the total intensity.
The contribution of the background intensities to the total intensities varies depending
on how well the sample diracts relative to the container. For example, Figure 3.3 shows
two extreme cases. In panel (a), the sample is nickel, a well-diracting material with Bragg
peaks that are several orders of magnitude higher than the background intensities. On the
other hand, the sample in panel (b) is amorphous salbutamol, a much poorer diracting
material. We see that the background intensities are of the same order of magnitude as the
total intensity.
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Figure 3.3: Examples of background intensity relative to total intensity, the samples were
contained in Kapton R capillaries in both cases. (a) Background intensity (green) plotted
with total intensity collected on a nickel sample (blue). The Bragg peaks from the nickel
are several orders of magnitude higher than the background signal. (b) Background in-
tensity (green) plotted with total intensity collected on amorphous salbutamol (blue). The
background intensity is of the same order of magnitude as the total intensity.
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Chapter 4
The PDFGetX3 Software
In this chapter, we introduce new software developed by members of the Billinge Group
for processing PDFs, PDFGetX3. PDFGetX3 is a successor to PDFGetX2, the current
gold-standard for making PDFs, which was also developed by the Billinge Group [Qiu et
al., 2004]. Although PDFGetX3 is able to process nearly all high energy PDF and TSPDF
diraction data, it is of particular importance to this thesis because it makes the PDF
technique more accessible to researchers in the life sciences and the pharmaceutical industry
and therefore ts in well with the theme of the thesis.
We rst briey discuss the motivation of why the program was developed and the
need that it fullls, then we devote most of the chapter to comparing PDFs made us-
ing PDFGetX3 to those made using PDFGetX2 (processed from the same raw data), and
nally we briey mention the novel parameter tuning feature of PDFGetX3.
4.1 Motivation for PDFGetX3
Although PDFGetX2 is a great software program, it has a few drawbacks. First, PDFGetX2
was written in the commercial IDL programming language and therefore requires the IDL
Virtual Machine to be installed on a computer for it to be used, however, the latest version
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of the IDL Virtual Machine does not support PDFGetX2 and a legacy version is dicult to
nd. Second, the program is quite complicated and sometimes frustrating for neophyte users
because they need to manually enable, disable, and sometimes provide starting values for a
whole host of data corrections (such as those described in Chapters 1 and 3) and parameters.
Third, PDFGetX2 does not support any means of batch processing, and requires that each
PDF be made individually. With the advent of the RAPDF method [Chupas et al., 2003],
time- or temperature-resolved measurements produce large numbers of data sets. Processing
each data set individually has proven to be inecient, even if most parameters across data
sets remain the same.
PDFGetX3 was written with usability and high throughput in mind. First, the program
was written in Python using only the Numpy library. This means that the program can be
used on practically any system that has the freely available (BSD license) Python program-
ming language installed. It has successfully been used on Windows Vista and Windows 7,
MacOS, and Linux. Furthermore, PDFGetX3 removes frustration by minimizing the user
interaction with the program. In order to process a data set, the user needs to provide,
in a plain text conguration le, very basic information about the experiment such as the
wavelength of the X-rays used, the chemical composition of the sample, and the range of Q
over which to perform the Fourier transform as in Equation (1.21). The user does not need
to enable or disable any corrections nor does he or she need to provide values for parameters
used in corrections. Finally, PDFGetX3 allows the user to batch process data after he or
she has set up the appropriate conguration le. For instance, if a user has made several
hundred temperature-resolved measurements on the same material, then he or she will need
to set up just one conguration le and then let PDFGetX3 sequentially process each data
set. Most importantly, PDFGetX3 is fast. A data set is usually processed in a fraction of
a second, so even several hundred measurements can be processed in just a few minutes.
More information on the program is in the PDFGetX3 manual in the Appendix of this
thesis.
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4.2 Comparison with PDFGetX2
The quality of the PDFs made with PDFGetX3 can be measured using qualitative and quan-
titative means. Qualitatively, the PDFs are plotted on top of those made with PDFGetX2
with an oset dierence curve. Quantitatively, the same structure model can be t to
PDFs made with both programs and the rened parameters can be compared to one an-
other. In this chapter, we do both to several classes of materials: Inorganic materials such
as bulk nickel and barium titanate, nanostructured -alumina, and bulk and nanocrystalline
cadmium selenide, as well as crystalline and nanostructured phases of the organic pharma-
ceutical carbamazepine. We choose these very dierent types of materials to show that
PDFGetX3 is a robust program that can handle all sorts of high energy X-ray data.
In all cases, PDFs from both programs are made from the same raw data and use the
same input parameters (i.e. Qmax, X-ray wavelength, chemical composition, and container
background). All data sets except the -Al2O3 were collected at high-energy synchrotron
instruments, however, the synchrotron is not a requirement. PDFGetX3 can handle data
from lab-based XRPD instruments as long as the Q-range is suciently large (more infor-
mation in Chapter 6). For example, the -Al2O3 data were collected with a silver anode
diractometer.
The PDF data points do not have error bars because uncertainties are not measured
when integrating around the Debye-Scherrer rings (Figure 1.1). Attempts are being made
to develop the proper methodology to do this, but they are beyond the scope of this thesis.
Instead, we follow the approach that has been used in the literature: We draw dashed
horizontal lines that represent 2 (standard deviations) in the dierence curve [Proen et
al., 2003; Peterson et al., 2003]. Furthermore, again in following examples in the literature,
the range in r space over which we calculate the dierence curve and the standard deviations
begins with the rst nearest neighbor peak, and, in the case of nanoparticles, ends at the
maximum size of the nanoparticle.
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In general, as we will see in the following examples, we nd that the PDFs made by
the dierent programs look somewhat dierent from one another at r values lower than the
rst nearest neighbor peak. This is mostly due to dierences in how the data are processed
by dierent algorithms and improper applications of corrections. Luckily, any peaks in this
range (i.e. before the nearest-neighbor peak) have no physical signicance. The PDFs look
almost exactly the same over the relevant range of data from the nearest neighbor peak and
onward.
We rescale the PDFs by a constant such that the nearest neighbor peak is the same
height between PDFs on the same plot. This is a standard procedure and has no eect
on data quality (in fact, the scaling parameter is almost always used when comparing
experimental data to models) [Peterson et al., 2003]. The relative scaling of peaks to one
another within the same PDF, which is preserved when scaling by a constant, is, however,
important.
As we discussed in Chapter 1, we t models to the PDFs by rening a variety of param-
eters such as lattice parameters, thermal factors, etc. using the program PDFgui [Farrow
et al., 2007]. When doing a typical renement, our goal is to minimize the goodness of t
parameter Rw. Please refer to the PDFgui manual for more information on the various
parameters and how renements are done. In this chapter, though, we are not as much con-
cerned with the perfect renement as we are concerned with reproducible results. Therefore,
in each case, we will compare the Rw value as well as the values of the rened parameters
without going into the implications of the t.
When we t structure models to PDFs, we generally want to choose the largest range of
r for the t in order to ensure the most independent observations [Egami and Billinge, 2003]
(unless we're interested in specic local ordering, as we are with -alumina). However, we
avoid the low-r region (below the nearest-neighbor peak) where non-physical peaks might
have a deleterious eect on the t. As a nal note, we will not tting structure models to
the pharmaceutical compounds in these examples. As discussed in Chapter 1, new modeling
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tools that are beyond the scope of this dissertation need to be developed to do this properly.
4.2.1 Nickel and Barium Titanate
First we look at pure nickel (Ni) and barium titanate (BaTiO3) in Figure 4.1. Both com-
pounds diract very well. Panel (a) shows the two PDFs of nickel plotted on top of one
another. The PDF made with PDFGetX2 is in blue and the PDF made with PDFGetX3
is in green with Qmax = 26.0 A
 1 in both cases. The dierence curve between the two
PDFs is red. The area between the dashed horizontal lines represents 2 in the dierence
curve. We see that there is almost no dierence between the PDFs after the Ni-Ni nearest
neighbor peak (at r = 2:2 A). We see the same behavior in panel (b) with barium titanate.
In general, it is quite easy to make PDFs of these compounds (there is a joke that the PDF
of nickel can be made with a ruler and graph paper), but they do oer a spring board for
us to look at more complicated compounds.
In Table 4.1, we see the parameters rened in tting the nickel model [Wycko, 1967]
to the PDFs and the Rw values from the ts. Not many parameters were rened in this t
because only one type of element is present, the lattice parameters are all equal (a = b = c),
and there is only one isotropic thermal parameter (Uiso = U11 = U22 = U33). Overall, we
see very good agreement between most of the parameters and the Rw values. The Rw from
PDFGetX2 is just slightly lower, but, realistically there is very little dierence.
Table 4.2 shows the rened parameters for tting BaTiO3 PDFs to a model [Megaw,
1962]. We see that more parameters were rened for this material than for nickel, since
all of the lattice parameters are no longer equal and neither are the thermal factors, plus
a dierent set of thermal factors is needed for each element. Regardless, we see that the
parameters agree very well with one another. The Rw from PDFGetX2 is a little bit lower.
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Figure 4.1: PDFs of (a) nickel and (b) barium titanate made with PDFGetX2 (blue) and
PDFGetX3 (green) with Qmax = 26.0 A
 1 in both cases. Dierence curve (oset) is in red.
The dashed lines represent two standard deviations in the dierence curve (r values below
the nearest neighbor peaks were not included in the standard deviation calculation).
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Table 4.1: Comparison of the parameters rened in tting the Ni model to the PDFs.
Parameter PDFGetX2 PDFGetX3
Qdamp (A 1) 0.055 0.057






Table 4.2: Comparison of the parameters rened in tting the BaTiO3 model to the PDFs.
Parameter PDFGetX2 PDFGetX3
Qdamp (A 1) 0.048 0.049
a = b (A) 3.995 3.995
c (A) 4.040 4.040
2 (A
2) 4.317 4.372
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Table 4.3: Comparison of the parameters rened in tting the -Al2O3 model to the PDFs.
Parameter PDFGetX2 PDFGetX3
Qdamp (A 1) 0.077 0.081
a (A) 3.394 3.394
b (A) 2.780 2.780









Next, we investigate -alumina (Al2O3) using X-rays from a silver anode diractometer
( = 0:56 A). The  phase of Al2O3 has a local nanocrystalline structure that is dierent
from the cubic and tetragonal structures of other alumina phases [Paglia et al., 2006]. For
this reason, a new structure model was developed for the local structure of -Al2O3 up to
r = 8 A (ICSD 173014) [Paglia et al., 2006]. Figure 4.2 shows the PDFs of -Al2O3 made
with PDFGetX2 and PDFGetX3. We see very good agreement between the PDFs. In fact,
the PDFGetX3 PDF looks better at low r values.
Rened parameters are in Table 4.3. Unlike in previous cases where we tried to use a
large r range for our renement, in this case we rened only over the range r = 1:5   8 A
because the model only applies over this range. For this reason, we wanted to rene few
parameters (this is why Uiso was used rather than separating out the thermal factors).
Regardless, though, we see very good agreement between the ts.
As mentioned previously, the -Al2O3 data were measured using a silver anode lab
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Figure 4.2: PDFs of -Al2O3 made with PDFGetX2 (blue) and PDFGetX3 (green) with
Qmax = 20.5 A
 1 in both cases. Dierence curve (oset) is in red. The dashed lines represent
two standard deviations in the dierence curve (r values below the nearest neighbor peaks
were not included in the standard deviation calculation).
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diractometer, and not a synchrotron. From this example we see that PDFGetX3 is ca-
pable of processing data from lab-based instruments (with sucient Q-range) as well as
synchrotrons.
4.2.3 Cadmium Selenide Nanoparticles
We now turn our attention to a more complicated class of materials: nanoparticles. Gen-
erally, nanoparticles do not diract as well as the bulk because they do not have long
range order and smaller nanoparticles diract worse than larger ones. In fact, it is quite
dicult to extract quantitative structural information from nanoparticles using standard
crystallography techniques [Billinge and Levin, 2007] (i.e. a copper-anode diractometer).
In Figure 4.3 we look at PDFs of three samples of cadmium selenide (CdSe) taken from
data that have previously been published by Masadeh et al. from the Billinge Group [Masadeh
et al., 2007]. The bulk CdSe in panel (a) is included for completeness. The nanoparti-
cles in panels (b) and (c) were calculated to have diameters of 37 A and 22 A, respec-
tively [Masadeh et al., 2007].
We see that in all three panels of Figure 4.3, the PDFs made with the two programs are
almost identical. The features are all reproduced beautifully by PDFGetX3, even though
many more corrections needed to be applied to the nanoparticle data in PDFGetX2 than
were needed for nickel or barium titanate. The low-r region looks a little bit dierent
between the PDFs, especially as the size of the nanoparticles gets smaller, but we remember
that this region contains no physical information. In fact, we might even argue that in panel
(c), the PDFGetX3 PDF looks cleaner than the PDFGetX2 PDF. At this point we again
want to stress the fact that the PDFs in PDFGetX3 were made in a fraction of a second
with little user interaction beyond inputting a few parameters.
Tables 4.4 and 4.5 contain the rened parameters for the CdSe samples compared to
a model [Wycko, 1967]. The Qdamp that was rened for the bulk was xed for the
nanoparticles. We again see very good agreement between all parameters. Furthermore,
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Figure 4.3: PDFs of (a) bulk CdSe and (b) 37 A, and (c) 22 A CdSe nanoparticles
made with PDFGetX2 (blue) and PDFGetX3 (green) with Qmax = 18.0 A
 1 in all cases.
Dierence curve (oset) is in red. The dashed lines represent two standard deviations in
the dierence curve (r values below the nearest neighbor peaks were not included in the
standard deviation calculation and, for the nanoparticle in panel (c), r values larger than
22 A were not included).
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Table 4.4: Comparison of the parameters rened in tting the CdSe model to the PDFs.
Parameter PDFGetX2 PDFGetX3
Bulk
Qdamp (A 1) 0.059 0.059
a = b (A) 4.299 4.299
c (A) 7.011 7.011
2 (A
2) 3.210 3.260









the Rw was lower for PDGetX3 in two out of three ts.
4.2.4 Drugs
The nal class of materials that we want to look at are organic pharmaceutical compounds,
since we will be discussing them exclusively in the rest of this thesis. These materials can
be crystalline, as we see in Figure 4.4(a) and (b), nanostructured as in Figure 4.4(c), or
amorphous (as we will see in Chapter 7). These materials tend to be made up of mostly
light, organic elements such as hydrogen, carbon, and oxygen that do not diract well,
therefore even crystal phase pharmaceutical compounds require quite a bit of tinkering in
PDFGetX2 to produce a good TSPDF.
In the examples here, we use three phases of the mood stabilizing drug carbamazepine
(CBZ), crystalline CBZ-I and CBZ-III as well as nanostructured CBZ. The TSPDFs of these
samples that were created with PDFGetX2 have been published in the literature [Billinge
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Table 4.5: Comparison of the parameters rened in tting the CdSe model to the PDFs.
Parameter PDFGetX2 PDFGetX3
37 A NP
a = b (A) 4.299 4.296
c (A) 7.007 7.007
2 (A
2) 4.661 4.736








Particle diameter (A) 36.38 35.33
Rw 0.194 0.173
22 A NP
a = b (A) 4.294 4.295
c (A) 6.857 6.863
2 (A
2) 4.966 5.198








Particle diameter (A) 23.13 23.34
Rw 0.262 0.265
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et al., 2010; Dykhne et al., 2011] and will be discussed in great detail in Chapters 5 and 6
of this thesis.
Like the nanoparticles in Figure 4.3, the TSPDFs in Figure 4.4 made with PDFGetX2
have quite a bit of noise at low r. This is because those data were quite dicult to process
and these were the best TSPDFs that could be made at the time of publication. We note
that the TSPDFs made with PDFGetX3 appear to be quite clean at low r in comparison
and require very little tinkering by the user.
As mentioned earlier, we did not t these TSPDFs to models because new modeling
tools need to be developed for this class of materials.
4.3 Tuning Feature
Although this chapter has just briey touched the surface of the capabilities of PDFGetX3,
one feature in particular deserves mention. The tuning feature allows the user to dynami-
cally tune input parameters such as the Qmax and background scale and instantly see the
eect that this will have on the PDF. This is possible because PDFgetX3 is able to process
a data set so quickly that it can adjust parameters and calculate a PDF on the y. This
extremely powerful feature allows the user to interact with the data in order to best choose
the parameters used in data processing.
More information on the program is available on the website of the Billinge Group
(http://www.dipy.org) and the manual is the Appendix of this thesis.
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Figure 4.4: PDFs of (a) CBZ-I, (b) CBZ-III, and (c) nanostructured CBZ made with
PDFGetX2 (blue) and PDFGetX3 (green) with Qmax = 20.0 A
 1 in all cases. Dierence
curve (oset) is in red. The dashed lines represent two standard deviations in the dier-
ence curve. (r values below the nearest neighbor peaks were not included in the standard
deviation calculation).
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Materials by Total Scattering
The work in this chapter was done in collaboration with Simon J. L. Billinge, Pavol Juhas,
Emil Bozin, Ryan Taylor, Alastair J. Florence, and Kenneth Shankland and published in
the journal CrystEngComm [Billinge et al., 2010].
This paper that this chapter is based on is a seminal work in ngerprinting crystalline
and so-called `X-ray amorphous' pharmaceutical compounds and a good demonstration of
the principles discussed in the rst three introductory chapters of the thesis. The use of
high-energy X-ray total scattering coupled with pair distribution function analysis produces
unique structural ngerprints from amorphous and nanostructured phases of the pharma-
ceuticals carbamazepine and indomethacin. The advantages of such facility-based exper-
iments over laboratory-based ones are discussed and the technique is illustrated with the
characterisation of a melt-quenched sample of carbamazepine as a nanocrystalline (4.5 nm
domain diameter) version of Form III carbamazepine.
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In this study, the commercial program PolySNAP (version 1.7.2 [Barr et al., 2004])
was used to calculate correlations between PDFs because, at the time that this study was
conducted, we had not yet developed our Pearson algorithm (Equation (1.24)) to do this.
In principle, the PolySNAP correlations work in almost the same way as Pearson, but rely
on a proprietary algorithm. A full set of Pearson correlations for the data in this chapter
is in Chapter 1 in Table 6.1 and also in Chapter 6 where we discuss the eect of Qmax on
ngerprinting.
5.1 Introduction
As we had discussed at length in Chapter 2, the majority of active pharmaceutical in-
gredients (APIs) are marketed as crystalline forms for reasons of stability. However, the
formation, stability and performance of amorphous solids are also of signicant interest
within pharmaceutical research and development. Whilst the amorphous state can confer
desirable properties to an API, such as increased aqueous solubility [Hancock and Parks,
2000], the inadvertent production of non-crystalline material during processing can also
lead to uncontrolled variability in physical and chemical attributes. The potential for com-
mercial exploitation of amorphous APIs is often complicated by their tendency to revert
to a more thermodynamically favorable, and less soluble, crystalline state. Although the
identication, characterization and quantication of amorphous pharmaceuticals has re-
ceived considerable attention, little is known about local ordering in amorphous APIs due
to the lack of reliable experimental probes. The powerful tools of crystallography begin
to lose their power for structures on the nanoscale; conventional X-ray powder diraction
(XRPD) patterns become broad and featureless in these cases (Figure 5.1) and are not
useful for dierentiating between dierent local molecular packing arrangements [Billinge
and Levin, 2007]. Accordingly, XRPD is generally used simply to identify such samples as
non-crystalline (i.e. X-ray amorphous).
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Figure 5.1: Molecular structures and laboratory Cu K1 XRPD patterns for X-ray amor-
phous melt-quenched samples of CBZ (top) and IND (bottom).
It has recently been suggested that Fourier transforming conventional laboratory XRPD
data (Typically Cu K radiation,  = 1:54 A; 2max = 60
; Qmax = 4:1 A 1) to obtain the
atomic pair distribution function (PDF) [Egami and Billinge, 2003; Warren, 1990] allows
more structural information to be extracted [Bates et al., 2006]. The PDF, G(r), yields
the probability of nding an atom at a distance r from any reference atom and so provides
information on local structure in real space. However, this approach is intrinsically limited
by the relatively low momentum transfer magnitude Q (4 sin()=) values typically ac-
cessible in the laboratory environment, resulting in a PDF of limited real-space resolution
(proportional to 2=Qmax). For an accurate PDF across a wide range of r, data should be
collected with low instrumental background and good counting statistics to high Q. These
requirements can be met by combining high-energy (synchrotron) X-rays with imaging plate
detectors.
In this work, a high-energy XRPDmethod known as total scattering [Egami and Billinge,
2003], coupled with Fourier transformation and PDF analysis, is applied to individual X-
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ray amorphous samples of the anti-epileptic drug carbamazepine (CBZ; Figure 5.1) and
the non-steroidal anti-inammatory drug indomethacin (IND). This approach is referred to
as the total scattering pair distribution function (TSPDF) method to dierentiate it from
the approach of obtaining the PDF from conventional laboratory XRPD data [Bates et
al., 2006]. The TSPDF method has been widely applied to inorganic materials to study
amorphous structures [Wright, 1998] and more recently crystalline and nanocrystalline sys-
tems [Egami and Billinge, 2003; Billinge, 2008b] but its application to molecular systems
has to date been very limited.
Up to this point in the thesis, we have been a little bit liberal in our use of the terms
`PDF' and `TSPDF', since TSPDFs are a subset of the PDF umbrella and the underlying
theory and corrections are the same for both. However, at this point, we nd it instructive
to refer exclusively to TSPDFs to highlight the requirement of high-energy X-rays and a
large Q-range.
5.2 Experimental Procedure
Melt-quenched samples of CBZ and IND as well as polycrystalline samples of CBZ-I and
CBZ-III [Grzesiak et al., 2003] and  [Chen et al., 2002] and  [Cox and Manson, 2003] IND
were measured with a lab-based diractometer and a synchrotron. Melt-quenched samples
were prepared by rapidly cooling molten compound in liquid N2, then lightly grinding the
compound, sieving it, and lling it into a 1 mm diameter Kapton R capillary. Crystalline
samples were also ground, sieved, and lled into capillaries of the same type and diameter.
5.2.1 Lab Diractometer
The laboratory data shown in Figure 5.1 were collected on a Bruker-AXS D8 diractometer
using capillary transmission geometry, primary monochromated Cu K1 radiation ( =
1:54056 A) in the range 2-40 2, 0.016 2 step size, 10 s per step, at 100 K.
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5.2.2 Synchrotron
Data were collected at 100 K at beamline 11-ID-B at the Advanced Photon Source (APS)
using the rapid acquisition PDF (RAPDF) method [Chupas et al., 2003]. Samples were
sealed in 1 mm diameter Kapton R capillaries and irradiated with X-rays of wavelength
 = 0:1370 A. A large area 2D image plate detector (MAR345) was placed centered on and
perpendicular to the incident beam 198 mm behind the sample. Sucient statistics in the
high Q-range were obtained using multiple exposures of the image plate, exposing for 300 s,
between 5 and 8 times for each data point. The separate exposures were summed together
before further processing, resulting in an integrated exposure time of 30 min per sample.
1D powder diraction patterns were obtained by integrating around the Debye-Scherrer
rings on the image plate images, correcting for beam polarization eects using the program
Fit2D [Hammersley, 1998]. Data were collected to Qmax = 31 A
 1 and Fourier transformed
using data to Qmax = 20 A
 1 to generate TSPDFs to rmax = 30 A.
5.2.3 Total Scattering Data Processing
The short wavelength used (0.137 A), combined with an appropriate data collection strategy
enables data to be recorded over a suciently high Q-range to provide the necessary resolu-
tion in real-space for quantitative structural analysis to be attempted. In these data, a use-
able Qmax = 20 A
 1 was achieved, equating to a real-space resolution of 2=Qmax = 0:31 A.
The data were corrected for multiple scattering, Compton scattering, and sample self-
absorption, and normalized by the incident intensity and number of scatterers in the sample
as described in Chapters 1 and 3. The total scattering reduced structure function, F (Q)
(Equation (1.20)), was calculated as per the steps in Chapter 1. The F (Q) was Fourier trans-
formed into the G(r). All of these steps were carried out using the program PDFGetX2 [Qiu
et al., 2004].
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5.3 Results
5.3.1 Carbamazepine
The total scattering data, presented as F (Q), and the resultant TSPDFs for the amor-
phous and polycrystalline samples of CBZ are shown in Figure 5.2. The F (Q) for the
melt-quenched sample (Figure 5.2(b)), measured over a wide enough range of momentum
transfer and properly normalized, is rich in information content compared to a conventional
laboratory-based XRPD measurement (e.g. Figure 5.1). Close inspection shows no clear
Bragg diraction, conrming a lack of long-range order in the sample. The F (Q) clearly
distinguishes the polycrystalline samples CBZ-III and CBZ-I (Figure 5.2(a) and (c), re-
spectively) with the melt-quenched sample showing a closer resemblance to that of CBZ-III
than CBZ-I.
Transforming F (Q) toG(r) (i.e. the TSPDF) allows interpretation and comparison to be
carried out in real space. There is a striking resemblance between the TSPDF of CBZ-III and
the melt-quenched sample. Full-prole comparisons of the TSPDFs in the range dominated
by inter-molecular interactions, 3 - 20 A, for the three samples using PolySNAP [Barr et al.,
2004] yielded a correlation co-ecient of 0.8389 for the melt-quenched and CBZ-III TSPDFs
(perfect match = 1.0). The next closest similarity was observed for melt-quenched CBZ and
Form I, but yielding a correlation coecient of only 0.6124. The PolySNAP correlations
between the three CBZ phases are in Table 5.1
Given such close agreement between the melt-quenched and Form III TSPDFs, the struc-
tural similarity between these samples was explored in more detail. The TSPDF of CBZ-III
was modied by attenuating the TSPDF peaks in the high-r region using a spherical charac-
teristic function to simulate the eects of reducing the range of structural coherence (or long
range ordering) on the data, assuming spherical particles, using Equation (5.1) [Guinier,
1963], where r is the r-grid the TSPDF is on, d is the particle diameter, and  is a step
function which is 0 when r > d. If the internal atomic arrangement of a nanocrystalline
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Figure 5.2: Total scattering diraction patterns and TSPDFs of CBZ. Panels (a) and (d)
correspond to CBZ-III, (b) and (e) to the melt-quenched sample and (c) and (f) to CBZ-I;
(a), (b), (c) show the total scattering data in the form of F (Q) whilst (d), (e), (f) are in
the form of the TSPDF, G(r).
Table 5.1: Summary of PolySNAP correlation coecients between CBZ-I, CBZ-III, and
melt-quenched (MQ) CBZ. Correlations higher than 0.8 are shown in bold (except when
they are trivially unity).
CBZ-I CBZ-III CBZ-MQ
CBZ-I 1 0.4467 0.6124
CBZ-III 1 0.8389
CBZ-MQ 1
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domain resembles that of a bulk crystalline analog, its TSPDF resembles that of the bulk
except that the amplitude of the TSPDF peaks is attenuated with increasing r due to the
loss of far-neighbor correlations outside the particle. This can be modeled by multiplying













G(r; d) = G(r)  f(r; d) (5.2)
The overlay shown in Figure 5.3 was obtained using a nanocrystalline domain diameter
of 4.5 nm. The excellent agreement between the attenuated TSPDF from CBZ-III and the
melt-quenched CBZ TSPDF is denitive proof that the local packing in the melt-quenched
sample is that of Form III with a range of structural coherence of 4.5 nm. It is interesting
to ask whether the sample is made up of discrete 4.5 nm nanocrystallites of Form III or
whether it is truly a homogeneous amorphous structure with short-range molecular CBZ-
III-like packing. The data suggest the former since the sharpness of features in the TSPDFs
is preserved with increasing r whilst their amplitude is simply reduced, which is not the
behavior seen in truly amorphous samples. We thus conclude that the structure of the
melt-quenched CBZ used in the measurement is actually nanocrystalline CBZ-III with an
average particle diameter of 4.5 nm. Although the TSPDF of the melt-quenched sample is
well explained by CBZ-III attenuated by the PDF characteristic function for a sphere, we
cannot rule out that there is a dispersion of nanoparticle sizes centered around the value
of 4.5 nm. For example, narrow dispersions with  10% polydispersity are well explained
using the characteristic function for a single sphere.
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Figure 5.3: Comparison of TSPDF from the melt-quenched amorphous sample (green) and
CBZ-III (blue), modied as if it were a 4.5 nm nanoparticle (see text for details). PolySNAP
correlation coecient 0.8601.
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5.3.2 Indomethacin
A similar analysis has also been carried out on a melt-quenched sample of IND, and the
results are shown in Figure 5.4. Again, F (Q) shows the melt-quenched IND sample to be
X-ray amorphous (no evident Bragg diraction) and rich in structural information. From
Table 5.2, the highest correlation coecient from full-prole comparisons of the TSPDFs
of melt-quenched,  and  IND in PolySNAP was 0.6770, returned for the melt-quenched
and -IND phases. This is signicantly lower than the highest value obtained for the CBZ
TSPDF comparisons. All other coecients were less than 0.5. Thus, the TSPDFs indicate
that the local structure of the melt-quenched IND sample at 100 K is largely distinct from
the  and  crystalline forms. This contrasts with the suggestion based on crystallization
and spectroscopic evidence that below Tg (315 K [Andronis and Zogra, 2000]) amorphous
IND has a local structure, with dimeric hydrogen bonding, similar to the  form [Shalaev
and Zogra, 2002]. Linear combinations of the  and  crystalline phases also do not give
good agreement with the TSPDF from the melt-quenched sample. Further comparisons with
the  Form of IND were not possible at the time of writing as neither a crystal structure
nor experimental TSPDF were available [Borka, 1974]. However, this result clearly shows
that the TSPDF can readily characterize distinct local molecular packing arrangements
in the amorphous IND sample. We note that, as with the CBZ, oscillations in the PDF
are apparent over the whole r-range shown and clearly extend beyond 20 A, which shows
that the melt-quenched IND sample we studied is also nanocrystalline rather than truly
amorphous.
5.4 Discussion
The key to obtaining useful TSPDF curves is not the use of synchrotron radiation per se
but collecting data to high Q with good statistics. This is possible from laboratory based
diractometers that have Ag ( = 0:556 A) or Mo ( = 0:7107 A) sources, where the fact
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Figure 5.4: Total scattering diraction patterns and TSPDFs of IND samples. (a) and (d)
contain patterns from IND , (b) and (e) to the melt-quenched sample and (c) and (f)
IND . The column (a), (b), (c) shows the synchrotron total scattering data in the form
of F (Q) and the second column, (d), (e), (f), contains the total scattering data in the form
of the TSPDF, G(r).
Table 5.2: Summary of PolySNAP correlation coecients between IND , IND , and
melt-quenched IND. Correlations higher than 0.8 are shown in bold (except when they are
trivially unity).
IND  IND  IND-MQ
IND  1 0.4057 0.6770
IND  1 0.4886
IND-MQ 1
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that  is a factor of  2-3 times smaller than that of a Cu source means that higher Q values
can be accessed for any given diraction angle. The current data were Fourier transformed
with a Qmax of 20 A
 1, which is certainly accessible with a Ag lab diractometer, although
a suitably congured Mo instrument would oer signicant practical advantages such as
higher incident ux, increased X-ray scattering and higher detector eciency. That said,
synchrotron measurements are advantageous because the requisite statistics can be obtained
over the whole Q-range in a short time (in this case 30 min) compared to many hours
on a laboratory-based source. Future developments in high intensity, short wavelength
laboratory X-ray sources will certainly help close this particular gap.
5.5 Conclusion
These results have a number of important implications. They show that TSPDF data can be
used to unambiguously dierentiate between dierent forms of amorphous or nanocrystalline
molecular solids. As such, TSPDF is an approach that can take the ngerprinting role for
amorphous pharmaceuticals that XRPD takes for polycrystalline pharmaceuticals. This
opens the door to future studies exploring the eects of processing or storage on amorphous
materials and of phase stability in molecular dispersions, for example. There can also be
sucient information in the TSPDF to enable the tting of well-dened structural models
for the molecular conformation and packing arrangements in amorphous and nanocrystalline
samples. Clearly this would have particular application in the case of the melt-quenched IND
TSPDF presented here, however the development of such models is beyond the scope of the
current work. This capability oers the potential to revolutionize the study of amorphous
samples, by illuminating the basic science underpinning the structure of non-crystalline
molecular materials to add to the wealth of thermodynamic and spectroscopic literature
available. Also, by tracking the evolution of structure of melt-quenched glasses for example,
this tool may help identify new crystalline polymorphs via an amorphous or nanocrystalline
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route.
As we hinted in the Discussion section, the work done in this chapter does raise the
very important question of what Q-range is sucient for ngerprinting nanocrystalline and
amorphous pharmaceuticals. We have seen that a Qmax of 20 A
 1 is enough to produce
TSPDFs with a good r-resolution, but this range is accessible only to synchrotron and Ag-
anode instruments, both of which have their drawbacks. Synchrotron beamtime needs to be
booked sometimes months in advance and is not always available for commercial use, and
Ag-anode instruments have low intensities which could result in very long data collection
times [Egami and Billinge, 2003]. On the other hand, measurements using a Cu-anode
diractometer would be ideal, particularly since this type of instrument is the cheapest and
most common, but it can only reach a theoretical Qmax of 8 A
 1. We answer this question
in Chapter 6 by doing a systematic study of the eect of Qmax on the quality and reliability
of PDFs used in ngerprinting pharmaceutical compounds.
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Chapter 6
Data Requirements for the Reliable
Use of Atomic Pair Distribution
Functions in Amorphous
Pharmaceutical Fingerprinting
The work in this chapter was done in collaboration with Ryan Taylor, Alastair Florence,
and Simon J.L. Billinge and published in the journal Pharmaceutical Research [Dykhne et
al., 2011].
In Chapter 5, we investigated the eectiveness of the total scattering pair distribution
function (TSPDF) method for ngerprinting disordered (i.e. nanostructured and amor-
phous) pharmaceutical compounds. We found that TSPDFs were able to identify that
melt-quenched carbamazepine had the same structure as its Form III polymorph. However,
we were left with the question of whether it would be possible to ngerprint pharmaceutical
compounds using X-rays with lower energies than that of a synchrotron.
In response, we have carried out a systematic study comparing the ecacy of nger-
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printing condensed phases of small molecule systems using atomic pair distribution functions
(PDFs) obtained from X-ray diraction data measured over dierent ranges of momentum
transfer, Q. Data collected over a wide Q-range, for example from high energy X-ray
synchrotron beamlines, contain more information and are expected to yield more reliable
results. However, we nd that reliable ngerprinting is still possible down to Q-ranges
accessible to silver and molybdenum laboratory sources, but data from copper anode labo-
ratory sources, which have the smallest Q-range, are unreliable for ngerprinting, yielding
ambiguous and potentially incorrect results. These ambiguities make data measured over
too narrow of a Q-range unsuitable for ngerprinting APIs and small molecule systems
and, in general, copper anode diractometers are undesirable for this purpose; however,
laboratory X-ray sources with either Mo or Ag anodes are well suited to this application.
6.1 Introduction
As discussed in Chapters 2 and 5, the majority of drug compounds, or active pharmaceutical
ingredients (APIs), are marketed in crystalline forms largely for reasons of physico-chemical
stability and processibility. However, the amorphous state is also of signicant interest
within the pharmaceutical industry, particularly as a possible means to enhance aqueous
solubility of APIs [Hancock and Parks, 2000]. In the development of new medicinal products,
poor oral bioavailability due to low aqueous solubility/dissolution rates of many crystalline
API candidates is increasingly a potential barrier to enabling treatments to be administered
using tablet or capsule formulations. However, to ensure that all batches of manufactured
dosage forms are bioequivalent, the selection of a robust solid form is necessary to ensure that
the batch-to-batch variability in raw material properties is minimized and that the selected
form is stable during all stages of processing, manufacture, and storage. An important
practical barrier to the development of amorphous APIs in product development is the lack
of reliable methods for ngerprinting amorphous APIs, for example to provide unambiguous
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structural identication of raw material or to highlight possible structural changes over time
that may lead to changes in product performance e.g. due to crystallization of the API.
Whilst largely routine for crystalline solids, traditional X-ray powder diraction (XRPD)
ngerprinting methods are invalid for amorphous forms due to the lack of long range atomic
structure [Billinge et al., 2010]. Recently, atomic pair distribution function (PDF) methods
have been suggested as an alternative approach for ngerprinting amorphous APIs [Bates
et al., 2006; Billinge et al., 2010] and for providing valuable insight into the local packing of
pharmaceuticals in non-crystalline forms. If these methods are validated as giving reliable
ngerprints of APIs in the amorphous state, they could make a signicant contribution to
expediting the wider commercial exploitation of amorphous pharmaceuticals.
Although the PDF has historically been used on inorganic materials, it has recently re-
ceived some attention from the pharmaceutical community and has been applied to molec-
ular materials in crystalline and amorphous phases. There are examples in the litera-
ture of PDFs of molecular materials obtained from X-ray diraction data from standard,
widely available copper anode laboratory based XRPD instruments [Sheth et al., 2004;
Bates et al., 2007; Sheth et al., 2005; Newman et al., 2008], and also TSPDFs obtained
from powder data collected on a high energy synchrotron source [Billinge et al., 2010].
The rst step in a PDF measurement is to collect powder diraction data with low noise
over some range of momentum transfer, Q, where Q is related to the Bragg angle, , which
is half the scattering angle, and the wavelength,  of the incident radiation: Q = 4 sin =
(Equation (1.2)). The data are then corrected for experimental artifacts and normalized to
obtain the reduced structure function, F (Q), which can be Fourier transformed to get the
PDF [Egami and Billinge, 2003]. This is readily done using available software [Qiu et al.,
2004].
We showed in Chapter 5 that powder diraction data collected over a wide Q-range can
successfully be used to dierentiate the local structure of X-ray amorphous pharmaceutical
forms (i.e. samples that do not give rise to measurable Bragg diraction on a standard
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laboratory diractometer) of carbamazepine and indomethacin from their respective crys-
talline forms, both in Q-space (raw data) and in real-space as the PDF [Billinge et al.,
2010]. This approach, referred to as total scattering pair distribution function (TSPDF)
analysis, is therefore a good candidate for ngerprinting amorphous small molecule mate-
rials. An alternative approach for ngerprinting amorphous forms within the laboratory
environment is to use powder diraction data from a conventional copper-anode laboratory
source (CALS) to obtain PDFs [Sheth et al., 2004; Bates et al., 2007; Sheth et al., 2005;
Newman et al., 2008]. Here we evaluate the relative ability for ngerprinting the inherently
low-Q CALS derived PDFs and TSPDFs obtained with higher energy sources.
In general, if there is too little information in a diraction data-set it will not be possible
to use it for ngerprinting as it will not give a uniquely identiable pattern arising directly
from the molecular packing of the particular form. For example, it has been pointed out
that, in contrast to crystalline forms, there is insucient information in the diraction pat-
tern of amorphous APIs when measured in the low-Q region accessible from a CALS [New-
man et al., 2008]. Indeed, the absence of diraction peaks in a CALS powder pattern is
often used as the basis to identify the sample as amorphous or more specically as `X-ray
amorphous' or `diraction amorphous'. This lack of information in a conventional CALS
diraction pattern collected from an amorphous API is the main origin of the diculty in
realizing reliable ngerprinting of non-crystalline APIs or solid dispersions of API. However,
when measuring diraction data over a wider Q-range, PDFs can be obtained that are more
information rich, and therefore more capable of being applied successfully in sample nger-
printing. This argument breaks down at the point where the structure-containing signal in
the diraction data disappears altogether. At this point the resolution is sample-limited
and there is no benet to measure over a wider range of Q. In most inorganic materials,
this occurs typically at values of Q = 30  40 A 1 [Egami and Billinge, 2003].
To access higher Q-ranges it is necessary to use shorter wavelength X-rays. For example,
the maximum Q-range accessible to a typical CALS instrument is  8 A 1, equivalent
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to 160 2, whereas for molybdenum-anode laboratory sources (MALS) and silver-anode
laboratory sources (SALS), it is  16 A 1 and  22 A 1, respectively. Q-ranges up to
 45 A 1 are accessible when measuring using high energy synchrotron radiation [Petkov et
al., 2000]. In this chapter we address the issue of the range of Q that is required for eective
ngerprinting of amorphous APIs. We also investigate the value of Q where scattering from
amorphous APIs becomes sample limited.
A second requirement for successful ngerprinting of any solid form is that for the data
to be representative they must be reproducible and uniquely attributable to the phase
being measured. As the PDF is derived from the raw data through a process of data
corrections and normalization, any ambiguities in the data reduction may lead to variations
in the resulting PDFs. Thus, a given data-set could potentially result in more than one
PDF. Clearly in such instances, the measured PDF is not unique and is of no value for
ngerprinting. As with powder diraction for ngerprinting polycrystalline phases, any
observed changes in the pattern should relate directly to changes in the structure of the
sample alone.
We nd that data collected over Q-ranges accessible from MALS and SALS instruments
yield PDFs that give unique and reliable ngerprints. The situation becomes more ambigu-
ous as the Q-range measured decreases and low-Qmax measurements from copper sources
are less reliably unique and the information content is not, in general, adequate to provide
a unique and therefore reliable ngerprint.
6.1.1 Theoretical Background
The reduced structure function F (Q) = Q[S(Q) 1] (Equation (1.20)) is obtained from raw
powder diraction data by correcting for experimental eects and normalizing the data,
which is then Fourier transformed to obtain the PDF, G(r) [Egami and Billinge, 2003]
(Equation (1.23). In practice it is not possible to know a-priori the proper normalization
factors, which depend on things such as detector eciency, beam size and sample volume
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and density that are not typically well known. However, the behavior of the structure func-
tion, S(Q), is known: S(Q) oscillates around unity and as Q ! 1, S(Q) asymptotically
approaches unity. If we assume that additive corrections to the data (for example, back-
ground subtraction, multiple scattering, and Compton scattering) have been well accounted
for, or are minimal, we can use the asymptotic behavior to ensure a correct normalization
by scaling the data such that it oscillates about hf(Q)i2 and approaches it in the high-Q
region [Egami and Billinge, 2003], as we explain below. In practice we don't measure S(Q)
to1 but to some nite value, Qmax, which is determined by the wavelength of the incident
radiation and the highest scattering angle used. However, the signal in the diraction data
dies out with increasing Q and is gone by a Q-value of 40-50 A 1 in most cases [Egami
and Billinge, 2003]. In practice, even when data are collected over a range limited to
Qmax = 15  20 A 1 it is possible to observe the decay of the signal.
The decay of the signal at high-Q allows for a reliable normalization of the data. By
denition, S(Q) oscillates around unity and the decay means that S(Q) asymptotically
approaches unity with increasing Q [Egami and Billinge, 2003]. Since S(Q) = I(Q)=hf(Q)i2
we need to multiply the measured intensity by a factor such that, in the high-Q region where
the signal has died, I(Q) = hf(Q)i2. We used the program PDFGetX2 [Qiu et al., 2004] to
carry out the corrections and the normalization. The data were corrected for background
scattering, self-absorption, and incoherent Compton scattering then normalized for incident
ux, number of scatterers, and atomic form factor squared, hf(Q)i2, to obtain the structure
function, S(Q).
In practice, PDFGetX2 assists the user with the corrections by optimizing the shape of
the S(Q) over a user-specied range of data, typically in the high-Q region. The program
varies a series of physical parameters such that the S(Q) oscillates around the hf(Q)i2 and
approaches 1 as Q approaches Qmax. This is an eective way of determining the proper
corrections when oscillations of the signal around hf(Q)i2 are small, i.e., in the high-Q
region. However, at low-Q, the signal is still oscillating strongly. The approximation used
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by the program no longer holds since the value of S(Qmax) depends on precisely where
Qmax falls in the oscillating signal. It is no longer true that the correct shape of the S(Q) is
obtained by matching I(Q) to hf(Q)i2 over some user-specied range of Q. Dierent S(Q)
shapes lead to a variability in the PDF obtained by Fourier transforming the data and it
is therefore possible to obtain qualitatively dissimilar PDFs by selecting dierent ranges of
data over which to run the optimization. When data are available extending to high-Q, the
ambiguity in determining the correct shape of the S(Q) is resolved and unique PDFs are
obtained from a given diraction pattern, as we show below.
The PDF, G(r), is obtained from the S(Q), by a Fourier transformation as per Equa-
tion 1.23. The Fourier transform is a linear transform and there is a unique relationship
between S(Q) and the resulting G(r). No information is added or removed in the trans-
form. However, in practice, what is transformed is the corrected, experimentally determined






Q[Sexp(Q)  1] sinQr dQ: (6.1)
There is still a unique relationship between Gexp(r) and Sexp(Q) if the transform is
carried out over the same Q-range, but ngerprinting will be compromised if Sexp(Q) itself
is not suciently unique, i.e., deviations of Sexp(Q) from the underlying S(Q) of the material
under study are small compared to dierences between the S(Q)'s of dierent materials of
interest. In the rst part of this chapter, we test this assumption for data measured to low
and high values of Qmax. We do this by obtaining dierent Sexp(Q) functions from the same
raw data using dierent, but reasonable, protocols for carrying out the PDF optimization
in PDFgetX2. This is done by xing Qmax but changing the range given to PDFgetX2 for
the automatic PDF optimization. Since the exact value of Qmax is a somewhat arbitrarily
chosen experimental parameter we also show the sensitivity of Sexp(Q) to the choice of Qmax
over some narrow but reasonable range of values for data with low- and high-Qmax's.
CHAPTER 6. DATA REQUIREMENTS FOR THE RELIABLE USE OF ATOMIC










Figure 6.1: Molecular structures of CBZ (left) and IND (right).
6.2 Experimental Procedure
6.2.1 Samples
TSPDF data were collected from melt-quenched (amorphous) samples of carbamazepine
(CBZ), an anti-epileptic drug, and indomethacin (IND), a non-steroidal anti-inamatory
drug (henceforth referred to as CBZ-a and IND-a, respectively), as well as polycrystalline
samples of CBZ Form I and Form III (CBZ-I and CBZ-III) [Grzesiak et al., 2003] and the
 [Chen et al., 2002] and  [Cox and Manson, 2003] forms of IND (IND- and IND-). The
molecules are shown in Figure 6.2.1.
Details of the sample preparation are described in Chapter 5. Briey, the amorphous
samples were prepared using a melt-quenching method whereby molten compound was
rapidly cooled in liquid N2, lightly ground, sieved, and lled into a 1 mm diameter Kapton
R
capillary.
6.2.2 X-Ray Powder Diraction Experiments
All samples were measured using a Bruker-AXS D8 diractometer using capillary geometry
with primary monochromated Cu-K1 radiation ( = 1:54056 A) and Lynxeye position
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sensitive detector (PSD) in the range 2-40 2 (i.e. Qmax ca. 2.8 A 1) with step size
0.016 2, 10 s per step at 100 K [Billinge et al., 2010]. Although this is well below the
potential Qmax accessible on the instrument, this reects the typical data range collected for
ngerprinting polycrystalline samples. Total scattering data were also collected at beamline
11-ID-B at the Advanced Photon Source (APS) at Argonne National Laboratory using the
rapid acquisition PDF method [Chupas et al., 2003]. A 2D image plate detector was placed
perpendicular to a high energy X-ray beam ( = 0:137024 A) 198 mm behind the sample.
Data were collected for 300 s and this was repeated between 5-8 times for a total collection
of about 30 min for each data-set.
6.2.3 Fingerprinting
After PDFs have been obtained from the data using the methods discussed above, we test
their ecacy at ngerprinting. This is done both qualitatively and quantitatively. For the
qualitative analysis we simply use a visual comparison of the plots of the PDFs. For the
quantitative analysis we use programs that quantify the similarity of curves. As discussed
in Chapter 5, we use the commercially available PolySNAP program, which uses a modied
version of the Spearman correlation parameter [Barr et al., 2004]. In addition to PolySNAP
we use a home-written program that computes the Pearson product-momentum correla-










(Equation (1.24)), where X
and x are the mean and standard deviation of a data set, respectively. Both correlation
techniques create an m m matrix that contains a correlation value r in the range -1 to
1 between each pair of m data-sets. The value 1 implies complete correlation, zero implies
no correlation, and -1 implies an anti-correlation. The correlation techniques are extremely
powerful because they ignore absolute scaling, but are sensitive to relative scaling and slight
shifts in peak positions.
We study the correlations between PDFs in the range r = 3:0   20 A. We chose this
range because the very local structure (i.e. r < 3:0 A) of all molecular samples is similar due
CHAPTER 6. DATA REQUIREMENTS FOR THE RELIABLE USE OF ATOMIC
PAIR DISTRIBUTION FUNCTIONS IN AMORPHOUS PHARMACEUTICAL
FINGERPRINTING 79
to intra-molecular atom pairs, for example, consisting of nearest and next-nearest neighbor
carbon-carbon bonds at 1.4 A and 2.4 A, respectively. Applying the correlation analysis to
the entire data range does not change the result signicantly but reduces the sensitivity to
nding dierences in molecular packing of the correlation analysis by including a range of
r-that is highly similar regardless of the packing.
6.3 Results
6.3.1 Uniqueness Tests
First we consider TSPDF data from the synchrotron which has a Qmax = 20.0 A
 1. Figure
2(a) shows 4 PDFs obtained from the same data-set but where the range of data used for
the automated normalization in PDFgetX2 was from 62%, 71%, 80% and 92% of the Qmax
to Qmax, respectively; e.g., in the rst, 62%, data were normalized from 12.5 A
 1 to 20 A 1.
It is clear from the gure that the resulting PDFs are all highly similar. This is supported
by the correlation analyses with the Pearson correlations for the PDFs all being larger than
0.99: the PDF generated is always unique regardless of reasonable variations in the selected
processing parameters.
This is not true for the data with Qmax = 2.8 A
 1 from the CALS data, as is evident
in Figure 2(b). Again the 4 PDFs are all from the same data-set obtained by providing
PDFgetX2 with the same relative Q-ranges as in Figure 2(a) for normalization. The four
curves have peaks shifted and even features disappearing. For example, the peak at 12 A is
wholly absent in two of the four PDFs. Correspondingly, the Pearson correlations are as
low as 0.73 between these PDFs.
6.3.2 Qmax Sensitivity
So far, we have looked exclusively at data collected from a synchrotron ( = 0.137 A) or
a CALS not used to its full potential ( = 1.54 A, 2max = 40 degrees). There are other
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Figure 6.2: PDFs of amorphous-phase CBZ with (a) Qmax = 20.0 A
 1 and (b) Qmax =
2.8 A 1 optimized over various ranges of Q. In panel a, all of the PDFs match up to each
other perfectly, while in panel b, the PDFs exhibit variations in peak positions, relative
intensities, and broadness.
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X-ray sources between these two extremes. These include molybdenum anode laboratory
sources (MALS), with a wavelength of 0.709 A [Deslattes et al., 2003] and silver anode
laboratory sources (SALS) with a wavelength of 0.559 A [Deslattes et al., 2003]. We choose
the maximum 2 value of 160, which corresponds to Qmax = 8.0 A 1, for the CALS, and a
reasonable 2, for example 90 degrees, which corresponds to a limit where experiments may
be completed in a short amount of time, for the MALS and SALS. The Qmax values that
correspond to these conditions, with 2max = 90
, are 12.5 A 1 and 15.9 A 1 for MALS
and SALS, respectively.
To provide a uniform comparison of these instruments conditions, and in the absence of
access to a complete set of suitable diractometers, we have simulated data for the three
instrument types using the data collected from the synchrotron only over the Q-range up
to the relevant Qmax values given above for each anode type. In this test we found that it
was important to renormalize the synchrotron data-sets for each value of Qmax. Although,
in principle, the data should require the same normalization factor regardless of Qmax, in
practice some deciencies in the data corrections mean that the normalization needs to
be tweaked for each Qmax. This underscores the importance of being able to carry out a
reliable normalization, though we note that the fact of having the higher-Q data available
allows us to make better corrections before the nal step of treating the normalization.
Figure 3(a) shows the results for the crystalline Form-III CBZ, with the low angle
2max = 40 degrees CALS data also shown for completeness.
It is clear from the gure that a Qmax of 12.5 A
 1, accessible to a MALS, is sucient to
obtain virtually all of the features that distinguish the underlying molecular packing (i.e., in
the region above r = 3 A). However, although the general shape of the PDF is reproduced
in the Qmax = 8:0 A
 1 data, there is a signicant loss of information. For example, features
such as the sharp peaks at 3.7 A and 4.4 A are completely lost. This suggests that, for
dierentiating the molecular packing in dierent forms of a typical API, an experiment with
a Qmax of 12.5 A
 1 should be adequate. Such an experiment is easily carried out with a
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Figure 6.3: PDFs of (a) amorphous-phase CBZ and (b) Form III CBZ with Qmax values
corresponding to, in order from top to bottom, a typical synchrotron setup, SALS, MALS,
CALS (2max = 90
) and CALS (2max = 40).
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MALS, but not a CALS.
For the low-Qmax = 2:8 A
 1 CALS data, there is a dramatic loss of information and
peak maxima in the curve do not even qualitatively correspond to the positions of sharp
peaks in the higher resolution PDFs. Data collected over this range are clearly inadequate
for ngerprinting.
It is evident from Figure 3(b) that the same conclusions can be drawn from the PDFs
obtained from these amorphous APIs. They are considered to be X-ray amorphous in the
sense that they have no sharp peaks in the powder diraction measurement on a CALS but,
as synchrotron based total scattering PDF measurements [Billinge et al., 2010] show, they
can have rather well dened local molecular packing. As with the crystalline Form-III we
see that a Qmax of 12.5 A
 1 yields virtually all the ngerprinting information, but there is
signicant loss of information on reducing to Qmax = 8:0 A
 1. We thus see that, as for the
crystalline APIs, amorphous APIs can be ngerprinted using a practical measurement on a
MALS.
We now turn to the quantitative correlation analysis using the Pearson correlation co-
ecients from these data, reproduced in Tables 6.1 and 6.2.
We see an overall trend that the Pearson correlation coecients increase with decreasing
Qmax for each of the same comparison-pairs (e.g., CBZ-III with CBZ-I or CBZ-III with CBZ-
a). This reects the fact that as the G(r) (i.e. PDF) curves broaden due to the decreasing
Qmax, the PDFs become less eective at dierentiating between dierent underlying struc-
tures: PDF curves from dissimilar structures are less discriminating as Qmax decreases and
the PDFs lose information content. However, this loss of information, and the consequent
changes in the Pearson correlation coecients, are quite small for Qmax > 12:5 A
 1. By
Qmax = 8:0 A
 1 the Pearson correlation coecients have increased signicantly for each
comparison-pair, to the extent that it is now dicult to distinguish CBZ-a between CBZ-III
and CBZ-I, whereas the synchrotron data clearly show that CBZ-a is made up of locally
Form-III molecular packing [Billinge et al., 2010]. We also see a false-positive for IND-a
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Table 6.1: Summary of Pearson correlation coecients between the PDFs shown in
Fig. 6.3.2. Correlations higher than 0.8 are shown in bold (except when they are trivially
unity).
CBZ-III CBZ-a CBZ-I IND- IND-a IND-
Qmax = 20 A
 1
CBZ-III 1 0.88121 0.580032 0.36072 0.520868 0.535466
CBZ-a 1 0.721854 0.499347 0.692577 0.585051
CBZ-I 1 0.4143 0.607663 0.353945
IND- 1 0.706309 0.477629
IND-a 1 0.648231
IND- 1
Qmax = 15:9 A
 1
CBZ-III 1 0.88806 0.587318 0.408013 0.540808 0.554994
CBZ-a 1 0.735184 0.528379 0.711449 0.603083
CBZ-I 1 0.461576 0.633917 0.371975
IND- 1 0.747408 0.512554
IND-a 1 0.656109
IND- 1
Qmax = 12:5 A
 1
CBZ-III 1 0.884121 0.602841 0.414968 0.532329 0.552159
CBZ-a 1 0.743738 0.550489 0.694594 0.596248
CBZ-I 1 0.493308 0.642929 0.385381
IND- 1 0.796457 0.546241
IND-a 1 0.648245
IND- 1
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Table 6.2: Summary of Pearson correlation coecients between the PDFs shown in
Fig. 6.3.2. Correlations higher than 0.8 are shown in bold (except when they are trivially
unity).
CBZ-III CBZ-a CBZ-I IND- IND-a IND-
Qmax = 8:0 A
 1
CBZ-III 1 0.896121 0.609902 0.488752 0.541615 0.588639
CBZ-a 1 0.803586 0.611696 0.717735 0.620615
CBZ-I 1 0.567149 0.668514 0.403731
IND- 1 0.874273 0.593747
IND-a 1 0.660049
IND- 1
Qmax = 2:8 A
 1
CBZ-III 1 0.592352 0.56047 0.242189 0.301645 0.315372
CBZ-a 1 0.738592 0.815624 0.889357 0.291114
CBZ-I 1 0.749409 0.688959 0.128833
IND- 1 0.95458 0.25323
IND-a 1 0.324015
IND- 1
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compared with IND- that is not seen in the higher resolution high-Qmax data. Finally, at
Qmax = 2:8 A
 1 the Pearson correlation don't provide any meaningful information. The
correlation between CBZ-III and CBZ-a, which we expect to be high, is not signicant and
there are more false-positives than in any other case.
6.3.3 Information content of PDFs
Although a PDF can be plotted on an arbitrary grid, by convention, PDFs, including
all of the PDFs shown above, are plotted on a relatively ne grid, with r  0:01 A.
However, it has recently been shown [Farrow et al., 2011] that the ideal grid spacing for
PDFs to maximize information content while minimizing correlations between data points
is a grid spacing slightly less than the Nyquist-Shannon sampling frequency, i.e., r  Qmax .
Therefore, the number of independent data points in a PDF, N , is directly proportional
to Qmax, since N  rmaxr = rmax(Qmax) . For example, the ideal grid spacings for Qmax =
20.0 A 1, 8.0 A 1, and 2.8 A 1 are 0.157 A, 0.393 A, and 1.122 A, respectively, which
means that the synchrotron PDF contains roughly 2.5 times more independent data-points
than the 160 2max CALS PDF, and 7.15 times as much as the 40 2max CALS data. For
illustration, Figure 4 contains the PDFs from Figure 3 on the Nyquist-Shannon grid.
We note how the CALS PDFs are much more coarse than those from the synchrotron
data, reecting their reduced information content and further conrming their limited value
in amorphous API ngerprinting.
6.4 Conclusion
We have studied the ecacy of ngerprinting small molecular solids using atomic pair distri-
bution functions (PDFs) obtained from data measured over dierent ranges of momentum
transfer, Q. The chosen ranges corresponded to the maximum Qmax value accessible to
copper-anode lab based XRPD devices, reasonable Qmax values accessible to molybdenum-
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Figure 6.4: PDFs of a Amorphous CBZ and b beta phase CBZ from Figure 6.3.2 plotted
on the Nyquist grid. The lower Qmax PDFs have a coarser grid.
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and silver-anode devices, and a synchrotron beamline. We found that the ability to reli-
ably ngerprint samples using PDF is closely related to the Qmax of the available data.
As Qmax decreases, the PDFs become broader and lower resolution and the information
content in the PDFs goes down. While the best results were oered by data collected at
the synchrotron beamline, it was still possible to ngerprint with data in the Q regime
attainable by silver and molybdenum lab-based instruments. However, ngerprinting failed
with the low Qmax simulating copper anode lab-based instrument. Furthermore, we also
found that data of a suciently high-Q could be robustly normalized resulting in a unique
PDF. However, for low-Qmax data dierent normalization protocols for the same dataset
resulted in a non-uniqueness in the resulting PDFs. This shows that data with a Qmax of
12.5 A 1 or above should be used for eective ngerprinting of pharmaceuticals. Such data
are easily obtained in a laboratory environment using a Mo or Ag anode X-ray source, or
at a synchrotron source where higher quality data and shorter counting times are possible.
We expect that other small molecular systems will have similar requirements.
Over the course of the past two chapters, we have laid the groundwork for the application
of TSPDF to pharmaceutical compounds by rst demonstrating a proof of concept and then
investigating the data requirements for the technique. However, we have not yet explored
a so-called truly amorphous compound, as the melt-quenched samples of CBZ and IND
turned out to be nanocrystalline. For this reason, in Chapter 7 we investigate two truly
amorphous compounds using TSPDF to determine whether we are able to divine out any
structural information from the amorphous phase.
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Chapter 7
Total scattering pair distribution
function analysis of amorphous
pharmaceuticals
The work in this chapter was done in collaboration with Simon J.L. Billinge and presented
to the pharmaceutical industry.
In Chapters 5 and 6, we laid the fundamental groundwork in the technique of using
TSPDFs to ngerprint small molecules (e.g. pharmaceutical compounds). However, so
far, we have only looked at two compounds, carbamazepine and indomethacin, and, the
X-ray amorphous melt-quenched samples of both turned out to be nanocrystalline rather
than truly amorphous. To further test the TSPDF technique, in this chapter we attempt to
ngerprint the crystalline and truly amorphous phases of two new compounds using TSPDF.
We also investigate the eects that temperature, static disorder, and dynamic disorder have
on the TSPDFs.
Furthermore, as we had discussed in Chapter 6, the high energy X-rays produced by a
molybdenum anode laboratory diractometer should theoretically provide for a sucient
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Q-range for ngerprinting with TSPDF. However, up to this point, all the data that we
have analyzed were actually collected at a synchrotron. In this chapter, we investigate
TSPDFs calculated from data collected using an actual Mo diractometer compared to
those collected using a synchrotron.
The analysis of individual TSPDFs is much more detailed in this chapter. While we have
spared the reader the gory details in the past and have been content to describe TSPDFs
in a general way, here we oer a much more detailed qualitative analysis by plotting several
TSPDFs on the same plot and splitting the r range to highlight dierences between areas of
mostly intra-molecular and inter-molecular correlations. As part of this detailed discussion,
we focus on specic features (i.e. peaks at certain r values) of the TSPDF and how they
change between phases and at dierent temperatures. The byproduct of such an exhaustive
study is that the material is quite dense compared to the previous chapters. However, this
type of analysis is key to understanding the power of ngerprinting using TSPDF.
The two compounds presented in this chapter are of a proprietary nature and will
henceforth be referred to simply as 'compound A' and 'compound B'.
7.1 Introduction
Little is known about the local ordering in amorphous and nanocrystalline APIs due to
a lack of reliable experimental probes. Conventional X-ray powder diraction (XRPD)
patterns of amorphous compounds become broad and featureless due to a lack of long range
atomic structure and are not useful for dierentiating between dierent local molecular
packing arrangements [Billinge et al., 2010]. This behavior is illustrated in Figure 7.1
where we see that XRPD data collected from a crystalline compound (blue) has a unique
structural ngerprint, while the data collected from an amorphous compound (green) oers
no information that could be used in ngerprinting. This used to be the end of the story
as far as ngerprinting amorphous phase compounds was concerned.
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Figure 7.1: Typical XRPD patterns of an amorphous compound (green) and a crystalline
compound (blue).
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Recently, atomic pair distribution function (PDF) and total scattering atomic pair dis-
tribution function (TSPDF) methods have been suggested as an alternative approach for
ngerprinting amorphous APIs [Bates et al., 2006; Billinge et al., 2010] and for providing
valuable insight into the local packing of pharmaceuticals in non-crystalline forms. If these
methods are validated as giving reliable ngerprints of APIs in the amorphous state, they
could make a signicant contribution to expediting the wider commercial exploitation of
amorphous pharmaceuticals.
The PDF, G(r), yields the probability of nding an atom at a distance r from any
reference atoms and so provides information on local structure in real space. It is calcu-
lated by taking the sine Fourier transformation of the structure function, S(Q), with the
relationship in Equation (1.23). The S(Q) is obtained by correcting X-ray diraction data
for self-absorption, multiple-scattering, incoherent scattering, etc. The details of these cor-
rections and calculations are in Chapters 1 and 3 and they are applied to the data using
special software, PDFGetX2 [Qiu et al., 2004].
The information content, particularly the resolution in r, of a PDF depends on the
information content of the S(Q), which in-turn depends on the magnitude of Qmax, the
momentum transfer, of the X-rays used. Q is related to the Bragg angle, , which is half
the scattering angle, and the wavelength, , of the incident radiation with Equation (1.2).
Generally, there are two ways to increase the Qmax that can be attained in an experiment.
The rst is to measure out to a higher 2max, which has a hard limit, and the second is
to increase the energy of the X-rays used, which is dependent on the source anode of the
diractometer.
As discussed in Chapter 6, the maximum possible Qmax values, typically measured in in-
verse angstroms, that are available to copper anode laboratory source (CALS), molybdenum
anode laboratory source (MALS), and silver anode laboratory source (SALS) diractome-
ters are 8 A 1, 16 A 1, and 22 A 1, respectively. Synchrotrons are able to go as high as
40 A 1 depending on the conguration. The analysis in Chapter 6 has shown that there is
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not enough information in data collected on CALS diractometers for proper PDF analy-
sis. However, MALS and SALS diractometers and synchrotrons are capable of producing
suciently information-rich TSPDFs [Dykhne et al., 2011].
After TSPDFs have been created, they can be `ngerprinted' against one-another using
qualitative and quantitative techniques. For qualitative analysis, we simply use a visual com-
parison of the plots of the PDFs [Billinge et al., 2010; Dykhne et al., 2011]. For quantitative
analysis, we use a home-written program that computes the Pearson product-momentum
correlation [Myers and Well, 2010; Dykhne et al., 2011] to quantify the similarity of curves
using Equation (1.24).
We study correlations between PDFs of crystalline compounds in the range r = 3:0 
20:0 A. We chose this range because the very local structure (i.e. r < 3:0 A) of all molecular
samples is similar due to intra-molecular atom pairs, for example consisting of nearest and
next-nearest carbon-carbon bonds at 1.4 A and 2.4 A, respectively. Applying the correlation
analysis to the entire data range does not change the result signicantly but reduces the
sensitivity to nding dierences in molecular packing of the correlation analysis by including
a range of r that is highly similar regardless of the packing.
In Chapter 5, we calculated the domain size of melt-quenched nanostructured carba-
mazepine (CBZ) using TSPDF [Billinge et al., 2010]. By looking at how the ripples die out
in a TSPDF we can tell the extent of structural coherence. However, it's very dicult to
tell whether this is because of distinct physical grains of that size or structural coherence
dying out due to disorder because the TSPDF dies out in the same way in both cases.
Here, we report the results of two TSPDF studies on two amorphous compounds, A
and B. The goal of our investigation was to ngerprint and determine whether we could
estimate the domain size or the range of structural coherence of the amorphous form of each
compound. Also, for compound A, we wanted to determine, using PDF and ngerprinting,
whether the amorphous forms created by using two methods - spray drying and cryomilling
- are similar.
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7.2 Experimental Methods
As mentioned earlier, two TSPDF studies were conducted. The rst was to measure all the
samples at a temperature of 100 K at a synchrotron. The second was to measure all the
samples at room temperature, 300 K, using a MALS diractometer. The measurements
were performed at dierent temperatures to see what eect, if any, temperature has on the
TSPDFs of APIs. In theory, there is less atomic motion at lower temperatures resulting
in sharper TSPDF peaks in well ordered crystals at low-T. At higher temperatures, peaks
broaden due to atomic motion and dynamic disorder in the compound. These measurements
are not ideal, though, because they were conducted on dierent instruments with dierent
experimental setups, which can have an eect on the resolution and broadening of peaks in
a TSPDF. An ideal experiment would be to do the temperature comparison on the same
instrument.
Data were collected on three crystalline forms and at least one amorphous form for each
compound at both temperatures. There were several amorphous forms of Compound A
that were synthesized using two dierent methods - cryomilling and spray drying.
7.3 Synchrotron
For the low temperature measurements at the synchrotron, amorphous samples were stored
in a -80 C fridge at Columbia University, transported in dry ice, and kept in dry ice until
they were needed for an experiment. Crystalline samples were kept in a regular refrigerator
until the day of the experiment.
Experiments were performed at beamline X7B of the National Synchrotron Light Source
(NSLS) at Brookhaven National Lab (BNL). Total scattering data were collected using the
Rapid Acquisition PDF method [Chupas et al., 2003]. A Perkin-Elmar 2D image plate
detector was placed 114.9 mm behind the sample, perpendicular to a high energy X-ray
beam with  = 0:3184 A. A spinner rotated the capillary holding the samples at 3 rpm.
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Data were collected from the sample at at 100 K in frames of 30 s, repeated 60 to 90 times
per sample. Measurements were integrated and normalized with respect to total collection
time using the software Fit2D [Hammersley, 1998]. TSPDFs were calculated from the
experimental data using the software PDFGetX2 [Qiu et al., 2004]. All PDFs were made
using Qmax = 16.0 A
 1 to match the maximum Qmax available to a MALS instrument.
7.4 Lab Diractometer
The room temperature measurements were conducted on an in-house PANalytical MALS
diractometer with  = 0:709 A. These experiments were not conducted by members of
the Billinge Group, hence we do not have access to the exact protocols used to measure
the data. However, we calculated TSPDFs from the data measured by PANalytical using
PDFGetX2 [Qiu et al., 2004] with Qmax = 16.0 A
 1, the maximum available to a MALS.
7.5 Results
7.5.1 Crystalline Compound B
As discussed earlier, conventional X-ray powder diraction techniques are unable to probe
amorphous phase compounds due to a lack of long range order in the compounds, as was
illustrated in Figure 7.1. However, when X-ray diraction data are collected on a suciently
high energy instrument, such as a synchrotron, and then Fourier transformed into a TSPDF,
real-space structural information becomes available.
Before we look at the amorphous phase, though, we rst want to get a feeling for the
features of a TSPDF by investigating typical TSPDFs of crystalline APIs. Figure 7.2, which
shows the three polymorphs of compound B, is representative of how TSPDFs of crystalline
compounds look.
In Figure 7.2(a), we see that the TSPDF peaks up to about 3 A in all of the crystalline
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Figure 7.2: (a) The region between 0 A and 3.2 A and (b) the region between
3.2 A and 20.0 A of the TSPDFs of the three crystalline forms of compound B. Data
collected at 100 K. Form  is in blue, form  is green, and form  is in red. All three
TSPDFs look the same in the low-r region, which corresponds to intra-molecular correla-
tions, and are completely dierent when r > 3:2 A, when inter-molecular correlations start
to dominate. The TSPDFs in (b) have been oset and multiplied by 4.0 to t on the axes.
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Figure 7.3: TSPDFs of the same formulations as Figure 7.2. Data gathered at 300 K on
the MALS setup. The TSPDFs in (b) have been multiplied by 5.0 to t on the axes.
forms look exactly the same. These peaks represent intra-molecular correlations from rigid
sub-groups in the molecule such as nearest neighbor bonds and rings. Since the same
molecule is present in all three forms of the compound, this region looks the same regardless
of the form. However, as we see in Figure 7.2(b), the TSPDFs start to look very dierent
from one another at higher r. At this point, inter-molecular bonds start to dominate the
TSPDF and, since all three forms of the compound have dierent molecular conformations
and packing, the TSPDFs look dierent. The higher r region is what is used to dierentiate
the crystalline forms from each other via ngerprinting using the TSPDF.
The TSPDFs in Figure 7.2 are all from data collected at 100 K. As discussed in the
Methods section, at this temperature there is less atomic motion than at room temperature.
Thus we would expect sharper peaks in the TSPDFs. For comparison, we look at the
TSPDFs of the crystalline compounds that were measured at room temperature on the
MALS setup.
We see by comparing Figure 7.3(a) with Figure 7.2(a) that the low-r range looks exactly
as it looked at low temperature, albeit with slightly broadened peaks. We also see that the
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Table 7.1: Summary of Pearson correlation coecients between the crystalline forms of
compound B in the range 3.0-20.0 A. Correlations higher than 0.8 are shown in bold (except
when they are trivially unity).
Form  Form  Form 
Temperature: 100 K
Form  1 0.551 0.436
Form  1 0.599
Form  1
Temperature: 300 K
Form  1 0.721 0.531
Form  1 0.728
Form  1
peaks at the high-r range are in the same positions as they were at low temperature but
are also broader. For instance, in Figure 7.2(b) the Form  (green) PDF has a triplet of
peaks between 10 A and 12 A, while in Figure 7.3(b), the same area looks like one broad
peak with a shoulder. We see a similar situation in the range 12-14 A in the Form  (red)
TSPDFs. TSPDFs tend to broaden with increasing temperature due to dynamic disorder,
meaning that the atoms tend to vibrate more at higher temperatures, and some larger scale
librational motions can also set in.
The investigation we have done so far is an example of qualitative ngerprinting. Gener-
ally, this process involves plotting TSPDFs on top of one another and looking for similarities
and dierences between the various forms. For quantitative comparison, we use the Pear-
son product momentum correlation described in the Introduction. The best way to display
the Pearson correlations is in a table as in Table 7.1. Empirically, we have found that
correlations above 0.8 mean that the two TSPDFs are highly correlated.
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We see from Table 7.1 that, as we would expect, the correlations between the crystalline
phases are quite low. However, we also see that the correlations increase with higher
temperature, since broad peaks tend to make PDFs look more similar to one another.
Overall, the above results show that PDF is a viable method for ngerprinting crystalline
compounds as currently done using standard crystallographic techniques. However, unlike
standard XRPD patterns, the PDF gives real space resolution to the features of a compound.
7.5.2 Amorphous Compound B
Now that we have become familiar with how a TSPDF looks, we introduce the amorphous
form of compound B. We have four measured data sets - one at 100 K and three at 300 K.
All four are plotted in Figure 7.4. The TSPDFs of the data measured at 300 K are blue,
green, and red, while the TSPDF of the data measured at 100 K is light blue. The low
temperature measurement is plotted with an oset in panel (b) for ease of viewing.
In Figure 7.4(a), we see that the low-r region looks exactly the same for all four amor-
phous measurements and is also identical to all of the crystalline measurements. This is
good news and as expected. From Figure 7.4(b), we see some interesting results. First, we
note that sharp features in the amorphous TSPDF disappear after about 10 A. There is
some additional signal in the form of broad features up to about 13.5 A (18 A at 100 K).
After 13.5 A the TSPDF goes at, modulated by noise uctuations. We can therefore esti-
mate the range of structural coherence to be about 13.5 A. This is the distance that we can
see structural information away from any arbitrary atom. Most likely, this distance does
not correspond to grain size, but more information about the compound would be needed
to be sure.
We also note that most of the structural feature are reproduced in all the amorphous
phase TSPDFs across temperatures. Structural features include the three sharp features at
4.0 A, 4.5 A, and 5.1 A, the valley that drops down to about 5.5 A, a peak at about 6.0 A,
and another peak at about 6.8 A. However, there is one obvious feature that sticks out - we
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Figure 7.4: (a) The region between 0 A and 3.2 A and (b) the region between
3.2 A and 20.0 A of the TSPDFs of the amorphous form of compound B. The three mea-
surements at room temperature are blue, green, and red, while the measurement at low
temperature is light blue. The room temperature phases are plotted on top of one another
and the low temperature phase is plotted with an oset for ease of viewing. The amorphous
forms look exactly the same at low r, and then have identical, reproducible, structures up
to about 7 A. All structural information is lost by about 13.5 A. The TSPDFs in (b) have
been multiplied by 6.0 to t on the axes.
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see a sharp peak in the 100 K (light blue) PDF at about 6.4 A which is not present in the
other measurements. This feature could be investigated further, but is clearly particularly
sensitive to temperature. However, this is beyond the scope of this study.
Figure 7.4 is important for two reasons. First, it corroborates that peaks in the TSPDF
of the amorphous samples are real structural features, and not just random noise, since
they are very closely reproduced across measurements that were taken at dierent times,
on dierent machines, under dierent experimental conditions. Second, it allows us to
estimate the range of structural coherence of the amorphous sample based on where there
are no more structural features in the PDF. This method is not exact, but it does provide
a good estimate.
Now that we have seen what crystalline and amorphous TSPDFs of compound B look
like separately, we combine them by plotting them on top of each other in Figure 7.5. We
plot the data up to 14 A because there is no signal beyond that point.
Figure 7.5 shows all four measurements that were gathered at 100 K: three from crys-
talline samples and one from an amorphous sample. The three crystalline forms are plotted
in dierent shades of blue and the amorphous is plotted in red. Visually we can ngerprint
in two ways - rst by determining which features in the PDF of the amorphous are in the
crystal structures, and second, by the process of elimination, determining which features in
the crystalline forms are not in the amorphous. The amorphous PDF shares some features
with all three crystalline forms, but, it appears to share the most features with Form , the
light blue PDF. These features include a shoulder at 3.6 A, peaks at 4.0 A, 5.3 A, 5.55 A,
and 6.05 A, and a valley at 5.4 A. This can lead us to believe that the local ordering of the
amorphous phase is similar to that of Form . On the other hand, we see that the sharp
peak present in the Form  TSPDF (dark blue) at 6.25 A is not in the amorphous PDF.
Also the shoulder at 5.8 A in the Form  corresponds to a trough in the amorphous phase.
Finally, we also note that the peak present in Form  and the amorphous PDF at 4.0 A
is shifted to 4.16 A in Form . These observations lead us to believe that the amorphous
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Figure 7.5: (a) The region between 0 A and 3.2 A and (b) the region between
3.2 A and 14.0 A of the PDFs of the three crystalline forms and the amorphous form
of compound B collected at 100 K. Form  is light blue, Form  is medium blue, Form 
is dark blue, and the amorphous form is red. The amorphous form looks just like the
crystalline forms at r < 3:2 A. It loses sharp features at around 6 A and all structural
information at around 14 A. The crystalline phase PDFs in (b) have been multiplied by
4.0 and the amorphous phase by 6.0 to t on the axes.
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Table 7.2: Summary of Pearson correlation coecients between the TSPDFs shown in
Fig. 7.5 in the range 3-7 A. Correlations higher than 0.8 are shown in bold (except when





phase probably does not have the Form  packing.
The most exciting result is possibly the observation of a very sharp peak in the amor-
phous phase at 4.5 A that is not present in any of the crystalline forms. This is a surprising
result. It is much easier to explain the loss of peaks on going from crystalline to amorphous
due to disorder in the packing, but the appearance of a new sharp feature in the amor-
phous TSPDF means that there is a new, specic packing arrangement or conformation
that is unique to the amorphous phase. Without the ability to model and rene the crystal
structure in real space, we won't know what it is. This needs further development of the
methodology, but the observation of a unique packing in the amorphous state now justies
such a development on the academic side. The possibility that it is an artifact in the data
can be clearly ruled out as we have four independent measurements of the amorphous state,
at two temperatures shown in Figure 7.4, and this feature is robust in all the measurements.
In addition to the qualitative observations above, we can also quantitatively compare the
TSPDFs to one another using the Pearson product momentum correlations discussed earlier.
We look at the correlations between each of the crystalline forms and the amorphous form
in the range 3-7 A because this is the range where we see sharp features in the amorphous
phase and so this region is the only one where it makes sense to compare the crystalline
and amorphous patterns.
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Table 7.2 conrms our observations. The highest correlations occur between the amor-
phous phase and Form , while the lowest correlations are between the amorphous and
Form . In general, Pearson correlations are used as a complementary tool to visually
comparing TSPDFs in ngerprinting. From experience, we have found Pearson correlations
greater than 0.8 signify a strong correlation between two sets of data, but this is not a strict
rule.
Next, we compare the crystalline and amorphous data collected at room temperature.
Although three amorphous data sets were collected, they are suciently similar that one
representative data set can be used in this analysis. Furthermore, as we have already
determined that the low-r range will look the same, only the high-r range plot is shown
below in Figure 7.6.
We see that all of the TSPDFs in Figure 7.6 look more similar to one another than in the
low temperature case. This is not surprising as thermal disorder decreases the sharpness of
features in the crystalline TSPDFs making them look more like amorphous TSPDFs which
have been broadened due to static disorder. The rst sharp peak at roughly 4.0 A, which
was slightly shifted in position in the three low temperature crystal forms, is now in the
same exact spot for all TSPDFs in the room temperature case. Similarly, we see that the
trough at around 5.7 A exists in all measurements. Overall, the amorphous phase seems to
look the most like Form  or Form  (light blue and medium blue, respectively). In addition
to the two sharp peaks at 4.0 A and 5.1 A, they also share a peak at 6.0 A. However, while
the amorphous phase and Form  both have a peak at 6.8 A, Form  does not have any
distinguishable features. As with the 100 K temperature data, Form  looks the least like
the amorphous TSPDF.
We again note that the sharp peak in the amorphous phase at 4.5 A still does not cor-
respond to any of the three phases. Since this peak is reproducible between the amorphous
data collected on dierent instruments at dierent temperatures, it is likely that the peak
contains real structural information. The fact that the peak does not exist in any of the
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Figure 7.6: The region between 3.2 A and 14.0 A of the TSPDFs of the three crystalline
forms and the amorphous form of compound B collected at room temperature. The three
crystalline forms are in dierent shades of blue while the amorphous form is in red. The
crystalline phase TSPDFs have been multiplied by 4.0 and the amorphous phase by 6.0 to
t on the axes.
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Table 7.3: Summary of Pearson correlation coecients between the TSPDFs shown in
Fig. 7.6 in the range 3-7 A. Correlations higher than 0.8 are shown in bold (except when





three crystalline forms at both temperatures means that it warrants further investigation.
We see in Table 7.3 that the correlations between the crystalline and the amorphous
forms are all substantially higher than they were at low temperature. Furthermore, while
Table 7.2 showed that the amorphous was far more correlated to Form  than the other two
forms, in Table 7.3 we see that the amorphous is just slightly more correlated to Form 
than Form . This can be partially explained by the broadening that occurs in the TSPDFs
at higher temperatures. The fact that has remained constant is that the amorphous form
is the least correlated to Form . Further investigation is necessary to determine which is
the ideal temperature for performing these types of measurements.
We can draw several conclusions from our analysis of compound B. First, we have
successfully ngerprinted the three crystalline forms of the compound against one another
and demonstrated the eects that temperature has on TSPDFs of APIs. Next, we have
demonstrated that the TSPDFs of the amorphous form of compound B are reproducible
and contain structural features. Using these PDFs we were able to estimate the range of
structural coherence to be roughly 13.5 A. Finally, when combining the crystalline and
amorphous TSPDFs, we saw that the amorphous form has packing most similar to that of
Form . However, due to the sharp peak at 4.5 A that is not present in any crystalline
form, we are unable to make any conclusions about the amorphous form packing and can
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only recommend further studies. In particular, temperature dependence studies should
be performed on the same instrument to determine the best temperature to collect data
without having to account for resolution eects such as broadening and damping that occur
naturally when comparing data collected on dierent instruments. Also, these additional
studies should explore why the peak in the amorphous samples at 4.5 A is not present in
any crystalline form.
7.5.3 Crystalline Compound A
For this compound, we have data collected from each of the three crystalline forms plus data
collected from amorphous forms that were created using two dierent methods, cryomilling
and spray drying.
First, we ngerprint the crystalline forms against one another, as we did for compound
B. The plots will not be shown here, but the Pearson correlations in Table 7.4 demonstrate
that, as expected, the three crystalline forms are quite dierent from one another at both
temperatures.
7.5.4 Amorphous Compound A
Similar to our investigation above with compound B, we rst want to see if there are
any structural dierences among the amorphous forms and see if we can determine the
structurally coherent domain. We do this by plotting all of the collected amorphous data.
Figure 7.7(a) contains all of the TSPDFs from the amorphous samples plotted on top
of one another in the low-r region. The three samples measured at 100 K were: one
cryomilled (light blue), and two spray dried (medium blue and dark blue). The two 300 K
measurements were of cryomilled (light green) and spray dried (dark green) samples. We
instantly see that the measurements do not perfectly agree with one another in the low-r
region as they had with compound B, but the general low-r structure is the same. We see the
expected C-C peaks at 1.4 A and 2.4 A and also a peak at 1.9 A. Within each temperature
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Figure 7.7: (a) The low-r regions of three TSPDFs of amorphous compound A collected
at 100 K in shades of blue and the two PDFs collected at 300 K in shades of green plotted
on top of each other. (b) The high-r regions of the same TSPDFs from panel (a) plotted
with an oset. The 100 K data (blue) have been multiplied by 5.0 to t on the same axes
with the 300 K data.
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Table 7.4: Summary of Pearson correlation coecients between the crystalline forms of
compound A in the range 3.0-20.0 A. Correlations higher than 0.8 are shown in bold (except
when they are trivially unity).
Form  Form  Form 
Temperature: 100 K
Form  1 0.375 0.372
Form  1 0.465
Form  1
Temperature: 300 K
Form  1 0.397 0.554
Form  1 0.559
Form  1
grouping the TSPDFs are almost the same (i.e. all three blue TSPDFs look just like one
another) and we just see a slight peak shift across temperatures by 0.05 A or less. The peak
at 2.4 A is a great example of peak broadening with increasing temperature. At 100 K, it
is sharp and tall, but then it broadens out and becomes shorter at room temperature.
We note that the 100 K TSPDFs in Figure 7.7(b) match up very well, even though
the samples were processed in dierent ways. We see peaks with structural information at
3.3 A, 3.8 A, 4.33 A, 5.7 A, and 6.1 A. Two of the forms have strong peaks at 4.85 A while
a third has a peak-shaped hump in the area. We also see some broad structural information
in the form of a broad feature between 8.5 A and 11.5 A, but no structural information in
r > 11:5 A. This is an important result because it implies that both amorphous forms are
the same, even though they were created using dierent processing methods. The Pearson
correlations among the three phases in the range 3.0-7.0 A are roughly 0.99. We also
estimate the range of structural coherence to be roughly 11.5 A because there is no signal
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beyond that point. This again probably does not correspond to a grain size and is instead
the distance that we can see away from an arbitrary atom.
The 300 K TSPDFs in Figure 7.7(b) also match up well to each other. We see peaks at
3.35 A, 3.8 A, 4.5 A, 4.9 A, 5.7 A, and 6.06 A. In some instances the peaks don't exactly
line up with each other as they do at 100 K, but these discrepancies are generally quite
small, less than 0.1 A, and can probably be chalked up to the dynamic disorder introduced
at higher temperatures. The Pearson correlation between the two TSPDFs in the range
3-7 A is 0.912, which is lower than what it was at low temperature, but still very high.
Finally, we can again estimate the range of structural coherence to be roughly 11.5 A.
When we compare the TSPDFs across temperatures, we see that many peaks are roughly
in the same positions, such as those at 3.3 A, 3.8 A, 5.7 A, and 6.1 A. Many of the peaks
are slightly shifted, but these shifts are less than 0.1 A and are expected. A very interesting
dierence is that the 300 K TSPDFs have a sharp peak at roughly 4.5 A, while the 100 K
TSPDFs have peaks on either side of it. Most likely, the increase in atomic motion that
results from the higher temperature caused the two peaks to combine into one big one.
Now that we have looked exclusively at the amorphous data and concluded that there
is no dierence between the various forms, we can compare them to the crystalline phases.
We begin by looking at the low temperature data in Figure 7.8.
We plot Figure 7.8 between 3 A and 12 A because there are no dierences in structure
at the low-r range and there is no structural information after about 11.5 A.
All three forms share a peak with the amorphous form at 3.8 A and at 4.3 A. However,
Form  (dark blue) reproduces these peaks the best. Furthermore, there is a hump between
4.7 A and 5.1 A that the amorphous form shares with Form  but not the other two forms.
From this, we can conclude that the amorphous form looks the most like Form . However,
we also note that the peak in the amorphous phase at 6.1 A does not have an analog in
any of the crystalline forms. In fact, they all have troughs at that point. We also see that
Form  looks the least like the amorphous form, particularly because it has a very strong
CHAPTER 7. TOTAL SCATTERING PAIR DISTRIBUTION FUNCTION ANALYSIS
OF AMORPHOUS PHARMACEUTICALS 111

















Figure 7.8: TSPDFs of the amorphous form of compound A (red) and three forms of the
crystalline compound, Form  (light blue), Form  (medium blue), Form  (dark blue)
collected at 100 K plotted between 3.0 A and 12 A. TSPDFs have been multiplied by 3.0
to t on the plot.
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Table 7.5: Summary of Pearson correlation coecients between the TSPDFs shown in
Fig. 7.8 in the range 3-7 A. Correlations higher than 0.8 are shown in bold (except when





features at 6.57 A that is not in the amorphous.
From Table 7.5 we see, as expected, that the lowest correlation is with Form . However,
we also see that the Pearson factor is comparable between Forms  and , though the
qualitative analysis indicated that Form  looked the most like the amorphous form. The
Pearson analysis does not yield a clear winner here, probably due to the sharpness of the
peaks in the crystalline phases compared to the amorphous case.
We can now do the same analysis on the data collected at room temperature.
All phases have peaks at 3.8 A, Forms  and  reproduce the peak at 4.4 A, while the
Form  peak is shifted to 4.2 A. Interestingly, the peak in the amorphous phase at 4.85 A
is replicated perfectly in Form , but in none of the other crystalline forms. Furthermore,
the rise in Form  at 5.55 A and drop at 6.1 A is imitated well in the amorphous phase. In
fact, almost all features of Form  are represented in the amorphous phase except a trough
in at 6.4 A, which coincides with a peak in the amorphous. In particular, the peak in the
amorphous at 6.1 A which had no analog at low temperature now looks like it is part of a
Form  peak.
A table of the Pearson correlations is in Table 7.6. Note that, since the two amorphous
forms are relatively similar to one another, but are not exactly the same, as they were at
low temperature, Pearson correlations for both forms are in the table, even though only one
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Figure 7.9: PDFs of the amorphous form of compound A (red) and three forms of the crys-
talline compound, Form  (light blue), Form  (medium blue), Form  (dark blue) collected
at 300 K plotted between 3.0 A and 12 A. The crystalline PDFs have been multiplied by
3.0 to t on the same axes as the amorphous.
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Table 7.6: Summary of Pearson correlation coecients between the PDFs shown in Fig. 7.9.
Correlations higher than 0.8 are shown in bold (except when they are trivially unity).
Cryomilled Spray Dried
Form  0.758 0.733
Form  0.737 0.739
Form  0.835 0.820
form was used for the visual analysis for simplicity sake.
First, we see in Table 7.6 that the correlations between the two amorphous phases and
the crystalline phases are roughly the same as each other. This lends further credence
to our hypothesis regarding the amorphous compound being the same regardless of how
it was produced. We also see that, in the 300 K data, Form  clearly has the highest
Pearson correlation with the amorphous forms with the others signicantly lower. Further
systematic studies need to be performed to study the relationship between ngerprinting
ecacy of amorphous TSPDFs and temperature dependence of the data collection.
We have three results from our analysis of this compound. First, we have shown con-
clusively that there is no dierence in the packing of the two dierent amorphous forms.
This can have big implications if one form is is easier or cheaper to process. Second, we
have estimated the range of structural coherence of the amorphous compound to be about
11.5 A at room temperature by determining the point at which we no longer have signal
in the PDF. Third, we believe that the amorphous phase has similar packing to that of
Form .
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7.6 Conclusion
In this chapter we have demonstrated the power of total scattering pair distribution function
analysis to study amorphous phase pharmaceutical compounds. Whereas regular crystal-
lography and powder X-ray diraction do not give us any information at all about the
structure and local molecular packing of non-crystalline molecules, the TSPDF gives us
relatively sharp peaks with structural information up to about 7 A and broad features as
high as 12-14 A. There are several results to this investigation: First, we have shown that
the amorphous phases that result from cryomilling and spray drying compound A are the
same. Second, we estimated the ranges of structural coherence for the amorphous phase
of each compound, 13.5 A for compound B and 11.5 A for compound A purely by visually
inspecting the amorphous TSPDFs. This is dierent from the domain size that we calcu-
lated for CBZ in a previous paper. While the CBZ sample was most likely nanostructured,
and thus had some ordering on the scale of a few nanometers, the compounds studied here
are truly amorphous. Third, we have concluded that the packing in the amorphous form
of compound B is distinct from any of the crystalline forms, and also cannot be explained
as a linear combination of those forms. The packing in the amorphous state is distinct in
some regard. In compound A the amorphous packing is similar to that of Form . Finally,
we found that temperature eects play an important role in the TSPDF of the amorphous
and crystalline phase compounds and so they need to be studied systematically on a single
instrument where all parameters except temperature are kept constant.
Additionally, we have proven the results of Chapter 6 by using data collected on a MALS
for pharmaceutical ngerprinting. This is an important result because of the advantages
that MALS has over SALS and synchrotron instruments (higher intensity than SALS and
more accessibility than the synchrotron).
Our results across Chapters 5, 6, and 7 have shown that TSPDF with ngerprinting can
be used to identify local structural information of crystalline, amorphous, and nanocrys-
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talline pharmaceutical compounds. However, we have yet to investigate compounds that
contain polymorphic or amorphous impurities or are mixtures of several phases. These
mixtures can develop, for example, from the application of processing techniques to reduce
particle size, such as milling. In Chapter 8, we investigate whether TSPDF and ngerprint-
ing could be used to quantify the mixing fraction of crystalline and amorphous components
in a recrystallizing compound.
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Chapter 8
Phase quantication at the




The work in this chapter was done in collaboration with Matthew Johnson and Simon J.L.
Billinge.
In previous chapters, we dealt exclusively with single phase APIs, whether they be crys-
talline, nanocrystalline, or amorphous. In this chapter, we make the next logical step and
investigate a mixture that contains crystalline and amorphous components using TSPDF
and ngerprinting.
One of the most challenging problems facing the pharmaceutical industry is to identify
and quantify the phase fractions in mixed phase samples that contain crystalline, nanocrys-
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talline, and amorphous components. Here we demonstrate an approach that accomplishes
this using high energy X-rays coupled with TSPDF analysis by studying samples of sulfam-
erazine, a sulfonamide antibiotic drug, recrystallizing from a cryomilled-induced amorphous
state. Samples milled under dierent conditions were shown to have signicantly dierent
phase compositions. The initial amorphous state was obtained by cryomilling the stable
Form 1 polymorph. This was then aged at low temperature to initiate controlled recrys-
tallization. We show that depending on the milling and aging protocol we see a mixture of
amorphous material with the metastable Form 2 polymorph. A minority of Form 1 is also
observed. We describe the approach that allowed us to quantify the phase fractions despite
the majority of the sample lacking crystalline order.
8.1 Introduction
Milling is a common method for reducing the particle size of a drug during manufacture.
Particle size reduction is desirable, for example, for a particular drug delivery method such
as for inhaled drugs that must access certain parts of the lung [Alagusundaram et al., 2010],
to improve processability [John, 2009], or in the case of poorly soluble drugs, to improve
bioavailability [Gowthamarajan and Singh, 2010]. Milling of the drug particle can lead to
a polymorphic and/or amorphous transformation. The creation of a disordered state as
a result of the breakdown of long range order, increases the molecular mobility and the
likelihood of spontaneous crystallization [Hancock and Zogra, 1997; Wildfong et al., 2006].
As milling is commonly used to reduce the particle size of manufactured drugs, the output
material must be tested for form and, where required, amorphous or polymorphic impurities
prior to release. Tests for impurities are conducted using dierential scanning calorimetry
(DSC) and X-ray powder diraction (XRPD), although it is dicult to quantify the level
of amorphous content using XRPD.
It is typical to call any material that produces a broad halo in an XRPD pattern 'X-ray
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amorphous', but this may not completely be the case. The material may also contain some
order in the form of nano-particles [Billinge et al., 2010] or a crystalline component. Tech-
niques to probe the structure of amorphous compounds or to identify the amorphous phase
fraction are limited. One technique that has been shown to probe amorphous structure
is atomic pair distribution function (PDF) analysis. This technique, which has typically
been applied to inorganic materials [Egami and Billinge, 2003; Billinge and Kanatzidis,
2004; Billinge, 2008b], has been suggested as an approach for ngerprinting amorphous
APIs [Bates et al., 2007] and investigating the local packing of pharmaceuticals in the dis-
ordered solid state [Bates et al., 2007]. We now know that the results of these early studies
are in question because the d-spacing range (Q range, where Q is the magnitude of the
scattering vector [Egami and Billinge, 2003]) over which the data were measured was not
sucient [Dykhne et al., 2011], but PDFs obtained from data of sucient quality and Q-
range are often rich in information and can reliably be used for ngerprinting [Dykhne et al.,
2011] and even studying the structure and size of nanocrystalline forms of API's [Billinge
et al., 2010]. To dierentiate the earlier low-Q PDF measurements from the later high-Q
measurements, we refer to the latter as total scattering PDFs (TSPDF). TSPDFs provide
local information on a compound in the angstrom to nanometer scale, potentially unlocking
the hidden world below the XRPD amorphous halo.
Here we apply the TSPDF technique for the rst time to the phase quantication of
amorphous and polymorphic forms of pharmaceutical compounds. Sulfamerazine, a sul-
fonamide drug widely used with other antibiotics [Maren, 1976], was chosen as the test
compound for this study as it was known to convert upon hard milling [Zhang et al., 2002]
from Form 1 to Form 2 in a short time scale. Sulfamerazine has three known polymorphic
forms: Form 1 [Caira and Mohamed, 1992], Form 2 [Acharya and Kuchela, 1982], and Form
3 [Hossain, 2006]. Using TSPDF we demonstrate that it is possible to extract, quantita-
tively, the phase composition of the samples as they recrystallize from the cryomilled form.
This was made more dicult as we didn't have available all the crystalline forms or a purely
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amorphous sample as controls. Instead, we use a sample that has mostly recrystallized into
Form 2 as a substitute for Form 2 and a TSPDF calculated from a single molecule of the
known crystal structure as a substitute for the amorphous. This demonstration increases
the potential applications of TSPDF analysis for studying amorphous and mixed phase
pharmaceutical compounds.
8.2 Experimental Methods
8.2.1 Sample Preparation and characterization
Two batches of sulfamerazine Form 1 (Sigma Aldrich 58876-50G) were used as input mate-
rial for a Retsch cryomill. The two production batches are dierent as the weight of sample
used in the cryomilling was varied to determine potential process yield.
For the rst batch, 600 mg of sulfamerazine was cryomilled in a 25 ml jar, milling
for 9 cycles of 3 min followed by 3 min cool-down (54 min total). A sample was taken for
XRPD using a CALS on a silicon wafer with the diractometer in reection geometry. Data
collection was over 10 minutes. The results showed that this material was x-ray-amorphous
after cryomilling as seen by the green curve in Figure 8.1(b).
For the second batch, 1500 mg of sulfamerazine was cryomilled in a 50 ml jar, milling
for 9 cycles of 3 minutes, followed by 3 min cool-down. The jar was allowed to warm to
room temperature before opening (about 2 hours) and then tested by XRPD, similar to
the previous batch. The diraction pattern indicated that the sample was still crystalline,
so the cryomilling procedure was repeated for a second time (108 min total). After this
second attempt, the XRPD results showed the material to be partially crystalline, but
the diraction trace did not match the input reference pattern indicating a polymorphic
transformation had occurred during the milling (green curve, Figure 8.1(c)).
Both batches were transferred from the jars to glass bottles and stored for about one
month in a freezer and were again characterized using XRPD before being brought to the
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Figure 8.1: (a) Experimental XRPD pattern of F1 (green) plotted with a Form 1 pattern
simulated from the structure model obtained from the CSD (blue). (b) XRPD pattern of
C1 collected directly after cryomilling (green) and 1 month later (blue). (c) XRPD pattern
of C2 collected directly after cryomilling (green) and 1 month later (blue).
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synchrotron (blue curves in Figure 8.1(b) and (c)). A pure Form 1 sample was measured
as a control (Figure 8.1(a)).
Henceforth, we will refer to data collected from the reference Form 1 sulfamerazine
standard as `F1', the rst cryomilled (small) batch as `C1', and the second cryomilled
(large) batch as `C2'.
8.2.2 Synchrotron Experiment
Powder samples were packed into Kapton R capillaries with 1 mm diameter and brought to
the National Synchrotron Light Source (NSLS) at Brookhaven National Laboratory (BNL)
in dry ice and kept in dry ice in the laboratory until they were put into the X-ray beam.
On the diractometer the capillary was immediately cooled to 100 K in a owing stream of
cold N2 gas using an Oxford cryostream
R cooler.
Total scattering data were collected at beamline X-7B at the NSLS using the rapid
acquisition PDF method [Chupas et al., 2003]. A Perkin-Elmar 2D image plate detector
was placed perpendicular to the X-ray beam ( = 0.3184 A) 114.9 mm behind the sample.
A spinner rotated the capillary holding the sample at 3 rpm. Data were collected for
30 s at 100 K and this was repeated between 60 and 90 times per sample, measurements
were all integrated and normalized with respect to total collection time using the software
Fit2D [Hammersley, 1998].
8.2.3 TSPDF Generation
Two programs were used to calculate PDFs. The rst, PDFGetX2 [Qiu et al., 2004], was
used to calculate TSPDFs from experimental data. This program applies corrections to the
data and Fourier transforms it from Q-space to real space. The second, PDFgui [Farrow
et al., 2007], was used to calculate PDFs from crystal structure les that are available in
databases such as the Cambridge Structural Database (CSD) [Allen, 2002]. Occasionally,
these crystal structures do not have information on the isotropic thermal parameters, Uiso,
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of a compound, which are necessary to calculate a PDF. In these cases a value of Uiso =
0.01 A2 was used. This value is appropriate for atomic vibrations in most materials at
moderate temperatures comparable to room temperature.
8.3 Results
8.3.1 XRPD analysis
First, we visually compare the XRPD data in Figure 8.1. As expected, from panel (a) we see
that the measured F1 diraction pattern clearly corresponds very well with that calculated
from the Form 1 structure model. Next, we consider the CuK diraction patterns of C1
and C2 samples before and after aging for 1 month. Panel (b) shows us that C1 was X-ray
amorphous right after the cryomilling, but transformed into a more crystalline phase after
a month. However, this phase is not fully crystalline as evidenced by the broad halo in the
middle of the plot. Finally, from panel (c), we see that C2 was mostly crystalline after
cryomilling and remained in the same phase over the course of a month, although it does
appear to have a small amorphous halo.
We can use XRPD to ngerprint the crystalline component of the aged C1 and C2
samples. This comparison is shown in Figure 8.2.
Careful examination of Figure 8.2(e), compared to panels (d) and (f), clearly identies
C2 as being in Form 2. However, as evidenced by Figure 8.2(a) and 8.2(b), we are unable to
determine which of the crystalline forms C1 corresponds to, as the XRPD pattern contains
features of both Form 1 and Form 2. There is no apparent intensity at the positions of
strong peaks in the Form 3 diraction pattern (8.2(c)) ruling this out as a constituent.
To supplement the visual comparison in Figure 8.2, we carry out a quantitative analysis
of the data using Pearson correlation analysis [Dykhne et al., 2011]. Since the XRPD data
are in Q-space, not real space, the Pearson correlation is calculated over the entire range of
data. The results are in Table 8.1.
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Figure 8.2: (a)-(c) XRPD data of C1 (green) plotted with calculated XRPD patterns of
Form 1, Form 2, and Form 3 in order from top to bottom (blue). (d)-(f) XRPD data of
C2 (green) plotted with calculated XRPD patterns of Form 1, Form 2, and Form 3 in order
from top to bottom (blue). Panel (e) identies C2 as having mostly the Form 2 structure,
while panels (a) and (b) show C1 contains features of both Form 1 and Form 2.
CHAPTER 8. PHASE QUANTIFICATION AT THE NANOSCALE USING THE
TOTAL SCATTERING PAIR DISTRIBUTION FUNCTION (TSPDF) METHOD:
RECRYSTALLIZATION OF CRYOMILLED SULFAMERAZINE 125
Table 8.1: Pearson correlation coecients between C1 and C2 and the crystalline Forms
1, 2, and 3. Coecients higher than 0.8 are shown in bold (except when they are trivially
unity).
C1 C2 Form 1 Form 2 Form 3
C1 1 0.626 0.439 0.459 0.257
C2 1 0.095 0.843 0.083
Form 1 1 0.145 0.338
Form 2 1 0.118
Form 3 1
The Pearson correlation coecients in Table 8.1 corroborate our assertion that C2 is
strongly correlated with Form 2, but not correlated to Form 1 or Form 3. On the other
hand, C1 does not correlate strongly with any of the crystalline forms. The correlation with
Forms 1 and 2 are roughly similar, while the correlation with Form 3 is lower.
We try to gain more insight into the C1 structure using TSPDF analysis.
8.3.2 Experimental TSPDF Analysis
Figure 8.3 shows TSPDFs of F1, C1, and C2 plotted with an oset and scaled to highlight
the high-r region. It shows that C1 and C2 clearly are a dierent phase than F1, even though
they were created by cryomilling batches of F1. Furthermore, the TSPDFs of the cryomilled
samples show us that they look quite similar to each another, with the C1 phase having
some peaks in the same positions as those of C2, but with lower amplitudes at higher r.
Pearson correlation coecients calculated in the range 3-20 A can be used to quantify the
relationship between the TSPDFs. The Pearson correlation coecients in Table 8.2 verify
the visual observations that there is a higher similarity between the two cryomilled samples
than with the precursor phase F1.
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Figure 8.3: TSPDFs of the three samples of sulfamerazine. From top to bottom: crystalline
F1, cryomilled C2, cryomilled C1. The TSPDFs of C1 and C2 look dierent from F1 and
similar to one another.
Table 8.2: Pearson correlation coecients between the TSPDFs of F1, C1, and C2 in the
range 3-20 A. Coecients higher than 0.8 are shown in bold (except when they are trivially
unity).
F1 C1 C2
F1 1 0.668 0.340
C1 1 0.892
C2 1
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Figure 8.4: Top: C1 in blue and C2 in green plotted on top of one another (Pearson
correlation is 0.892). Bottom: C1 in blue and F1 in red plotted on top of one another
(Pearson correlation is 0.668). The axis have been scaled to focus on the high-r region.
8.3.3 Mixing Fraction Measurement
From the top of Figure 8.4, where we visually compare C1 and C2 by plotting them on
top of one another, we see that the two TSPDFs share many similar features. However,
the C2 peaks have a higher amplitude than those of C1. We also see that some features in
C1, such as the peak at around 8.2 A, are not reproduced in C2. From the bottom part of
Figure 8.4 we see that there is less agreement between C1 and F1 than there was with C2.
However, some features do match up. For instance, the aforementioned C1 sharp peak at
8.2 A corresponds well to an F1 peak in the same position.
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The information in Figures 8.1, 8.2, and 8.4, suggests that C1 is a mixture of Form 1,
Form 2, and amorphous components. To test this theory, in Figure 8.5 panel (a) we plot
the TSPDF curves of C1 (blue) and C2 (green) and a dierence curve (red) with C2 scaled
such that the values at high-r match up well. We notice that the dierence curve looks a
lot like F1. In panel (b) we plot the dierence curve from panel (a) (red) along with F1
(indigo) scaled such that its high-r values match that of the dierence curve between C1
and C2. Interestingly, we see fantastic agreement with F1. We subtract F1 and plot the
dierence curve in panel (c) (orange). It appears that the intramolecular carbon-carbon
rst and next nearest neighbor peaks are apparent in this curve. To test this idea, we
plot the PDF of a single sulfamerazine molecule on top of it (black). Apart from the noise
inherent in taking the second dierential, this curve agrees rather well, especially in the
low-r region. If the amorphous state is lacking in signicant short range order, the PDF of
the amorphous form will resemble the PDF of the single molecule, as we see here.
The analysis in Figure 8.5 gives us an idea for quantifying phase fractions including
an amorphous phase fraction in C1. We have experimental Form 1 data, but we do not
have pure experimental Form 2 data. However, from Figure 8.2(e) and Table 8.1 we know
that C2 has mostly converted to Form 2 so we use it as a substitute for Form 2, although
we keep in mind that there appears to be a little bit of an amorphous halo in C2 as well.
We don't have pure amorphous data, but, as we have demonstrated in Figure 8.5, we can
model the local structure of an amorphous phase by calculating a PDF of a single molecule
of Form 1 sulfamerazine from a known structure (CSD refcode: SLFNMA02) using SrFit, a
home written Debye PDF calculator. The idea here being that the PDF of a single molecule
contains strong peaks from nearby intra-molecular atoms similar to the behavior exhibited
in Figure 8.5(c). We choose Form 1 as the base molecule because this is the original form
of the compound. We will refer to this calculated PDF as .
When a PDF is calculated by software, whether it be from experimental data, as is the
case with C1, C2, and F1, or from a model, as we do with , it is scaled by the software.
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Figure 8.5: (a) C1 (blue) with 33% of C2 (green), the dierence is in red. (b) The dierence
curve from panel (a) (red) with 12% of F1 (indigo), the dierence is in orange. (c) The
dierence curve from panel (b) (orange) with 55% of the F1 model (black). In panels (a)
and (b), the TSPDFs to the right of the vertical line at r = 3:17 A have been multiplied
by 4.0 to highlight the data in the high-r region.
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This scaling factor is dependent on the algorithm used in the calculation, so for instance
even two PDFs calculated from the same experimental data using dierent corrections can
be on a dierent scale. This is not a problem for regular ngerprinting, as we did above,
where the curves are scaled for convenient comparison, for example, so that the tallest peaks
match. However, this becomes a problem when quantifying mixing fractions because the
scale of each PDF in the mixture aects its contribution to the whole.
We must place the TSPDFs of the components of the mixture (C2, F1, and ) onto an
absolute scale. This was done such that the integrated areas of the rst carbon-carbon peak
in the radial distribution functions (RDFs) are the same and the same as that for C1. The
RDF gives the number of atoms in an annulus of thickness dr at distance r from another
atom [Egami and Billinge, 2003], which in our case means that the integrated area of the
rst peak is proportional to the coordination number of carbon, which should be the same
in all our RDFs.
The RDF, R(r) is calculated from the PDF by
R(r) = rG(r) + 4r20;
where 0 is the average number density.
After we have found the appropriate scaling factors from the RDF, we apply an opti-
mization routine that varies the mixing parameters of the three components:
xF1 + yC2 + z
x+ y + z = 1
where x, y, and z are the mixing fractions of F1, C2, and  respectively. We set the Pearson
correlation between the mixture and C1 as our target function to maximize.
The mixing fractions that produced the highest Pearson correlation (0.9765) are: 12%
F1, 33% C2, and 55% . This means that the normalized TSPDFs of the three components
combined in those fractions add up to the TSPDF of C1.
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Figure 8.6: Fingerprinting of C1 (blue) with the calculated TSPDF of the mixture contain-
ing 33% C2, 12% F1, and 55%  (green) (Pearson correlation is 0.9765). The TSPDFs to
the right of the vertical line at r = 3:17 A have been multiplied by 4.0 to highlight the data
in the high-r region.
Figure 8.6 contains C1 plotted with the total TSPDF of the mixture. We see that almost
all features of C1 are reproduced beautifully in the mixture.
8.4 Discussion
While both C1 and C2 predominantly crystallized as Form 2, C2 is more completely re-
crystallized than C1, which has a large amorphous component. We hypothesize that this
is due to the eects of temperature. C2 was allowed to warm to room temperature after
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cryomilling, while C1 was not. Therefore, it rapidly recrystallized at a temperature close to
room temperature. On the other hand, low temperature seems to inhibit recrystallization
because C1 was kept at low temperature for a month but still maintained an amorphous
component. The recrystallizing state in C1 predominantly consists of a non-crystalline
phase, but with a signicant proportion of Form 1 and Form 2. The growth of Form 2 from
the amorphous state has been seen before [Zhang et al., 2002] though is not necessarily
expected since the stable form, and the form that was cryomilled to create the precursor,
is Form 1.
One of the major advantages of using the TSPDF is that with it we can quantify the
amorphous phase component in a mixture of amorphous and crystalline material because
both the crystalline and amorphous components contribute intensity to the carbon-carbon
nearest neighbor peaks. This means that after we subtract the crystalline components,
which we do by scaling them at high-r, as demonstrated in Figure 8.5, any intensity left in
the peaks is due to contributions from the amorphous.
One may, at rst, nd it curious that the TSPDFs of C1 and C2 match up so well, as we
see in Figure 8.4, even though C1 is only a third Form 2, while C2 is mostly Form 2. This
occurs because the amorphous content is concentrated in the low-r, intramolecular, peaks.
This is incidentally the same reason that allows us to model the amorphous contribution
to the mixture using a calculated PDF of a single molecule. When we get out to high-r,
intermolecular, peaks then the Form 2 content of C1 is nearly 3 times that of Form 1, and so
we naturally observe good agreement with C2. Similarly, despite the C1 sample being more
than half amorphous, the TSPDF technique is clearly able to quantify minority crystalline
components at the 10% level.
These results help cement TSPDF as an accessible technique that can be used for eec-
tive ngerprinting of pharmaceutical APIs.
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8.5 Conclusion
Using high energy X-rays coupled with TSPDF analysis, we quantied the phase fractions
of crystalline and amorphous components in a mixed phase sample of sulfamerazine recrys-
tallizing from a cryomilled-induced amorphous state. Even though the mixture consisted
of a majority of an amorphous component (55%), the TSPDF was sensitive to the phase
fractions of two crystalline components as well. These results demonstrate that TSPDF
is an important tool in tackling some of the major challenges facing the pharmaceutical
industry.
In the next chapter, we again demonstrate the quantication of mixing fractions in an
API, only this time we know the expected mixing fractions ahead of time, so that we can
compare them to those calculated with TSPDFs.




In Chapter 8 we found the mixing fraction of polymorphic and amorphous components in a
recrystallizing compound using TSPDF. However, no other techniques were used to verify
the mixing fractions, and they were not known a priori, so an argument might be made
that we can't be sure of the results of a TSPDF study.
Additionally, in previous chapters we have measured samples of powders that contain
only the API. However, as we discussed in Chapter 2, actual pharmaceutical tablets for oral
ingestion are usually a mixture of two components - the API and the excipient. For nger-
printing with TSPDF to be a useful technique for quality control and litigation purposes,
the API needs to be properly identied when it is in a mixed phase with excipient.
To address the above questions, in this chapter we do two simple investigation on the
over-the-counter (OTC) analgesics (pain killers), Tylenol R and Sudafed R. First, we n-
gerprint the TSPDF of an a priori known mixture of two components with the TSPDFs of
the constituent components and second we ngerprint the TSPDF of Tylenol against three
polymorphs of its API.
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9.1 Sample Preparation and Measurement
The main API in Tylenol is acetaminophen [de Villiers et al., 2998] (it is also known as
paracetamol), a non-steroidal anti-inammatory drug, and the main API in Sudafed is
phenylephrine [Troup and Mitchner, 1964], a decongestant. Tablets of both compounds
were purchased at a local drug store.
Three samples were prepared. A sample of pure Tylenol was prepared by grinding up
a tablet using a mortar and pestle into a ne powder and then lling the powder into a
Kapton R capillary 1 mm in diameter. A pure Sudafed sample was prepared the same way.
A mixture was prepared by grinding together equal parts Tylenol and Sudafed (roughly
300 mg each) with a mortar and pestle and then lling a capillary with the mixed powder.
Samples were measured at beamline X7B at the NSLS using X-rays with  = 0.3184 A.
These data were collected at the same time as the sulfamerazine data, so the full experi-
mental details are in Chapter 8 and will not be reiterated here. TSPDFs were made with
PDFGetX3 using the methods outlined in Chapters 1-4. They were compared to PDFs
made with PDFGetX2 using the methods in Chapter 4 to verify proper data processing.
Samples of the three polymorphs of acetaminophen [Perrin et al., 2009] were procured
by our collaborators at PANalytical and measured on their silver anode diractometer
with  = 0:56 A. TSPDFs of all the data were calculated using PDFGetX3 and with




Figure 9.1 shows the TSPDFs of the three samples, with the mixture of Tylenol and Sudafed
in blue, pure Tylenol in green, and pure Sudafed in red. We see that the mixture PDF shares
features with both components. Table 9.1 shows the Pearson correlations between the three
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Table 9.1: Summary of Pearson correlation coecients between the PDFs shown in Fig. 9.1.
Correlations higher than 0.8 are shown in bold (except when they are trivially unity).
Mixture Tylenol Sudafed
Mixture 1 0.882 0.780
Tylenol 1 0.414
Sudafed 1
TSPDFs. As expected, we see low correlations between Tylenol and Sudafed and pretty high
correlations between each component and the mixture. The correlation between Tylenol
and mixture is above our threshold for signicance, and the correlation between Sudafed
and the mixture is just below.
We use a similar technique to optimize the mixing fraction of Tylenol and Sudafed in
the mixture as we used in Chapter 8 to optimize the polymorphic and amorphous mix-
ing fractions. The main dierence being that we now have two components rather than
three. Briey, we rst put all the TSPDFs onto the same absolute scale such that the in-
tegrated areas of the rst carbon-carbon peaks in the radial distribution functions (RDFs,
Equation (1.22)) are the same, then we then apply an optimization routine that varies the
mixing parameters of the two components:
xT + yS (9.1)
x+ y = 1 (9.2)
where T and S are the TSPDFs and x and y are the mixing fractions of Tylenol and Sudafed
respectively. We set the Pearson correlation between the Tylenol-Sudafed TSPDF and the
mixture as our target function to maximize.
As we see in Figure 9.2, the highest Pearson correlation (0.993) occurs with the mixing
fraction with 49% Tylenol and 51% Sudafed. We see that the t is nearly perfect. Even
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Figure 9.1: TSPDFs of the Tylenol-Sudafed mixture (blue), Tylenol (green), and Sudafed
(red). The y-axis has been scaled to highlight the high-r region where the PDFs are dierent.
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magnied 4x, the dierence curve is very tiny. The mixture of 49-51 Tylenol-Sudafed is
almost exactly the 50-50 we were expecting.
Overall, we have shown with this very simple example that TSPDF coupled with n-
gerprinting using Pearson correlations is a powerful way to identify the proportions of
components in a mixture of APIs. The results here act as a `sanity check' of sorts for the
results in Chapter 8, showing that the mixing fractions that we quantify with TSPDF are
correct.
9.2.2 Fingerprinting APIs and Excipient
Now, we turn our attention to the issue of identifying an API that is mixed with excipient
using ngerprinting. This has implications in quality control (i.e. quick identication of a
pill on a production line) and for litigation purposes (i.e. a company is sued for using a
patent protected API with a dierent excipient composition).
To test the TSPDF's ability to do this, we ngerprint Tylenol against the three poly-
morphs of its constituent API, acetaminophen. By weight a Tylenol pill is roughly 80%
API (500 mg of API per pill, total weight of the pill is roughly 625 mg), so we would expect
it to ngerprint well. In Figure 9.3, we see the TSPDF of Tylenol (blue) plotted with the
three crystalline forms of acetaminophen. We instantly see that Tylenol looks very much
like Form I, not like the other two forms. The TSPDFs of the Form II and Form III APIs
are, in general, a little bit noisy, but these factors are outside of our control (Form III in
particular is quite hard to synthesize [Burley et al., 2008], so the sample was very small).
The fact that there is enough signal for us to ngerprint shows the robustness of the tech-
nique. The Pearson correlations are in Table 9.2 where we clearly see that the correlations
between Tylenol and Form I are much higher than the correlations between any other forms.
We have shown that TSPDF can be used to ngerprint the API in a pill containing an
API and excipient mixture, at least when the API is a large fraction of the mixture. Future
investigations where the API accounts for a smaller weight fraction of a pill will need to
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Figure 9.2: TSPDFs of the Tylenol-Sudafed mixture (blue) and the calculated mixture of
49% Tylenol and 51% Sudafed (green) with an oset (red). The Pearson correlation is
0.993. The TSPDFs have been multiplied by a factor of 4.0 for r values greater than
4 A(dashed line).
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Figure 9.3: TSPDFs of Tylenol (blue) plotted on top of TSPDFs of (a) Form I, (b) Form
II, and (c) Form III (all in green), Qmax = 16 A
 1 in all cases. Tylenol clearly looks very
much like Form I, and not like the other forms.
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Table 9.2: Summary of Pearson correlation coecients between the PDFs shown in Fig. 9.3.
Correlations higher than 0.8 are shown in bold (except when they are trivially unity).
Tylenol Form I Form II Form III
Tylenol 1 0.856 0.484 0.517
Form I 1 0.504 0.594
Form II 1 0.630
Form III 1 1
be performed. If the excipient consists of mostly polymers, then, in theory, the polymers
should not produce a signal beyond the rst few peaks and the TSPDF could still be used
to identify the API.
9.3 Conclusion
The two results in this chapter are reasonably basic, but far reaching. First, were able
to quantify the mixing fractions of two over-the-counter pain medications. We found taht
the mixing fractions calculated from the TSPDFs were almost exactly the expected mixing
fractions from sample preparation. This result is complementary to the results in Chapter
8 and acts as a case in point demonstration of the technique. Second, we ngerprinted the
API in a pill containing an API-excipient mixture. This result demonstrates that TSPDF
could be a useful technique for quality control and litigation purposes.
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Chapter 10
Conclusions
A major challenge facing the pharmaceutical industry is that it is becoming more dicult
to bring new drugs to market because many candidate compounds exhibit poor aqueous sol-
ubility. One of the proposed solutions to increase solubility is to formulate the compounds
in a non-crystalline state. However, traditional X-ray powder diraction (XRPD) tech-
niques that are relied upon by the industry begin to lose their eectiveness when disorder
is introduced because diraction patterns become broad and featureless.
In this thesis, we attempted to show that high energy X-rays coupled with the total
scattering pair distribution function (TSPDF) and ngerprinting analysis could be used
to identify the local structure of non-crystalline pharmaceutical materials when XRPD
methods break down. Our hypothesis was that the larger range of momentum transfer,
Q, aorded by high energy X-rays would let us collect diuse scattering intensities, which
contain information about a sample's local structure, and the TSPDF would let us work
in real-space where we could view intra- and inter-molecular correlations. As we have seen
over the course of this thesis, our hypothesis proved successful and we were able to make
important contributions to the eld.
In our rst study, we successfully used synchrotron X-rays to ngerprint three phases,
two crystalline and one nanostructured, of two pharmaceutical compounds, carbamazepine
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(CBZ) and indomethacin (IND). We also found that the disordered form of CBZ was actually
the nanostructured Form III polymorph with a 4.5 A diameter. When we rst embarked on
this project, we were not sure what to expect, as such systematic studies of active pharma-
ceutical ingredients (APIs) have not previously been attempted using TSPDF. Fortuantely,
the investigation was successful and became a proof of concept that showed that useful
information that is not available via traditional XRPD could be obtained from the TSPDF.
One of the key insights was that ngerprinting could be done via direct comparison, mean-
ing that no structural renement was necessary to identify the nanostructured phase. This
made the technique much more attractive and accessible to the pharmaceutical industry.
The results of the rst study were encouraging, but they also introduced several issues
that needed to be addressed before the technique could take o among pharmaceutical
researchers. The rst issue is that we had not dened exactly what we meant by `high
energy' X-rays and what sort of accessible Q range was needed for TSPDF investigations
of pharmaceuticals. We showed that synchrotron radiation was energetic enough to get the
job done, and we showed that a copper-anode diractometer not used to its full potential
was not, but there is a spectrum of X-ray diractometers in between. To answer this
question, we took the next logical step in developing the methodology by investigating
exactly the data requirements for the reliable use of TSPDFs in ngerprinting, since not
all researchers, particularly not those in industry, have unlimited and immediate access to
a synchrotron. We found that molybdenum- and silver-anode diractometers can be used
to collect reliable total scattering data, however copper-anode diractometers, even when
used to their maximum potential, will not produce reliable results.
The other issue that our initial study raised was that, at the time, there were no auto-
mated methods of quickly generating many TSPDFs and comparing them to one another.
This was another barrier to the adoption of the technique. Since high-throughput scan-
ning techniques used in drug discovery produce a lot of data, manually making TSPDFs
one a time and plotting them two at a time for comparison were not ecient approaches.
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In response, we developed PDFGetX3, a new program for processing total scattering data
that requires very little user interaction and is capable of automatically batch processing
data sets. We also introduced the use of Pearson correlations to quantitatively compare
TSPDFs. The Pearson correlations allow the researcher to focus his or her attention on
data that display strange behavior (i.e. high correlations when they should be low or vice
versa) instead of plotting every data set.
In our initial studies and development of the methodology, we had only analyzed nanos-
tructured compounds. Luckily, though, our initial work attracted the interest of the phar-
maceutical industry and we were able to obtain two proprietary compounds, which we called
Compound A and Compound B in this thesis, in a truly amorphous form for investigation.
We found that, unlike the nanostructured APIs which had attenuated signal out to high r,
TSPDFs of truly amorphous compounds give sharp peaks with structural information up
to about 7 A and broad features up to 12-14 A. However, this signal still provided more
information than what could be obtained from traditional crystallographic techniques. Us-
ing ngerprinting, we discovered that the amorphous phases that result from cryomilling
and spray drying Compound A are the same. This bit of information could have impor-
tant implications on the compound if one of the amorphization techniques is easier and/or
cheaper than the other. We also found that the local packing of the amorphous form of
Compound A is similar that of the  polymorph, while the local packing of the amorphous
form of Compound B is distinct. Although the analysis was not quite as straightforward
with these materials as it had been with CBZ and IND, our results denitely added valuable
insight into the local structure of these compounds and allowed us to continue to develop
the technique.
After ngerprinting Compounds A and B, we noticed that we had exclusively concerned
ourselves with ngerprinting single phase APIs. However, the pharmaceutical industry
was very concerned with being able to quantify mixing fractions of crystalline and non-
crystalline components in APIs that had undergone a particle size reduction process such
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as cryomilling. Therefore, it seemed logical for us to attempt to ngerprint a sample of
sulfamerazine that was recrystallizing from a cryomilling-induced amorphous state. Using
TSPDF, ngerprinting, and an in-house optimization code, we found that the recrystallizing
sample was a mixture of 33% C2 (which mostly consisted of Form 2), 12% Form 1, and 55%
non-crystalline components. This was an incredibly exciting result because it showed that
TSPDF can be used to ngerprint complex mixtures consisting of several polymorphs of a
compound in addition to the amorphous. Furthermore, the results showed that TSPDF was
able to quantify a minority crystalline component at roughly the 12% level in the presence
of a majority non-crystalline phase. Finally, we demonstrated that the calculated TSPDF of
a single molecule of sulfamerazine could be used to quantify the amorphous mixing fraction.
The results of this investigation are probably the most exciting results of the thesis. Our key
insight in the study was the realization that the integrated area of the rst carbon-carbon
peak in the radial distribution function (RDF) of each data set could be used to normalize
each TSPDF onto an absolute scale. Without that insight, we would have been unable to
calculate the correct mixing fractions.
We followed our study of the quantication of mixing fractions of recrystallizing sulfam-
erazine by looking at a much simpler mixture of two over-the-counter pain medications as
a case in point. We found that the mixing fractions calculated from the TSPDFs coincided
almost exactly with the expected mixing fractions from sample preparation. Although there
were no non-crystalline components in play this time, the result did act as a `sanity check' of
sorts to prove that our algorithm for calculating mixing fractions was working as expected.
Our nal result is that we were able to ngerprint the correct polymorphic form of the
API acetaminophen in a Tylenol that contained the API and excipient. This result is inter-
esting for two reasons. First, the ngerprinting worked even though the data were collected
on two types of instruments (Tylenol data collected on a synchrotron, acetaminophen data
on a silver-anode diractometer), which shows ngerprinting TSPDFs is insensitive to the
instrument used. Second, the result demonstrates that TSPDF ngerprinting might be-
CHAPTER 10. CONCLUSIONS 146
come a useful technique for quality control (for example, to test pills during manufacture)
or litigation (for example, to show that a certain compound is infringing on the patent of a
dierent compound).
Overall, all of the studies that we've done have denitely shown that our technique works
well and that there is a lot of potential for some very interesting and fruitful collaboration
between academia and the pharmaceutical industry in bringing a new class of APIs to the
market. We have received a lot of interest from the pharmaceutical industry to continue
developing the technique and also to investigate compounds that are of interest to them.
10.1 Future Work
Although we have laid the foundation for ngerprinting using TSPDF, there is still a lot of
work that needs to be done to expand the technique. For instance, as we observed in Chapter
7, temperature has an eect on the dynamic disorder of the TSPDFs, which translated to
peaks being broader at higher temperatures. However, the exact behavior of the eect of
temperature changes on the TSPDFs of crystalline, nanostructured, and amorphous APIs
needs to be further examined. One way to do this would be to use temperature-resolved
TSPDF studies by collecting RAPDF data from a sample as it was warmed up or cooled
down over some pre-dened temperature range. This type of analysis could produce dozens
of data sets that need to be analyzed using tools like PDFGetX3 and Pearson correlations
to investigate how the local structure evolves with temperature.
Another area where further investigation is needed is in ngerprinting of the API in
an API-excipient mixture. We successfully ngerprinted acetaminophen with Tylenol, but
Tylenol is roughly 80% acetaminophen by weight. Other APIs need to be investigated
where the API to excipient ratio is lower. It might be that below a certain threshold in the
API-excipient ratio, the signal of the API will no longer be distinguished from the noise
of the excipient. On the other hand, though, many excipients are polymers and might not
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produce signal in the TSPDF beyond the rst few peaks, so the high-r region could still be
used for ngerprinting.
In addition to API-excipient mixes, API-polymer mixes might also prove to be a fertile
ground for TSPDF research. Since amorphous phase APIs are metastable, there is always
a risk that they will revert to a thermodynamically favorable (and less soluble) crystalline
state. Therefore, there is tremendous interest in developing a reliable means of stabilizing
non-crystalline APIs. One suggested route to achieving this goal is through formulating the
API in a dispersion in a water-soluble polymer. However, it is dicult to understand the
structural composition of the dispersions [Craig, 2002] and some characterization techniques
have failed. Similar techniques to what we have employed in Chapters 8 and 9 may be used
in this investigation.
Finally, as we have mentioned several times in this thesis, there currently do not exist
TSPDF tools designed specically to model the structures of disordered APIs. For TSPDF
to grow from a ngerprinting technique to an inexorable tool of the pharmaceutical industry,
these modeling paradigms need to be developed. One idea for doing this is to allow users to
label certain functional groups of atoms, such as a carbon ring, as `rigid', so as to constrain
certain parameters (i.e. atom positions) of the entire group, and to label other atoms, such
as a chain of carbons, as `oppy', meaning that they are able to move with fewer constraints.
We hope that further developments in the modeling methodology will bring TSPDF to the
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Appendix A
Safety Guide for Handling
Pharmaceuticals
This is a guide I wrote for handling the pharmaceutical samples that we have worked with
throughout this thesis. Having it in the thesis is useful for completeness and also as a
reference for future students who wish to continue this work.
A.1 Introduction
Now that the Billinge Group has started to collaborate with pharmaceutical researchers
and industry, safety precautions have become a top priority. This document is a guide, a
summary, and a task list for how to handle pharmaceutical samples from the moment that
they arrive until they are disposed of.
A.2 Preparation
When you nd out that a pharmaceutical sample is on its way from a collaborator, the
rst thing to do is check the MSDS form. You can either ask the collaborator to send you
the MSDS form or check out a chemical website such as Sigma Aldrich's MSDS database
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(http://www.sigmaaldrich.com/safety-center.html) for information. In particular, look at
sections 2 and 8. Section 2 identies the potential hazards of the material (e.g. inhaled,
swallowed, exposed to skin, etc.) while section 8 lists how to protect oneself from hazards.
MSDS forms will give you an indication of how to safely approach samples. Also, make sure
to ask collaborators what additional precautions are needed.
Once the hazards are known, the next step is to check to make sure that there is ample
space in the fridge for the sample(s). Storing pharmaceutical compounds in the fridge is
particularly important for amorphous phase materials because it might slow down their
transformation into a crystalline phase. At the time of writing, we do not yet have a fridge,
so we share a fridge with the Herman Group in Mudd Room 1141. We intend to procure a
fridge soon.
A.3 When Samples First Arrive
Note: Always wear gloves when handling samples, no exception.
Samples will most likely arrive in a box with the MSDS forms attached. Check the MSDS
forms to ensure that you received the right materials. If you have received the wrong ma-
terials, contact the collaborator who sent them to gure out what's wrong. Collaborators
might decide to send the MSDS forms by email rather than packing them with the samples.
In this case, print out a copy of each MSDS form and store it near the samples.
The samples should arrive packed in sealed, labeled vials. While wearing nitrile gloves,
check that the labels on the vials match with the MSDS forms and what is expected from
the collaborator. If the vials are not labeled, contact the source of the samples and do not
open them.
Check how much sample you have received. Very small amounts of sample are needed
for synchrotron experiments since the sample will be loaded into kapton capillaries that
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are roughly 3-4 mm long with a 1 mm diameter. If you have received a large amount
of each sample (i.e. several grams), consider sub-sampling the material into smaller vials
and sending the rest back to the collaborator. Since pharmaceutical materials need to be
handled with extra care and are harder to dispose of, it's easier for us to just send extra
material back to the source than worry about it ourselves. Please note that you shouldn't
sub-sample too little of the material because you will need it to load the capillaries, after
all, and it could be a dicult process.
Put all of the relevant sample information into your lab notebook and also on the wiki
for your project.
Once you have completed the checking and labeling, put the samples into secure con-
tainers, for example by double- or triple-bagging the samples, and then put the containers
into the fridge.
A.4 Filling Capillaries
The samples all need to be in sealed kapton capillaries before they can be taken to the
synchrotron. Kapton capillaries can be obtained from the Cole-Parmer website under the
name "polyimide tubing". Typically, we use tubing with 0.0395" (1.0 mm) inner diameter
and 0.0435" outer diameter (1.1 mm).
All work that is done with the samples should be performed in a functioning fume hood.
Before lling a capillary, we need to prepare the fume hood. To do this:
 Make sure you have the necessary supplies. These are:
1. The sample powder (in a vial)
2. A capillary cut to be roughly 1.5 inches long
3. Clay
4. Mortar and pestle
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5. Ethanol (or another solvent)
6. Regular white sheets of paper
7. Weighting paper
8. Kimwipes (or other laboratory cleaning tissues)
9. Plastic bags for disposal
10. Long, thin pieces of wire that can be used as plungers to push the powders into
the capillaries
 Cover the area where you intend to work in the fume hood with white sheets of paper.
This will facilitate cleanup later.
 Clean the mortar and pestle and wire plunger with the ethanol.
 Make sure you have some Kimwipes on hand to clean up spills.
To ll a capillary:
 Seal one side of the capillary with modeling clay.
 Pour some of the sample powder into the mortar. Crush it with the pestle. It is
important to have a ne powder for the experiment or the data might be spotty. If
you have a sieve, try to sieve the powder as well.
 There are two methods you could use to load the powder into the capillary. The rst
is to try to scoop up the powder from the mortar into the capillary. Run the capillary
through a small pile of powder making a scooping motion, then tap the capillary
(while its in a vertical position) against a horizontal surface to get the powder to
settle. This method is a bit messy, so be sure you don't get powder all over the place.
The alternative is to use a funnel of some sort to try to funnel the powder into the
capillary. In either case, you will have to use the wire plunger to pack the sample into
the capillary so that it's tightly backed.
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 Once you're done loading the sample, seal the other side of the capillary using modeling
clay. Put the capillary into its own plastic bag and put that bag into the same bag
as the sample vial. Clean everything up. Put used Kimwipes, weighting paper, and
the paper that you lined the bottom of the fume hood with into the bag that was set
aside for disposal. Label the bag using the environmental safety labels from Columbia
facilities and then contact Environmental Health & Safety (EHS) to pick up and
dispose of the waste.
A.5 Bringing the Sample to the Beamline
Generally, we want to bring only the sealed capillary to the beamline. This way, we can
ensure that potentially toxic samples are never spilled at the experiment and no waste
management / clean-up is necessary. It is also much easier for us to take the capillaries
back home.
In preparation for travel, the capillaries should be in small, labeled plastic bags (I use
snack size Ziploc bags). These small bags should be in larger, labeled plastic bags (I use
either quart-sized or gallon-sized Ziploc bags). All of these bags should be in a cardboard
box. The MSDS forms should also be close at hand for all materials. The box holding the
samples should also include things that might be useful at the beamline such as some extra
capillaries, clay, and wire plunger.
The experimental box should be in a piece of luggage or a bag. If you are ying, check
in the luggage with the samples, rather than carrying it on.
A.6 Disposing of Samples
After all relevant experiments are complete and you are sure that you will not to use certain
samples again, then pack the samples into plastic bags that are labeled using Columbia's
environmental safety labels, and then contact EHS to pick up and dispose of the waste.
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A.7 General Tips
This section is a summary of a conversation with a researcher at a pharmaceutical rm
about the best way to handle pharmaceutical samples.
 Standard protection when handling toxic pharmaceutical materials includes: fume
hood (to be used in all cases), glasses, disposable lab coat, gloves (to be used in all
cases), and possibly a dust mask as well (if the sample is known to form dust clouds).
 A fume hood is necessary because many samples are toxic if inhaled.
 In case of skin or eye irritation (e.g. allergic reaction), ush with copious water and
make sure to contact the proper safety people.
 In case of spill, use water to clean up the spilled material, collect it, and then dispose
of it as above.
 Section 8 of the safety data sheet contains information on exposure control. Always
read this when you get a new sample shipped to you.
 Don't try to put too much of a sample into capillary at once.
 Use nitrile gloves to handle substances. These substances are dry, so there will be no
solvent interaction with gloves.
 Clean up each sample and put on a fresh pair of gloves before handling the next
sample.
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Appendix B
PDFGetX3 Documentation
This appendix contains the documentation for PDFGetX3, current as of June 1, 2011. This
documentation is provided in the thesis a supplement to Chapter 4, which introduces the
PDFGetX3 software. This version of the documentation omits the installation instructions.
Please refer to the http://www.dipy.org website for information about the software and
the latest version of the manual. Please note that PDFGetO is not PDFGetX3. PDFGetO
is a web-based front-end for the PDGetX3 engine, and therefore information about input
parameters and command line arguments do not apply.
B.1 Introduction
PDFGetX3 represents the next step in the creation of high quality PDFs that can be used
for productive research purposes. Just by inputting a few parameters into a user-friendly
conguration le, a user will be able to automatically and rapidly create and plot PDFs
using PDFGetX3.
This code was written by members of the Billinge Group at Columbia University in-
cluding: Timur Dykhne, Pavol Juhas, Christopher Farrow, Simon Billinge.
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B.2 Quick-Start Guide
More information on how the program works is in the Using PDFGetX3 section, the Exam-
ples section contains instructions on how to run the examples included with the program,
and the Tutorial section contains a step-by-step guide for processing a data set and changing
input parameters.
To run PDFGetX3, input data need to be in the proper format. Please refer to the
section Input Files for more information. The minimum conguration parameters needed
for data processing are:
 The wavelength of the X-rays in the experiment;
 The chemical composition of the material;
 The Qmax;
 The format of the input data (2, Q (A 1) or Q(nm 1))
For more information on the conguration parameters or conguration le, refer to the
Using PDFGetX3 and the Conguration and Command Line Options sections.
Once we have the input parameters and an input data le, we run PDFGetX3 at the
command line with:
>> rapdfgetx [DATA-FILE-NAME] -b BACKGROUND-FILE-NAME -c CONFIG-FILE-
-NAME
where [DATA-FILE-NAME] is the name of the le containing the data we want to pro-
cess, [BACKGROUND-FILE-NAME] is the name of the le containing intensities collected from
the background (if available), and [CONFIG-FILE-NAME] is the name of the le contain-
ing the conguration information. Note that if the conguration le has the default name
rapdfgetx.cfg and is in the same folder as the data, then it will be detected automatically
without the -c option. Also note that if the background le name is in the conguration
le, then it does not need to be dened at the command line.
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B.3 Input Files
PDFGetX3 accepts inputs in the form of two-column data where the rst column contains
values expressed in terms of 2 in degreees, Q (momentum transfer), in nm 1, or Q in A 1
and the second column contains intensities. The user denes the type of data in the rst
column using the dataformat parameter in the conguration le or at the command line.
PDFGetX3 is generally smart about ignoring metadata in the header of a data le, but
it will get confused if the data le is extremely peculiar. For instance, if one of the data
columns has letters in addition to numbers. If PDFGetX3 is having trouble loading a data
le, then we should open it in a text editor to verify that it contains legible data.
B.4 Using PDFGetX3
Using PDFGetX3 is simple and straightforward. First, we set up a conguration le with
all of the necessary parameters dened, then we run the program at the command line, and
nally we plot the output. We iterate these steps until we are satised with the results.
B.4.1 Conguration
The rst thing that we need is a conguration le. The conguration le contains the
necessary parameters that are needed to produce PDFs using PDFGetX3.
Note: Output les from PDFGetX2 and PDFGetX3 can also be used as conguration
les. This is useful if we have pre-made PDFs but are not sure how they were made.
B.4.1.1 Creating a Conguration File
First, we check if our data came with a conguration le (usually les with a .cfg extension).
If we don't have a conguration le, then we can easily create a template of a conguration
le by running the following at the command prompt in Windows or terminal window in
Linux:
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>> rapdfgetx --template > config.cfg
Where config.cfg is what we want to call our conguration le. This command will output
a conguration le named config.cfg that contains a template that can be modied to
suit our needs. The le name config.cfg was chosen here as an example. Any le name
can be used.
The cong le can be opened using any text editor, such as WordPad or Vim. Once
opened, a typical cong le will look like Figure B.1. Any text in the conguration le that
begins with a hash mark (#) will be ignored.
The order in which PDFGetX3 gathers conguration information is as follows: rst it
searches the users home directory for a le named .rapdfgetx.cfg, then it searches the
working directory for a le named .rapdfgetx.cfg, and nally it searches the working
directory for a le named rapdfgetx.cfg. If any of these les are found and they contain
enough conguration information for PDFGetX3 to run, then the user will not need to
manually dene a conguration le at the command line using the -c option.
B.4.1.2 Sections of the Conguration File
The user can add sections to conguration les with congurations that are specic to a
certain compound or sample. For instance, if the working directory has data collected from
two dierent compounds, for example NaCl and BaTiO3, then the main rapdfgetx.cfg
conguration le can have two sections, [NaCl] and [BaTiO3], that contain conguration
information specic to just those compounds (e.g. composition, Qmax, and wavelength),
and get the rest of the information from the [DEFAULTS] section. The user can then call each
section using the --section option at the command line (please refer to the Conguration
and Command Line Options section of this appendix).
Using this feature, it is possible to have one main conguration le that contains informa-
tion about many dierent samples, rather than many conguration les that are specically
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Figure B.1: Template of a conguration le.
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made for each sample.
B.4.1.3 Options in the Conguration File
There are many options that can be turned on and o in the conguration le, the details
of which are in the auto-generated template and in the Conguration and Command Line
Options section. Options are enabled by setting them equal to some value in the congu-
ration le. For instance, to set the wavelength to 0.709 A, we would add or modify the line
wavelength=0.709 in the conguration le. The options that are needed for PDFGetX3 to
run are: dataformat, wavelength, composition. Additionally outputtype is necessary
for the software to output a le.
B.4.2 Running PDFGetX3
Once we have adjusted parameters in the conguration le, we are ready to run the program.
To do so, we open a terminal window (in Linux) or command prompt (in Windows), navigate
to a folder containing the raw data les that we want to process, the background intensities
(optional), and the conguration le, and execute rapdfgetx.py with the following command:
>> rapdfgetx [DATA-FILE-NAME] -b [BACKGROUND-FILE-NAME] -c [CONFIG-
-FILE-NAME]
Note: If outputtype is not dened in the conguration le, then we will also need to
add outputtypes=x or -t=x where x is the type of le that we want to output (the four
options are: `gr', `fq', `sq', or `iq') or else there will be no output even if the program runs
successfully.
B.4.3 Plotting
More information on exactly what is contained in les output by PDFGetX3 is in the Output
Files section. Once we have an output (for example, a G(r) or F (Q)) we naturally want to
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plot it. We can use the plot argument at the command line when running PDFGetX3 to
plot data right after they are processed. Additionally, if we want to plot an output without
running PDFGetX3 (and thereby reprocessing data), we use the plotdata program. It can
be run from the command line as follows:
>> plotdata [DATA-FILE-NAME] [DATA-FILE-NAME-2] ...
Where [DATA-FILE-NAME] corresponds to the PDFs that we want to plot. The plotdata
script can accept multiple inputs and plot them all on top of one another. The plot window
allows us to zoom in and out on the data and save an image of the plot contents. However,
it does not allow for any sort of data manipulation. To manipulate the data, we need to
load them into a data manipulation/plotting program, such as Excel, Origin, Kuplot, or
Python (with the Matplotlib library).
B.5 Output Files
PDFGetX3 can output up to four dierent data le types:
 I(Q): This le consists of the intensities after the data have been converted to Q-space,
if necessary, and the background has been subtracted.
 S(Q): This le contains the structure function.
 F(Q): This le contains the reduced structure function.
 G(r): This is the PDF.
We can choose which les to output either in the conguration le via the outputtype
parameter, or at the command line with the --outputtypes or -t options.
The the structure of each type of output le is roughly the same. The header contains
metadata such as the version of the software and the conguration information while the
body of the le contain two columns of x-y data. Figure B.2 shows a typical PDF output
le.
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Figure B.2: A .gr (G(r)) le output by PDFGetX3.
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B.6 Examples
PDFGetX3 comes with several examples in the examples directory of the installation. Each
example includes the following les:
 A .chi le which contains the raw intensities plotted versus 2 collected from a
synchrotron beamline. Some examples also include a background data le (also in
.chi format) while others do not.
 A rapdfgetx.cfg conguration le.
 A PDF (le with .gr extension) with rapdfgetx in its name and a PDF with pdfgetx2
in its name. These two les are PDFs made with PDFGetX3 and PDFGetX2, respec-
tively, from the same experimental data.







Note that several of the example compounds were discussed at length (with images and
model renement results) in Chapter 4.
B.7 Tutorial
In this tutorial we will make and compare several PDFs of nickel by adding or removing
the background, varying the Qmax, and tuning parameters in interactive mode.
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B.7.1 Getting Started
First we navigate over to the examples folder in our PDFGetX3 directory and then to the
Ni folder. The le named ni300mesh 300k nor 1-5.chi contains the raw data collected
from the beamline. We can open the le in a text editor to verify its contents. The
rst column contains two-theta values and the second column contains intensities. The
le kapton_bgrd_300k_nor_2-3.chi contains the measured background intensities, in this
case an empty Kapton R capillary.
In addition to the data les, we also see the conguration le rapdfgetx.cfg, which
contains all of the conguration parameters for the experiment.
Finally, there are two more les in the folder. One has pdfgetx2 and the other has
rapdfgetx in the le name. Both have .gr extensions. These are sample PDFs that we can
compare our output to. The le with pdfgetx2 in the title was created using the PDFGetX2
software, while the le with rapdfgetx in the title was created using PDFGetX3.
B.7.2 Setting Up a Conguration File
The conguration le, rapdfgetx.cfg is already set up to make a PDF of this particular
nickel data set. If we run the program using the conguration as it is now, we will get a
PDF with the background subtracted and a Qmax of 26 A
 1. Before we do that, though,
we should make a copy of the conguration le and give it a dierent name, for example
config.cfg.
We will modify the contents of this le to see what eects Qmax and background sub-
traction have on the resulting PDF. Modifying a cong le is easy. We just need to change
the parameters using a text editor.
In this new conguration le, put a hash mark, `#', in front of the line backgroundfile
= kapton bgrd 300k nor 2-3.chi. The hash mark comments out that line of text so that it
will be ignored by the program. PDFGetX3 will now no longer do a background subtraction
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when processing this data set if this new conguration le is used.
B.7.3 Running PDFGetX3
Now lets run the program. Open a terminal or command prompt and navigate over to the
folder where the data les and conguration le are stored. Run the program with:
>> rapdfgetx ni300mesh 300k nor 1-5.chi -c config.cfg
This will create a PDF with the lename ni300mesh_300k_nor_1-5.gr. The default
behavior of PDFGetX3 is to always create output les with the same le name root as the
data les. This can be changed using the outputname parameter in the conguration le
or the --outputname argument at the commandline. If a le with the name already exists
in the folder, then PDFGetX3 will give a warning and not overwrite the existing les. To
force PDFGetX3 to overwrite the les, use the --force argument at the command line.
Note that if the conguration le was given a dierent name, then we substitute that
name for config.cfg.
B.7.4 Plotting the Output
Now that we have made a new PDF, lets plot it and the PDF with the background subtracted
on top of one another. To plot, we use the plotdata program as follows.
>> plotdata ni300mesh 300k nor 1-5.gr ni300mesh 300k nor 1-5-rapdfgetx.gr
Where ni300mesh 300k nor 1-5.gr can be replaced with the le name of the PDF that
has just been generated, if an alternative name was chosen, and ni300mesh 300k nor -
1-5-rapdfgetx.gr is the name of the pre-made PDF from the examples folder.
The output will look like Figure B.3. We see that the background subtraction does not
have a large eect on the PDF. This is because the Ni sample diracts more strongly than
the capillary that the sample is contained in.
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Figure B.3: PDFs of nickel with and without background subtraction.
B.7.5 Changing Qmax
Now, we want to see what eect adjusting the Qmax will have on the PDF. We again open
the conguration le with a text editor. First, we reintroduce the background subtraction
by removing the hash mark (#) in front of the line beginning with backgroundle. Then
we go to the line that says qmax = 26.0 and change this value to 16.0, so the line should
read qmax = 16.0. Save your changes.
Now, we run the program as we had done previously:
>> rapdfgetx ni300mesh 300k nor 1-5.chi -c config.cfg --force
Note that we have now introduced the command line option --force. The reason for using
the force command is because PDFGetX3 does not automatically overwrite existing les.
Therefore, if we had not used the force command, the program would respond by telling
you that the output le already exists.
After we run the program with the --force command, PDFGetX3 outputs a new PDF
with the new Qmax. To determine what eect a change in Qmax has on the PDF, we plot
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Figure B.4: PDFs of nickel with dierent Qmax values.
PDFs on top of one another, as before:
>> plotdata ni300mesh 300k nor 1-5.gr ni300mesh 300k nor 1-5-rapdfgetx.gr
The output should look like Figure B.4. Note that the lowering Qmax aects the peak
intensity.
B.7.6 Tuning Parameters in Interactive Mode
One of the most powerful features of PDFGetX3 is the ability to tune various parameters
in interactive mode. In the previous section, we compared two PDFs with dierent Qmax
values. But, what if we want to see what eect an entire range of Qmax can have on a PDF
and we don't want to run the program a bunch of times? To do this, we tune parameters
in interactive mode.
First, to enter interactive mode, we run PDFGetX3 with the -i command line option.
For example, to enter interactive mode with the Ni data and the rapdfgetx.cfg congu-
ration le, we enter interactive mode with:
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>> rapdfgetx ni300mesh 300k nor 1-5.chi -i --force
This launches us into the interactive Python session with the PDF data pre-loaded.
Now, for this example, lets say we want to see what eect a change in Qmax has on the
PDF and on the reduced structure factor, F (Q). To do this, rst set which variables we
wanted to plot by typing:
>> config.plot=["fq","gr"]
In the interactive session. Next, we dene the parameter that we want to tune by typing:
>> tuneconfig(qmax=(10,20))
In this case, we want to tune Qmax between 10.0 A
 1 and 20.0 A 1.
Now, a plot window should appear with the reduced structure function, F (Q), in the
top half, and the PDF, G(r), in the bottom half. As we move the mouse through the plot
window from left to right, the Qmax changes. The title line of the plot shows us the current
value of Qmax. When we click the mouse in the window, we set the Qmax as that value.
Figure B.6 shows the tuning window.
We might also be interested in having a baseline PDF to visually compare our tuned
PDF to. For example, to test the eects of varying Qmax, we can compare a tuned PDF to
the PDF with Qmax of 26 A
 1 that we made earlier in this tutorial. To do this, we simply
run PDFGetX3 with the --plot command line option:
>> rapdfgetx ni300mesh 300k nor 1-5.chi -i --force --plot="fq,gr"
This will put us into interactive mode with a plot window already open. The F (Q) and
G(r) in this plot window were made with the parameters preset in the conguration le.
Now, we can run tuneconfig again to see how a PDF made with a lower Qmax compares
to the one with a Qmax of 26 A
 1 by typing:
>> tuneconfig(qmax=(10,25))
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Figure B.5: Tuning the Qmax of nickel. Here it is at around 17 A
 1.
Now, when we move the mouse on the plot, we see that the blue F (Q) and G(r) correspond
to the original PDF while the green F (Q) and G(r) are being tuned. The plot should look
like Figure B.6.
This tutorial has gone through the basic steps necessary to create good PDFs using
PDFGetX3. We can refer to the Conguration and Command Line Options section for a
list all of the available options.
B.8 Conguration and Command Line Options
PDFGetX3 is very exible in allowing the user to customize how he or she want the program
to run. Tables B.1, B.2, B.3, and B.4 show the options that are available in the conguration
le and command line, what argument they take, and what they do. Note that the command
line options that are more than a letter long have two dashes (--), while those that are a
letter long have one dash (-).
Notes from the tables:
APPENDIX B. PDFGETX3 DOCUMENTATION 170
Figure B.6: Comparing PDFs of nickel by tuning the Qmax. The reference (blue) has
26 A 1, while the tuned PDF (green) is at around 14 A 1.
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Table B.1: List of parameters that can be dened in the conguration le or at the command
line, the type of argument that they take, and what they do.
Cong File Command
Line





Tells PDFGetX3 the format the data
collected using an X-ray instrument are
in. twotheta means the that intensi-
ties are plotted versus two-theta in de-
grees. Qnm means that the intensities
are plotted versus Q in inverse nanome-
ters. QA means that the intensities are
plotted versus Q in inverse angstroms.
This option is required!
backgroundle --background
or -b






Results to be saved, by default none. iq
is the intensity after background sub-
traction and normalization onto a reg-
ular grid in Q-space; sq is the structure
factor; fq is the reduced structure fac-
tor; and gr is the PDF. Note more than
one argument is accepted.
wavelength --wavelength
or -w
number (A) X-ray wavelength in angstroms (re-
quired)
plot --plot or -p `iq', `sq', `fq',
`gr'
Outputs to be plotted after the process-
ing is complete, none by default
APPENDIX B. PDFGETX3 DOCUMENTATION 172
Table B.2: Continuation of the list of parameters that can be dened in the conguration
le or at the command line, the type of argument that they take, and what they do.
Cong File Command
Line
Argument (1) What it Does
composition --composition Chemical com-
position
Chemical composition of the sample
(2). This option is required!
bgscale --bgscale number Factor by which to scale the back-
ground data, by default 1
qmin --qmin number (1/A) Minimum Q value to use in Fourier
transform in inverse angstroms, by de-
fault 0
qmax --qmax number (1/A) Maximum Q value to use in Fourier
transform in inverse angstroms. Re-
quired!
rmin --rmin number (A) Low limit of r-grid in angstroms, by de-
fault 0
rmax --rmax number (A) Upper limit of r-grid in angstroms, by
default 30
rstep --rstep number (A) r-grid step size in angstroms, by de-
fault 0.01
inputle lename Names of les to be processed, one per
line. Ignored if any inputs are given at
command line
datapath --datapath directory name Directories to search for les in addi-
tion to the current directory
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Table B.3: Continuation of the list of parameters that can be dened in the conguration
le or at the command line, the type of argument that they take, and what they do.
Cong File Command
Line
Argument (1) What it Does
outputdir --directory
or -d
directory name Directory for output les. Current di-
rectory used by default
outputname --outputname
or -o
lename Base name (before extension) for out-






Starts an interactive Python session af-
ter processing data
verbose --verbose `error', `warn-
ing', `info', `de-
bug'






Select the conguration le to use,
rapdfgetx.cfg is used by default
force --force `yes' in cong
le
Overwrite output les, if they exist. By
default PDFGetX3 does not overwrite
les
N/A --help or -h Lists all available command line argu-
ments and what they do
N/A --version or
-V
Displays the program version




Section name Select the active section in the cong
le (4)
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Table B.4: Continuation of the list of parameters that can be dened in the conguration
le or at the command line, the type of argument that they take, and what they do.
Cong File Command
Line







Choose the algorithm that the PDF
calculator uses. By default, the default
mode is used
N/A --pattern see description
in notes (5)
Process arguments in le name as a
pattern (5)
N/A --list List all input les, useful when creating
a pattern
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1. Argument: The argument is what we set the option parameters to. Some parameters
accept one or more of a specic set of arguments. For instance, dataformat can be one
of `twotheta', `Qnm', or `QA'. In other cases, parameters accept strings such as a le
name or numbers. Finally, for some command line options, no argument is necessary.
2. Composition: This is a string containing letters and numbers. Supported formats are
`PbTi0.5Zr0.5O3', `Pb Ti0.5 Zr0.5 O3' or `Pb 1 Ti 0.5 Zr 0.5 O 3'. Space characters
are ignored, unit counts can be omitted, but it is important to use proper case for
atom symbols. Elements can repeat in the formula (e.g., `CH3 CH3'), but parenthesis
are not supported.
3. Interact: The interactive mode lets the user enter an interactive Python session with
the variables from processing the PDF already loaded. Help can be found at the
interactive Python prompt. If you enable the interactive session from the command
line, then no argument is needed. To enable it from the conguration le, you must
make it true as follows: interact = yes.
4. Section: Conguration les can have sections devoted to dierent materials in addition
to the [DEFAULT] section. For example, there could be a [NaCl] section that contains
parameters specic to that material (e.g. wavelength, Qmax, composition, etc).
5. Pattern: The pattern option lets the user process many sets of data sequentially
without having to manually type the name of each data le. Using pattern allows the
user to dene a rule by which PDFGetX3 will process data sets. For instance, if we
have datasets named test 1.chi, test 2.chi, test 3.chi in the same folder, they can all
be processed using the following command line argument:
>> rapdfgetx --pattern "test <1-3>"
The available options for patterns are:
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 ^start match start only at the beginning of the string
 end$ match end only at the end of string
 <7> match number 7 preceded by any number of leading zeros
 <1-34> match an integer range. The matched number may have one or more leading
zeros
 <7-> match an integer greater or equal 7 allowing leading zeros
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